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The Rh(I)-catalyzed allenic carbocyclization reaction is a powerful strategy for the assembly of 
densely functionalized cyclic cross-conjugated trienes.  This methodology exhibits excellent 
functional group compatibility, and allows for the construction of five-, six-, and seven-
membered rings in high yields from allene-yne precursors.  In this thesis, progress towards the 
total synthesis of (–)-fumagillol and (–)-ovalicin is reported.  The entire carbocyclic skeleton of 
both structurally related natural products has been synthesized in a single synthetic 
transformation via an allenic carbocyclization reaction.  It is anticipated that the allylic hydroxyl 
group of the functionalized cross-conjugated can be used for the chemo- and stereoselective 
installation of epoxides and hydroxyl groups incorporated in both sesquiterpenes. 
The constitutional group selectivity of the β-hydride elimination step in the allenic 
carbocyclization reaction has been investigated.  We found that TMS-alkynyl allenes with an 
appending isobutylene group can be reacted under Rh(I)-catalyzed allenic carbocyclization 
reaction conditions to afford regioisomerically pure cross-conjugated trienes in good yields.  The 
examples within, indicate that a coordinating alkene can be incorporated into the allene-yne 
substrate to control the β-hydride elimination step of the cyclization reaction to yield trienes with 
a 1,1-disubstituted alkene side chain.   
The Allenic Carbocyclization Reaction of Allene-ynes: Progress towards the Syntheses 
of Fumagillol and Ovalicin 
Jolie E. DeForrest, Ph.D. 
University of Pittsburgh, 2009
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1.0  THE ALLENIC CARBOCYCLIZATION REACTION OF ALLENE-YNES: 
PROGRESS TOWARDS THE SYNTHESES OF FUMAGILLOL AND OVALICIN  
1.1  INTRODUCTION: THE ALDER-ENE REACTION 
The Alder-ene1, 2 reaction is a powerful and atom-economical process3 that is used for carbon-
carbon bond formation.  This reaction occurs between two carbon-carbon π bonds with one 
carbon-carbon double bond bearing an allylic hydrogen.  During the course of the reaction, the 
allylic hydrogen is transferred to the alkene.  As shown in Scheme 1, one σ bond migrates and 
one σ bond is formed at the expense of one π bond.  The thermal Alder-ene reaction requires 
elevated temperatures (typically 250 - 600°C) and can be accomplished either intra- or 
intermolecularly. 
Z
H Y
X Z Y
X
H  
Scheme 1: Intermolecular Alder-ene Reaction 
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1.2 THE TRANSITION METAL-CATALYZED ENYNE CARBOCYCLIZATION 
REACTION 
The use of transition metals in carbocyclization processes, like the Alder-ene reaction, allows for 
mild reaction conditions, increased efficiency of synthetic transformations, and often higher 
functional group tolerance than their respective thermal processes.  Transition metals are also 
advantageous as they can be designed to meet the requirements of specific carbocyclization 
precursors.4  
One example of a transition metal-catalyzed carbocyclization reaction is the 
cycloisomerization of 1,6-enynes. As seen in Scheme 2, enyne 1 can be reacted with a variety of 
palladium,4, 5 ruthenium,6-8 titanium,9 iron,10 and rhodium11 transition-metal complexes to yield 
cyclic 1,3- and 1,4-dienes.  
1 2 3
+
R2
R1 R
1
R2
R1
R2
 
Scheme 2: Cycloisomerization of Enyne 1 
Three different mechanistic pathways have been proposed for this reaction.  The first 
process (path a, Scheme 3) involves oxidative coupling of the alkene and alkyne moieties of 
enyne 4 to form metallocycle 5, which upon β-hydride elimination and then reductive 
elimination produces 1,3- and 1,4-dienes 6 and 7.  Ruthenium,7 titanium,9 and rhodium11 
catalysts are a few of the transitional-metal complexes that can react with enynes via this 
mechanism. A different pathway (path b), where X = H, halogen, or OAc is favored for 
palladium catalyst systems and has been extenstively studied by Trost and coworkers.12  In this 
 3 
case, the catalyst undergoes addition to the alkyne of enyne 4 to form alkenylmetal species 8.  
The alkene in intermediate 8 can then insert into the carbon-metal bond of the alkenylmetal 
moiety to produce 9, which after β-hydride elimination gives cyclized compounds 10 and 11.  
The less commonly observed mechanistic pathway c can occur when palladium13 and rhodium14 
catalysts are reacted enynes possessing an allylic activated group.  This reaction results in the 
formation of metal π-allyl complex 12, which cyclizes to 1,4-diene 13.14, 15 
R1
R2
M
R2
R1
R2
R1
R1
R2
X
M
R2
R1
X
R2
M X
R2
X
a
b
c
M = transition metal; R1 = H or leaving group; X = H or nucleophile
4
5 6
8
13
10
12
R2
R1
9
M
X
R2
R1
7
+
R2
R1
X
11
+
 
Scheme 3: Proposed Mechanisms for the Carbocyclization of 1,6-Enynes14, 15 
The transition metal-catalyzed carbocyclization reaction of 1,6-enynes has been 
successfully applied to natural product synthesis.  For example, Trost and coworkers used a 
palladium-catalyzed carbocyclization reaction as a key transformation for the construction of the 
cyclohexyl framework of (+)-cassiol (Scheme 4).16  Alkynone 14, when reacted with 
Pd2(dba)3·CHCl3 and formic acid in 1,2-dichloroethane (DCE) at room temperature, produced 
cyclohexenone 15 in 83% yield as a 3 : 1 mixture of diastereomers at C1.  The “ligandless” 
 4 
palladium catalyst allows for bidentate coordination of the enyne 14, which is required for the 
cycloisomerization process.  This synthesis also illustrates the benefit of a transition metal-
catalyzed process over a thermal one; for example, heating 14 to 500 °C only produces a trace 
amount of product.  
O
TMS
OTBDMS
OTBDMS
TBDMSO
HCO2H, DCE, 
rt, 83%
O TMS
OTBDMS
OTBDMS
TBDMSO
O
OH
OH
HO
(+)-Cassiol14 15
Pd2(dba)3•CHCl3
1
 
Scheme 4: Palladium-Catalyzed Enyne Carbocyclization of Enyne 14, A Synthesis of (+)-Cassiol16 
 Additionally, Trost and Krische employed a palladium-catalyzed enyne carbocyclization 
reaction in the synthesis of picrotoxinin and the structurally related compounds picrotin, 
corianin, and methyl picrotoxate (Scheme 5).4  Trost obtained bicyclic carbocycle 17 in 70% 
yield from enyne 16 using palladium(II)acetate, 2-(diphenylphosphino)benzoic acid (dpba) and 
1,3-bis(dibenzophospholyl)propane (dbpp) in refluxing DCE.  An extensive survey of reaction 
conditions showed that combining dbpp, a ligand capable of internal proton delivery, with the 
small Lewis acidic ligand dpba would produce an optimal ligand system for this particular 
carbocyclization reaction.  Trost’s design and development of the unique palladium catalyst 
employed for the cycloisomerization of enyne 16 exemplifies the advantage of using tunable 
transition metals catalysts for carbobocyclization processes.  
O
TBSO
Br
OTBS
CH3
O Br
OTBS
CH3
TBSO
OH
O
O
O
O
Pd(OAc)2, dpba
dbpp, DCE, reflux
70%
O
Picrotoxinin16 17  
Scheme 5: Palladium-Catalyzed Carbocyclization Reaction of Enyne 16, A Synthesis of Picrotoxinin4 
 5 
Zhang and coworkers have effectively applied a rhodium-catalyzed carbocyclization 
reaction to a formal synthesis of (+)-pilocarpine (Scheme 6).17  Reacting enyne 18 with 
[Rh(COD)2Cl]2, (R)-BINAP, and AgSbF6 resulted in the formation of α-alkylidene-γ-
butyrolactone (R)-19 in 99% yield and 99% ee, a structure that allowed Zhang to intersect 
Büchi’s synthesis of (+)-pilocarpine.  Butyrolactone (R)-19 was assembled in 91% overall yield 
and 99% ee in two steps from commercially available 2-butynoic acid and (Z)-2-buten-1,4-diol, 
demonstrating the utility of the transition-metal catalyzed carbocyclization reaction in natural 
product synthesis.  
Alternatively, Büchi constructed (R)-19 with the desired stereochemistry at C1 through a 
five step synthesis featuring an asymmetric reduction reaction and subsequent Claisen 
rearrangement of the resulting chiral allylic alcohol.18  This approach, however, produced α-
alkylidene-γ-butyrolactone (R)-19 in only 20% overall yield and 92% ee. 
1
O O
OH
[Rh(COD)Cl]2
R-BINAP
AgSbF6, DCE, rt
99%, >99% ee OO
O
H
OO
N
N
(+)-pilocarpine18 19  
Scheme 6: Rhodium-Catalyzed Carbocyclization of Enyne 18, A Synthesis of (+)-Pilocarpine 
1.3 THE RHODIUM-CATALYZED ALLENIC CARBOCYCLIZATION REACTION: 
THE CONSTRUCTION OF CYCLIC CROSS-CONJUGATED TRIENES  
The Brummond group has been interested in the design and development of the Rh(I)-catalyzed 
allenic carbocyclization reaction, which effectively uses an allene in place of the alkene 
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component to access cyclic cross-conjugated trienes.19  An example of the allenic 
carbocyclization is depicted in Scheme 7. Allene-yne 20 is reacted with 2 mol% of 
[Rh(CO)2Cl]220 to afford carbocyclic triene 21 in 72% yield; producing the E isomer of the 
alkenyl silane exclusively as evidenced by the 4.5% nOe between H1 and H2.  The appending 
alkene, however, is produced as a mixture of E:Z isomers in a 5:1 ratio. 
•
CH2C7H15
TMS
2 mol% [Rh(CO)2Cl]2
toluene, 90 °C, 72%
TMS
C7H15
20 21 E : Z, 5 :1
H1
H2
4.5% nOe
 
Scheme 7: The Allenic Carbocyclization of Allene-yne 2019 
Brummond and coworkers19 have proposed that the mechanism for the Rh(I)-catalyzed 
allenic carbocyclization reaction involves oxidative coupling of the rhodium catalyst to the 
alkyne and external double bond of the allene in allene-yne 22 to produce metallocycle 24 
(Scheme 8).  Metallocycle 24 then undergoes β-deuteride elimination giving intermediate 25 
followed by reductive elimination of the metallo-deuteride to produce cross-conjugated triene 26.  
A deuterium-labeling study showed that the reaction occurs with complete and stereoselective 
transfer of a deuterium to the exocyclic alkene, supporting the postulated mechanism. 
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Scheme 8: Proposed Mechanism for the Rh(I)-Catalyzed Allenic Carbocyclization Reaction19 
The Rh(I)-catalyzed allenic carbocyclization reaction developed in the Brummond group 
has proven to be a powerful strategy for the assembly of structurally interesting cross-conjugated 
trienes.  As seen in Scheme 9, this methodology is well-suited for the formation of five-, six-, 
and seven-membered rings in yields of 65-95%.21-24  This rhodium(I)-catalyzed transformation 
also exhibits excellent functional group compatibility.  For example, free hydroxyl groups are 
tolerated during the course of the reaction as evidenced by the formation of trienes 30 and 31 in 
good yield.21  Other functional groups such as benzamide,22 oxazolidinone,23 and amide24 groups 
are also tolerated as illustrated by formation of trienes 27-29, and 35-36 in excellent yields.  
Additionally, piperdine and pyran derived cross-conjugated trienes such as 32 and 33 can be 
accessed from allene-yne precursors in high yields of 85% and 74% respectively.19  
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Scheme 9: Cross-Conjugated Trienes Constructed via an Allenic Carbocyclization Reaction 
1.4 CROSS-CONJUGATED TRIENES IN LIBRARY DEVELOPMENT AND 
NATURAL PRODUCT SYNTHESIS 
Cross-conjugated trienes are an exciting class of compounds because of their potential for rapid 
increases in molecular complexity.  For example, cross-conjugated trienes have been extensively 
employed as Diels-Alder substrates to access fused polycyclic ring systems.21, 25-28  In 2006, 
Brummond and coworkers designed imino-oxazolidinone fused trienes of type 37 for the 
construction of novel heterocyclic scaffolds.29  As seen in Scheme 10, cross-conjugated triene 37 
undergoes a stereoselective intermolecular Diels-Alder reaction with N-phenylmaleimide (38) to 
give monocycloadduct 39 in 73% yield as a single diastereomer. This cycloaddition reaction 
occurs from the less sterically hindered face of triene 37, opposite of the angular methyl group, 
and with endo selectivity.  The triene was designed so that the presence of the electron 
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withdrawing carbonyl functionality prevents a second Diels-Alder reaction with N-
phenylmaleimide from occurring, thus maximizing the diversity potential of this scaffold. 
Diene 39 was subsequently transformed into polycyclic compound 41 in 71% yield as an 
8 : 1 mixture of diastereomers when reacted with diethyl fumarate (40) at 90 °C.  Alternatively, 
the enone moiety of 39 can undergo a hetero-Diels-Alder reaction with ethyl vinyl ether (42) in 
the presence of Eu(fod)3 to afford pyran 43 in 95% yield as a single diastereomer.  This 
methodology cleverly demonstrates the utility of the cross-conjugated triene moiety for the 
formation of unique heterocyclic structures via diastereo- and chemoselective cycloaddition 
reactions, and was used in the synthesis of a library of compounds by the UPCMLD.30  
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Scheme 10: Cycloaddition Reactions of Amino-Acid Derived Cross-Conjugated Triene 3729 
More recently, Brummond and coworkers have shown that hydroazulenones such as 46 
can be synthesized from five-membered cross-conjugated trienones (Scheme 11).31  Using 
reaction conditions developed by Davies,32 triene 44 was reacted with E-diethyl-4-diazo-2-
pentenedioate (47) and rhodium(II) acetate to yield hydroazulenone 46 as a single diastereomer 
in 47% yield.  This formal [3 + 4] cycloaddition proceeds through the selective cyclopropanation 
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of the vinyl group in 44 by the rhodium-stabilized vinylcarbenoid to produce cis-
divinylcyclopropane 45.  This strained intermediate then undergoes a Cope rearrangement to 
afford the seven-membered ring of bicyclo[5.3.0]decadienone 46.  The small amount of trans-
divinylcyclopropane formed during the reaction is recovered (not shown). 
The skeletal diversity of these small molecules was further expanded by reacting cis-
diene 46 with 4-methyl-1,2,4-triazoline-3,5-dione (48) to produce the Diels-Alder adduct 49 in 
high yield.  This methodology has allowed the synthesis of 44 hydroazulenoisoindoles 
resembling 49, two of these compounds were found to inhibit nuclear accumulation of GFP-GR 
at low micromolar concentrations as tested by Day and Johnston.31  The selective chemical 
transformations of the double bonds in trieneones similar to 44 has provided access to natural-
product like hydroazulenoisoindoles and illustrates the synthetic potential of the cross-
conjugated triene scaffold.  
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Scheme 11: A Tandem Cyclopropanation/Cope Rearrangement of Trieneone 4431 
Shair and coworkers have synthesized the potent angiogenesis inhibitor (+)-cortistatin A 
(58) from a cyclic cross-conjugated triene precursor (Scheme 12).33  This enantioselective 
synthesis of 58 began by converting enantiomerically pure Hajos-Parrish ketone34 into tricyclic 
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intermediate 50 via a twelve-step reaction sequence (not shown).  With diene 50 in hand, a regio- 
and diastereoselective cyclopropantion reaction with dibromocarbene was performed to access 
cyclopropane 51. A subsequent silicate-directed ring expansion reaction with 
tris(dimethylamino)sulfonium difluorotrimethylsilicate was then used to access vinyl bromide 52 
(66% yield for two steps).   
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Scheme 12: Synthesis of (+)-Cortistatin A from Cross-Conjugated Triene 5433 
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The key intermediate 54 was obtained in 84% yield through a palladium-catalyzed 
coupling reaction between vinyl bromide 52 and the vinyl boronic ester 53. Chemoselective 
dihydroxylation of the disubstituted alkene in cross-conjugated triene 54 was used to construct 
the allylic diol moiety of cortistatin A, via Sharpless’ asymmetric dihydroxylation protocol.  The 
resulting diol was then subjected to a three-step reaction sequence involving aceylation of the 
diol and deprotection/oxidation of the primary alcohol to give aldehyde 55. 
Reacting 55 with dimethyl amine and zinc dibromide (ZnBr2) resulted in a tandem aza-
Prins cyclization and transannular etherification reaction (Scheme 12).  The MEM protecting 
group was removed in situ to yield the polycyclic compound 57 in 65% yield over three steps.  
The C-3 stereocenter was produced in >95% diastereoselectivity during the aza-Prins cyclization 
and is attributed to the coplanar geometry of Ha and the internal N-methyl group of iminum ion 
56.  This preferred geometry minimizes A(1,3) strain and prevents nucleophilic addition from the 
Re face.  Shair and coworkers were able to transform amine 57 into (+)-cortistatin A in six steps. 
The synthetic utility of the cross-conjugated triene moiety is clearly demonstrated by 
Shair’s elegant synthesis of (+)-cortistatin A.  For example, selective functionalization of the 
unsaturated system in cross-conjugated triene 54 provided access to the diol moiety of 58, and 
set the stage for the key tandem aza-Prins/transannular cyclization reaction.  
1.5 BIOLOGICAL ACTIVTY OF FUMAGILLOL, OVALICIN, AND RELATED 
SESQUITERPENES 
As evidenced by the examples in the previous section, the functionally compact nature of the 
cross-conjugated triene makes it an attractive building block for the construction of biologically 
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active compounds and natural products.  We envision that fumagillol (60), ovalicin (61), and 
structurally related cyclic sesquiterpenes can be synthesized from a cross-conjugated triene 
precursor (Figure 1).   
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Figure 1: Fumagillin and Related Spiroepoxides 
In 1949, fumagillin (59) was isolated from the microbial organism Aspergillus fumigatus 
(Figure 1).35, 36 Through chemical degradation and X-ray crystallographic analysis, the structure 
and stereochemical configuration of fumagillin and fumagillol were established.37-39  Originally, 
fumagillin was classified solely as an anti-microbial agent since it possessed antibiotic activity 
against Staphylococcus aureus.35  In 1990, Folkman and coworkers discovered that fumagillin 
also showed in vivo inhibition of angiogenesis, the generation of new blood vessels.40  
Angiogenesis is believed to be important for tumor growth, and synthetic inhibitors of 
angiogenesis such as TNP-47041, 42 (63) and CDK-73143 (64) have been developed as potential 
anti-cancer drugs.  Currently, fumagillin and TNP-470 are some of the only drug treatments for 
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micosporidiosis, a disease caused by microscopic parasitic infection that is often seen in HIV-
positive patients.44-46 
In 1968, Sigg and Weber isolated ovalicin (61, Figure 1) from culture filtrates of the 
fungus Pseudeurotium ovalis Stolk.47  This sesquiterpene alkaloid was found to be more potent 
than fumagillin (59), exhibiting the same activity as TNP-470 (63).  However, unlike fumagillin 
and TNP-470, ovalicin has been found to be stable at room temperature for at least two years.48  
Fumagillin, ovalicin, and other structurally related spiroepoxides selectively target 
methinone aminopeptidase 2 (MetAP-2) but are not inhibitors of the closely related enzyme 
methinone aminopeptidase 1 (MetAP-1).49, 50  These metalloproteases have been shown to co-
translationally remove the N-terminal methionine residue in specific protein targets;49, 51 
however, the complex relationship between inhibition of MetAP-2 and the medical utility of 
fumagillin remains unclear.52-54  
The mechanism of inhibition by this class of sesquiterpenes has been shown to be related 
to its spiroepoxide functionality;49, 55 removal of this functionality results in a 1000-fold decrease 
in MetAP-2 inhibition50 (Scheme 13).  Removal of the side chain epoxide, however, has been 
shown to have little effect on activity.50   One proposed mechanism of action suggests that 
His231 in the MetAP-2 binding site acts as a nucleophile to open the protonated spiroepoxide 
(66), which produces a covalent bond between the histidine residue and the methylene of the 
spiroepoxide (67).56  It has been found that fumagillin-binding affinity increases at low pH,57 
further supporting the presence of the protonated spiroepoxide in the mechanism of action. 
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Scheme  13: One Model for MetAP-Inhibition57 
1.6 SYNTHETIC STRATEGIES TO FUMAGILLOL AND OVALICIN 
1.6.1 Previous Syntheses of Fumagillol 
Fumagillol’s selective inhibition of angiogenesis in tumor cells has made it an attractive target 
for total synthesis.  There are two main synthetic strategies employed for the construction of 
fumagillol.  One strategy involves the formation of the cyclohexyl framework with the side chain 
already intact (colored in blue, Scheme 14).  Corey and Snider took advantage of this approach 
with their elegant synthesis of (±)-fumagillol by employing a regioselective Diels-Alder 
cycloaddition between α-bromoacrolein and the functionalized triene 68.58  This transformation 
allowed for the construction of the complete carbocyclic framework of fumagillol in a single step 
(Scheme 14).  
Kim and coworkers59 also assembled the carbocyclic skeleton of (–)-fumagillol in a 
single synthetic transformation.  As seen in Scheme 14, intermediate 69 is synthesized via a 
glycolate Claisen rearrangement and then subjected to an intramolecular ester enolate alkylation 
reaction. It is worth noting that the alkylation reaction afforded the desired 
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cyclohexancarboxylate in an 11 : 1 diastereoselectivity, which was attributed to the “H-eclipsed” 
transition state geometry of 69.  
More recently in 2001 and 2004, Eustache60 and Langlois61 both employed a ring closing 
metathesis reaction to construct the principal framework of (–)-fumagillol.  Interestingly, 
Grubbs’ first generation catalyst was found to be effective for this key cyclization reaction for 
both syntheses. 
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Scheme 14: Previous Syntheses of Fumagillol 
Another synthetic strategy involves the formation of a functionalized cyclohexane 
followed by addition of the side chain in a separate step (shown in orange).  This approach was 
first employed by Sorensen and coworkers, who synthesized (±)-fumagillol by performing a 1,4-
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addition of organocuprate reagent 71 onto the electron-deficient olefin in (±)-enal 70 in the 
presence of BF3·OEt3 (Scheme 14).62  This addition occurred with high regio- and 
diastereoselectivity, giving a 3 : 1 mixture of the desired : undesired aldehyde 78 (Scheme 15).  
Four years later, in 2003, Sorensen published the enantioselective synthesis of fumagillol by 
using (–)-enal 79.63  Sorensen’s enantioselective synthesis has subsequently been intersected by 
Simpkins,64 Langlois,61 Mootoo,65 and Hayashi.66 
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Scheme 15: Sorensen's Route to Fumagillol 
Taber’s synthesis of (–)-fumagillol used a unique C-H insertion process to construct 
cyclopentene 72 with retention of configuration from alkene 80 (Scheme 16).67  Cyclopentene 72 
was then converted to cyclohexenone 81 through a ring expansion process using ozonolysis 
followed by an aldol condensation. Vinyl stannane 82 was reacted with n-BuLi and 
copper(I)cyanide to produce a cuprate that was added to enone 81  via 1,4-addition.  This copper-
mediated reaction produced the anti addition product in a 96 : 4 diastereomeric ratio. 
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Scheme 16: Taber's Synthetic Strategy to (–)-Fumagillol 
In 2005, Mootoo and coworkers used a highly stereoselective oxocarbenium ion-alkene 
cyclization as the key transformation for their formal synthesis of fumagillin.65  As seen in 
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Scheme 17, alkene 76 was transformed into cyclohexane 83 upon reaction with methyl triflate 
(MeOTf) and 4-methyl-2,6-di-tert-butylpyridine (DTBMP).  Ozonolysis of 83 produced methyl 
ketone 84, which was then reacted with benzothiazole sulfone 85 and LiHMDS to give the 
corresponding trisubstituted alkene as a 1:6 mixture of E/Z isomers.  The desired E-isomer was 
obtained via Vedejs’ two-step isomerization procedure68 and was subsequently converted into 
intermediate 86, constituting a formal synthesis. 
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Scheme 17: Mootoo's Oxocarbenium Ion Cyclization of 76, A Formal Synthesis of Fumagillin 
Most recently, Hayashi and coworkers have completed enantioselective total syntheses of 
(–)-fumagillol and other members of the fumagillin family from the common intermediate 88 
(Scheme 18).66 Their route begins by transforming ketal 87 into bis(trimethylsilyl ether) 
cyclohexane 88 via a four-step reaction sequence featuring a proline-mediated asymmetric α-
aminoxylation and cyanation of the resulting hydroxy ketone with TMSCN and Et3N.  Aldehyde 
88 ws converted into enone 77, which was subjected to a diastereoselective Michael addition 
with a vinyl zincate reagent prepared from (E)-2-bromo-6-methylhepta-2,5-diene, t-BuLi, and 
Me2Zn.  The conjugate addition product was converted into (–)-fumagillol in six steps. 
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Scheme 18: Hayashi's Route to (–)-Fumagillol 
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1.6.2 Previous Syntheses of Ovalicin 
Like fumagillol, ovalicin’s potent biological activity has made it a popular target for 
natural product synthesis (Scheme 19).  E. J. Corey and coworkers published both racemic and 
enantioselective synthetic routes to ovalicin in 198569 and 199448 respectively.  Corey’s racemic 
synthesis involved the stereoselective addition of vinyllithium reagent 90 to epoxy enone 89 to 
produce the desired tertiary alcohol in 83% yield.  The enantioselective synthesis involved an 
OsO4-biscinchona alkaloid catalyzed dihydroxylation to produce enantiopure epoxy enone 89, 
which was then converted to ovalicin using the previously developed protocol.  
In 1994, Bath and coworkers synthesized (–)-ovalicin in three steps from functionalized 
epoxy ketone 91 (Scheme 19).  Intermediate 91, in turn, was obtained from commercially 
available L-quebrachitol, which already contains the C-2 methoxy group present in ovalicin.  The 
side chain of ovalicin was then installed by reacting vinyllithium 90 with the ketone moiety of 
91.70 
To date, Bath’s synthesis of ovalicin has been intersected at epoxy ketone 91 by Barco,71 
Takahashi,72 Mulzer,73 Yadav,74 and Hua.75  Ketone 91, however, has been accessed from a 
variety of naturally occurring chiral materials such as (–)-quinic acid (92), D-mannose (93), and 
D-ribose (96) by Barco, Takahashi, and Yadav, respectively.  
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Scheme 19: Previous Syntheses of Ovalicin 
Similar to his fumagillol synthesis, Hayashi has also synthesized ovalicin from 
bis(trimethylsilyl ether) cyclohexane 88.66  As seen in Scheme 20, 88 is transformed into epoxy 
alcohol 98 via reduction of the aldehyde, mesylation of the resulting alcohol, and elimination to 
give the desired epoxide moiety at C6. Oxidation of 98 with Dess-Martin periodinane gives the 
analogous ketone, which is then treated with acid and TBSCl to yield cyclohexenone 94.  
Reacting enone 94 with vinyllithium reagent 90 allows for installation of the side chain in 91% 
yield.  The addition product was transformed into ovalicin in five steps.  
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Scheme 20: Hayashi's Route to Ovalicin 
 Mulzer and coworkers73 employed an enantioselective Diels-Alder reaction between 
Trost diene 9576 and α-bromoacrolein in the presence of BF3·OEt3 for their synthesis of  (–)-
ovalicin (Scheme 19).  This cycloaddition reaction occurred with endo selectivity and produced 
the Diels-Alder adduct in 75% yield as an 8:1 mixture of diastereomers.  
 Most recently in 2008, Hua and coworkers utilized an intramolecular Heck reaction of 
alkenyl iodide 97 for the construction of the cylohexyl framework of ovalicin (Scheme 19).75  
The 4-methylenecyclohexene product was then converted into epoxy ketone 91, which can be 
transformed into ovalicin via known protocol.  
1.6.3 Brummond and Coworkers’ Previous Approach to Ovalicin 
Brummond and coworkers’ novel approach towards ovalicin employed an allenic 
carbocyclization reaction for the construction of the carbocyclic skeleton with the side chain 
already intact.  This strategy is advantageous as selective oxidation reactions of the cross-
conjugated triene system will produce the oxygenated framework of ovalicin. 
  Work done in our group by Jamie McCabe showed that cross-conjugated trienes 100 and 
101 could be obtained in a 90:10 isomeric ratio from allene-yne 99 in 95% yield (Scheme 21).  
The appending trisubstituted double bond of triene 100 was formed as a 2:1 mixture of E:Z 
isomers.77  
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Scheme 21: Rh(I)-catalyzed Carbocyclization of Allene-yne 9977 
With cross-conjugated trienes E-100/Z-100/101 in hand, the silyl protecting groups were 
removed with TBAF to give diols E/Z-102 and 103, which were separable via column 
chromatography (Scheme 22).  The primary alcohol of E-102 was then selectively protected with 
TBSCl and Et3N to give silyl ether 104 in 75% yield.  Subsequent alcohol-directed 
dihydroxylation of triene 104 with TMEDA and OsO4 (1 equiv) resulted in the formation of 
osmate esters 105 and 106 in 90% yield as a 6:1 isomeric mixture.  A small discrepancy found in 
the 1H NMR of 105, however, prevents conclusive evidence as to whether the desired osmate 
ester was obtained.77 
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Scheme 22: Synthesis and Oxidation of Triene 10477 
The high yield and functional group compatibility of the Rh(I)-catalyzed allenic 
carbocyclization reaction is illustrated by the cyclization of allene-yne 99.  Moreover, the 
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densely functionalized carbocyclic skeleton of E-104 demonstrates the utility of the cross-
conjugated scaffold in natural product synthesis. 
1.6.4 Retrosynthetic Analysis: Brummond / DeForrest Approach to Fumagillol / Ovalicin 
via an Allenic Carbocyclization Reaction  
Retrosynthetically, we envision that fumagillol can be obtained from diol 107a and ovalicin from 
triol 107b (Scheme 23).  We plan to construct the skipped diene side chain of intermediates 107a 
and 107b from the primary allylic alcohol of 108a and 108b via an oxidation and homologation 
reaction sequence.67  In turn, 108a and 108b will be prepared via diverging transformations 
involving selective oxidations of cross-conjugated triene 109.  More specifically, we plan to use 
the hydroxyl group of triene 109 as a chemoselective control element for the sequential 
introduction of epoxides and hydroxyl groups embedded in these natural products.  A cross-
metathesis reaction will be used to convert the 1,1-disubstituted alkene of triene 109 into the 
trisubstituted alkene of 108a/b.  Cross-conjugated triene 109 can be accessed from allene-yne 
110 via the Rh(I)-catalyzed allenic carbocyclization reaction previously developed in our 
laboratory.19  Considering the isomeric mixtures of trienes previously reported by McCabe,77 
allene-yne 110 was chosen for our syntheses as the two sites available for β-hydride elimination 
are identical and will only produce cross-conjugated triene 109.  
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Scheme 23: Retrosynthetic Analysis of Fumagillol and Ovalicin from Allenyne 110 
1.7 RESULTS AND DISCUSSION: SYNTHESIS AND FUNCTIONALIZATION OF A 
CROSS-CONJUGATED TRIENE PRECURSOR FOR THE SYNTHESES OF 
FUMAGILLOL AND OVALICIN 
1.7.1 Synthesis of Cross-conjugated Triene 109  
Allene-yne 110 can be prepared in two steps from known propargyl tetrahydropyranyl ether 
11178 and aldehyde 11279 (Scheme 24).  Employing Brandsma’s80 procedure for the construction 
of propargyl alcohols, the alkyne terminus of 111 was first deprotonated with n-BuLi  at –50 °C, 
and then reacted with aldehyde 112 (Conditions A).  Warming the reaction to –20 °C gave 
propargyl alcohol 113 in 78% yield.  The formation of propargyl alcohol 113 is supported by the 
IR spectrum, which has the characteristic alcohol and alkyne absorbances at 3396 cm-1 and 2167 
cm-1, respectively.81 
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With propargyl alcohol 113 in hand, we investigated the aluminum-mediated reduction 
protocol developed by Landor and coworkers for the formation of allene-yne 110 (Scheme 24).82  
Reacting propargyl alcohol 113 with LAH in refluxing diethyl ether produced allene-yne 110 in 
81% yield.  Interestingly, decreasing the reaction temperature (–20 to 0 °C) gave a separable 
mixture of the corresponding allylic tetrahydropyranyl ether (22%) and the desired allene-yne 
110 (21%).   
+
O
TMSH
THPO
Conditions A: n-BuLi, ether, -50 to -20 °C, 78%
112111
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reflux
Conditions A:       113, 78% 
Conditions B: (R)-113, 73%
      110, 81%
(R)-110, 45%
TMS
THPO
•
HO
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                       Et3N, toluene, 73%
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Scheme 24: Synthesis of Racemic and Enantioselective Allene-yne 110 and (R)-110 
The formation of allene-yne 110 is evidenced by a resonance at 5.12-5.06 ppm (m) in the 
1H NMR, corresponding to the allene proton, and a resonance at 199.8 ppm in the 13C NMR, 
corresponding to the sp hybridized carbon of the allene.81 
Allene-yne (R)-110 has also been prepared in high enantioselectivity from terminal 
alkyne 111 and aldehyde 112 utilizing enantioselective alkynylation protocol developed by 
Carreira and coworkers (Scheme 24).83  The formation of propargyl alcohol (R)-113 was 
accomplished in 73% yield by adding aldehyde 112 (1 equiv) to an excess of alkyne 111 (3.1 
equiv), triethylamine (3.1 eq), (+)-N-methylephedrine (3.1 equiv), and zinc triflate (3 equiv) over 
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4 h via syringe pump addition (Conditions B).  The 1H NMR and 13C NMR of propargyl alcohol 
(R)-113 are in agreement with the spectral data obtained for 113. 
Reacting propargyl alcohol (R)-113 with LAH in refluxing ether gave chiral non-racemic 
allene-yne (R)-110 in 45% yield (Scheme 24).  The low yield obtained for (R)-110 is likely due 
to the small scale on which the reduction reaction was performed.  For example, reacting 1.1 
mmol of propargyl alcohol (R)-113 with LAH gave allene-yne (R)-110 in 45% yield, whereas 
subjecting 9.0 mmol of propargyl alcohol 113 to the same reaction conditions gave allene-yne 
110 in an increased 81% yield.  The spectral data obtained for (R)-110 matches that obtained for 
110.  
Mosher esters 114 and (R)-114 were synthesized from the analogous allenic alcohol 
precursors to determine the enantiomeric excess of (R)-110.  As seen in Scheme 25, subjecting 
allene-ynes 110 and (R)-110 to esterification reaction conditions with  (R)-(+)-alpha-methoxy-
alpha-(trifluromethyl)-phenylacetic acid, N,N’-dicyclohexylcarbodiimide (DCC), and 4-
dimethylaminopyridine (DMAP) resulted in the desired esters 114 and (R)-114 in crude yields of 
82% and 85%, respectively.  
110
•
HO
TMS
DCC, DMAP
O
OH
Ph
F3C
MeO
CH2Cl2
(R)-110
•
O
TMS
O
Ph
MeO
F3C
      114, 82 % crude yield
(R)-114, 84 % crude yield  
Scheme 25: Formation of Mosher Esters 114 and (R)-114 
The 19F NMR of racemic allene-yne 114 shows two resonances with equal integrations at 
-72.1 ppm and -72.2 ppm, indicating that 114 is a 1:1 mixture of two diastereomers (Figure 2).  
The 19F NMR of (R)-114 shows the same two resonances at -72.1 ppm and -72.2 ppm, however, 
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with integrations of 1F and 28F, respectively.  The integrations in the 19F NMR of (R)-114 show 
that allene-yne (R)-110 was produced in 93% ee.  The absolute configuration of (R)-110 was 
assigned by analogy to Carreira’s substrates, which showed that employing (+)-N-
methylephedrine as the chiral additive for the alkynylation reaction produces the R-enantiomer of 
the propargyl alcohol product.84 
  
Figure 2: 19F NMR of Racemic Allene-yne 114 and Enantioenriched Allene-yne (R)-114 
 
With allene-ynes 110 and (R)-110 in hand, the rhodium-catalyzed allenic 
carbocyclization reaction was employed for the construction of cross-conjugated trienes 109 and 
(R)-109.  Reacting allene-yne 110 with 5 mol% of [Rh(CO)2Cl]2 in 1,4-dioxane at 65 °C resulted 
in cross-conjugated triene 109 in 76%  yield (Scheme 26).  Similarly, subjecting chiral allene-
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yne (R)-110 to the cyclization reaction conditions resulted in cross-conjugated triene (R)-109 in 
75% yield.  The high yield obtained for cross-conjugated trienes 109 and (R)-109 demonstrates 
the synthetic utility of the Rh(I)-catalyzed carbocyclization for natural product synthesis, as (R)-
109 possesses the cyclohexenol scaffold found in ovalicin and fumagillol.  
110
(R)-110
      109, 76 % 
(R)-109, 75 %
•
HO
TMS TMS 5 mol% 
[Rh(CO)2Cl]2
HO
1,4-dioxane, 65 °C
 
Scheme 26: Formation of Racemic and Chiral Cross-conjugated Trienes 109 and (R)-109 
  The formation of cross-conjugated trienes 109 and (R)-109 is clearly evidenced by the 
1H NMR data (Table 1).  For example, the 1H NMR of (R)-109 shows resonances at 5.70 ppm 
and 5.53 ppm that correspond to Ha (d, J = 3.5 Hz) and the vinyl silane proton Hb (singlet), 
respectively. The other resonances in the alkene region at 5.00 ppm (dq, J = 3.0, 1.5 Hz) and 
4.88-4.85 ppm (multiplet) correspond to the appending 1,1-disubstituted alkene protons Hc.  The 
resonance at 4.35 ppm corresponds to Hd (ddd, J = 7.0, 5.0, 3.5 Hz).  The allylic protons He and 
Hf correspond to the resonances at 2.58 ppm and 2.37 ppm, while the neighboring methylene 
protons Hg and Hh correlate to the resonances at 2.04 ppm and 1.71 ppm, respectively. 
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Table 1: 1H NMR of Cross-conjugated Triene (R)-109 (CDCl3, rt, 500 MHz) 
 
 Chemical Shift Spin multiplicity J Values (Hz) 
Ha 5.70 ppm d 3.5 
Hb 5.53 ppm s ----- 
Hc 5.00 ppm dq 3.0, 1.5 
Hc 4.88-4.85 ppm m ----- 
Hd 4.35 ppm ddd 7.0, 5.0, 3.5 
He 2.58 ppm  ddd 14.5, 8.0, 3.5 
Hf 2.37 ppm dddd  14.5, 10.0, 3.5, 1.0 
Hg 2.04 ppm ddt 12.5, 8.0, 4.5 
Hh 1.71 ppm dddd 12.5, 10.5, 7.0, 4.0 
 
Cross-conjugated triene 109 can be synthesized in three steps from alkyne 111 and 
aldehyde 112 in 47% overall yield and can be conducted on multigram scale.  This synthetic 
strategy also offers the possibility for the asymmetric syntheses of (–)-ovalicin and (–)-
fumagillol, becuase Carreira’s enantioselective alkynylation protocol can be utilized for the 
assembly of propargyl alcohol (R)-113. 
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1.7.2 Alcohol-Directed Epoxidation of Triene 109: Formation of a Pivotal Intermediate 
for the Syntheses of Ovalicin and Fumagillol 
With the racemic and enantioselective syntheses of cross-conjugated triene 109 in hand, 
we explored an alcohol-directed epoxidation protocol to selectively functionalize the endocyclic 
alkene of triene 109.  To our delight, we found that reacting triene 109 with 1.5 mol% of vanadyl 
acetyl acetonate85 and tert-butyl hydroperoxide in benzene at 40 °C produced bis-allylic epoxide 
115 in 77% yield as a single diastereomer (Scheme 27).  The formation of 115 is supported by 
the 1H NMR, which shows a resonance at 3.22 ppm (d, J = 2.0 Hz) corresponding to Ha, and the 
absence of the resonance at 5.70 ppm (d, J = 3.5 Hz) corresponding to the endocyclic alkene 
proton of 109.  
HO
109
OHO
115, 77%
benzene, 40 °C
VO(acac)2 (1.5 mol%)
t-BuOOH,
TMSTMS
Ha
116, trace
O
TMS
Hb
+
 
Scheme 27: Formation of Epoxide 115 from Triene 109 
  Interestingly, applying the VO(acac)2/TBHP epoxidation protocol to triene 109 at –15 to 
25 °C only resulted in the corresponding enone in 8% yield.  The low yield obtained could be 
due to the volatility of 116.  The formation of 116 is evidenced by the 1H NMR, which no longer 
shows the resonance at 4.35 ppm corresponding to Hb. Vanadium-catalyzed enone formation has 
also been observed by Teranishi and coworkers during their vanadium-catalyzed epoxidation 
studies of cyclic allylic alcohols.86  
 The vanadium-catalyzed epoxidation conditions used for the construction of epoxide 115 
from triene 109 were found to be superior to the other methods explored.85  For example, 
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treatment of triene 109 with Ti(OiPr)4, DIPT, and tert-butyl hydrogen peroxide in the presence of 
4 Ǻ molecular sieves87 only resulted in the recovery of starting material.  Additionally, 
subjecting 109 to buffered peracid epoxidation reaction conditions with m-CPBA and Na2HPO4 
gave a mixture of compounds that were inseparable via column chromatography. 
1.7.2.1 Diverging Palladium-Catalyzed Transformations of Epoxide 115 
 
Next, diverging palladium-catalyzed transformations of epoxide 115 were investigated to access 
the oxygenated cyclohexyl core of ovalicin and fumagillol (Scheme 28).  It is envisioned that 
allylic epoxide 115 can be transformed into diol 117 via a palladium-catalyzed hydrogenolysis 
reaction and into carbonate 118 through a palladium-catalyzed CO2 insertion reaction.  These 
diverging transformations will allow for the assembly of both structurally related natural 
products from a single intermediate. 
OHHO
117
118
O
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HO
O
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 fumagillol (60)
O HO
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Scheme 28: Projected Diverging Transformations of Epoxide 115 to the Oxygenated Rings of 60 and 61 
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1.7.2.2 Palladium-Catalyzed Hydrogenolysis of Epoxide 115: Synthesis of Diol 117a/b 
 
Construction of the cis-diol moiety of fumagillol began with palladium-catalyzed hydrogenolysis 
protocol developed by Tsuji and coworkers.88  Reacting epoxide 115 with Pd2(dba)3·CHCl3, tri-
n-butylphosphine, formic acid, and triethylamine in 1,4-dioxane at 40 °C gave a separable (1:1) 
mixture of diols 117a and 117b in a 62% combined yield (Scheme 29).  The diastereomeric ratio 
was established by integrating the resonances corresponding to the vinyl silane proton of 117a/b 
at 5.33 ppm and 5.18 ppm in the crude 1H NMR.  
Pd2(dba)3·CHCl3
n-Bu3P, formic acid, NEt3
1,4 -dioxane, 40 °C, 62%
HOHO
TMSTMS
OHO
115 117a
HOHO
TMS
117b
+
dr = 1:1
 
Scheme 29: Formation of Diols 117a/b from Epoxide 115 
Molecular modeling*
                                                 
*modeling study conducted using Cache worksystem Pro Version 6.1.12.33, AM1 energy minimization 
 
 
 predicts that the desired diol 117a exists in a conformation where 
one of the hydroxyl groups and the appending alkene are in an equatorial orientation, and the 
other hydroxyl group is in an axial position (Table 2, the silyl methyl groups have been removed 
for clarity).  Calculations predict an axial-axial coupling between Hb and Hc (typically between 
8-10 Hz) and an axial-equatorial coupling (usually 2-3 Hz) between Hb and Ha.  The predicted J 
values are indeed observed; the axial-axial coupling between Hb and Hc is observed to be 9.7 Hz, 
and the axial-equatorial coupling between Hb and Ha is 2.9 Hz. 
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Table 2: 1H NMR Assignment of Diol 117a (500 MHz, CDCl3)  
 
HOHO
TMS
117a  
 Chemical Shift (ppm) Spin multiplicity J values (Hz) 
Ha 4.14-4.12 m ------- 
Hb 3.73 dd 9.7, 2.9 
Hc 3.12 d 9.7 
Hd 2.38 td 13.1,  4.4 
He 2.31 dt 13.5, 4.4 
Hf 1.99 dq 13.4, 4.4 
Hg 1.59-1.49 m ------- 
 
Diastereomer 117b also adopts a chair-like conformation (Table 3, the silyl methyl 
groups have been removed for clarity).  A resonance in the 1H NMR corresponding to Hb appears 
as a dddd, resulting from axial-axial coupling with HI (11.5 Hz), equatorial-equatorial coupling 
with Ha and Hg (2.5 and 4.5 Hz), and coupling with the hydroxyl proton He (9.0 Hz).  A 
resonance at 4.13 ppm corresponding to Ha is a doublet due to coupling with Hh.  Additionally, 
the resonance corresponding to Hc at 2.79 ppm is a broad singlet.  These observed coupling 
constants give some evidence that 117b was obtained.   
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Table 3: 1HNMR Assignment of Diol 117b (500 MHz, CDCl3) 
 
HO OH
TMS
117b  
 Chemical Shift (ppm) Spin multiplicity J values (Hz) 
Ha 4.13 d 8.5 
Hb 3.69 dddd 11.5, 9.0, 4.5, 2.5 
Hc 2.79 bs -------- 
Hd 2.59-2.54 m -------- 
He 2.11 d 9.5 
Hf 2.05-1.96 m -------- 
Hg 2.05-1.96 m -------- 
Hh 1.53 d 8.0 
HI 1.50-1.43 m -------- 
 
The mechanism for the palladium-catalyzed hydrogenolysis reaction begins with 
stereoselective opening of the epoxide ring to produce π-allylpalladium species 119 (Scheme 
30).  Formic acid insertion produces π-allylpalladium formate 120, which decarboxylates to the 
palladium hydride complex 121.  Reductive elimination yields diol 117 with the hydride 
delivered to the more substituted side of the π-allyl complex.88  The mixture of diastereomeric 
diols 117a and 117b produced from bis-allylic epoxide 115 is likely due to inversion of the 
palladium catalyst during the reaction.89 
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Scheme 30: Proposed Mechanism for the Conversion of Epoxide 115 into Diol 117a/b 
 
A molecular modeling study*
                                                 
*modeling study conducted using Cache worksystem Pro Version 6.1.12.33, AM1 energy minimization 
 
 suggests that the 1,1-disubstituted alkene present in bis-
allylic epoxide 115 prefers to reside perpendicular to the alkylidenecyclohexane ring, which 
minimizes unfavorable van der Waals and allylic A(1,3) steric interactions (Figure  3, the silyl 
methyl groups have been removed for clarity).  The energy minimization calculation infers 
optimal orbital overlap between the epoxide and the vinyl silane, suggesting that the π-
allylpalladium species forms at the vinyl silane moiety rather than the 1,1-disubstituted alkene. 
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Figure 3: Minimum Energy Conformation of Epoxide 115 
1.7.2.3 Palladium-Catalyzed CO2-Insertion of Epoxide 115: Formation of Carbonate 118 
 
With a synthetic strategy to access the oxygenated framework of fumagillol from epoxide 115, 
oxidation protocol to access the masked triol moiety of ovalicin was explored.  Subjecting 
epoxide 115 to Trost’s palladium-catalyzed CO2 insertion reaction conditions gave carbonate 
118 in 87% yield as a single diastereomer (Scheme 31).90  The proposed mechanism for the 
formation of carbonate 118 involves an SN2 type metal-mediated epoxide opening to produce π-
allylpalladium complex 119.  The newly generated alkoxide then undergoes nucleophilic 
addition to carbon dioxide, producing intermediate 122, which then cyclizes to yield desired 
carbonate 118 as a single diastereomer. 
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Scheme 31: Formation of Carbonate 118 from Epoxide 115 
The IR spectrum of carbonate 118 has an absorbance at 1814 cm-1, which is characteristic 
for the carbonyl stretch of cyclic carbonates.  Furthermore, the 13C NMR spectrum has the 
resonance at 153.1 ppm that is typically observed for the carbonate carbonyl carbon.81   
The formation of 118 as the cis carbonate is evidenced by the 1H NMR coupling 
constants (shown in Table 4).  Molecular modeling*
                                                 
* modeling study conducted using Cache worksystem Pro Version 6.1.12.33, AM1 energy minimization 
 
 has shown that carbonate 118 adopts a 
conformation where the hydroxyl group resides in the equatorial position.  In this conformation, 
the resonance corresponding to Hb is an apparent triplet of triplet resulting from coupling with 
the hydroxyl proton Hf (10.9 Hz), axial-axial coupling with Hg (10.9 Hz), and axial-equatorial 
coupling with both Ha (4.2 Hz) and Hd (4.2 Hz).   
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Table 4: 1HNMR Assignment of Carbonate 118 (600 MHz, CDCl3) 
 
 
 Chemical Shift (ppm) Spin multiplicity J values (Hz) 
Ha 4.84 d 3.5 
Hb 4.04 tt 10.9, 4.2 
Hc 2.62 dt 14.7, 4.1 
Hd 2.08 dq 12.6, 3 
He 2.04-1.99 m ------- 
Hf 1.96 d 9.9 
Hg 1.68 qd 11.5, 4.2 
 
The trans carbonate, like the cis carbonate, also adopts a conformation where the 
hydroxyl group is in the equatorial position (as shown by molecular modeling*
                                                 
* modeling study conducted using Cache worksystem Pro Version 6.1.12.33, AM1 energy minimization 
 
 in Figure 5).  In 
this configuration, the calculated dihedral angle between Ha and He is 36°, which would result in 
a coupling constant in the range of 5-6 Hz rather than the observed 10.9 Hz coupling constant 
(Table 4). 
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Figure 4: Minimum Energy Conformation of trans-Carbonate 118 
1.8 INVESTIGATING THE REACTIVITY OF THE CROSS-CONJUGATED 
TRIENE MOIETY AND DERIVATIVES TOWARDS CROSS-METATHESIS: 
APPENDING THE ISOBUTYLENE SIDE CHAIN OF OVALICIN AND FUMAGILLOL 
TO THE TRIENE 
With the development of well-defined catalysts such as Schrock’s molybdenum alkylidene 123, 
Grubbs’ ruthenium carbene complexes 124 and 125, and the Hoveyda-Grubbs catalyst 126, 
olefin metathesis has become one of the most powerful and popular transition-metal catalyzed 
methods for carbon-carbon bond formation (Scheme 32).91-94  Ring-closing metathesis (RCM), 
for example, is routinely used to construct small, medium, and large ring systems from acyclic 
dienes.  The intermolecular variant cross-metathesis (CM), has been shown to have more 
limitations, exhibiting poor stereo- and product selectivity.91-95 However, despite these 
limitations, cross-metathesis is extensively employed by the organic community to construct 
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functionalized olefins from simple alkene precursors.91-95   It is our goal to use cross-metathesis 
to convert the 1,1-disubstituted alkene in triene 109 into a trisubstituted alkene that can be 
converted into the side chain of fumagillol and ovalicin (Scheme 28). 
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Scheme 32: Catalysts Commonly used for Olefin Metathesis 
While conjugated systems have been shown to be poor cross-metathesis substrates due to 
the electron deficient nature of the conjugated system and poor regioselectivity of the catalyst,95, 
96 previous work done in our group done by Branko Mitasev97 showed that reacting cross-
conjugated triene 127 with 10 mol% of Grubbs 2nd generation ruthenium carbene 125 produced 
functionalized triene 128 in 72% yield.  The thermodynamically favored E isomer was produced 
exclusively (Scheme 33).  Considering this result, we pursued cross-metathesis for the 
functionalization of the 1,1-disubstituted alkene in triene 109. 
10 mol% 125
SiMe3
CH2Cl2, reflux
 6h, 72%
N
MeO2C
127
Cbz N
MeO2C
128
Cbz
SiMe3
 
Scheme 33: Conversion of Cross-Conjugated Triene 127 to Allyl Silane 128 via Cross-metathesis97 
Generally, 1,1-disubstituted olefins are considered to be troublesome cross-metathesis 
substrates.  However, active catalysts such as 124,91-94 125,98, 99 and 126100, 101 have been 
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successfully used to construct tri- and tetrasubstituted alkenes.  Molecular modeling* of triene 
109 has shown that allylic A(1,3) strain forces the appending 1,1-disubstituted alkene away from 
the cyclohexene ring, making it more accessible for coordination and subsequent reaction with 
the CM catalyst (Figure 5, the silyl methyl groups have been removed for clarity). 
 
Figure 5: Minimum Energy Conformation of Triene 109 
 As seen in Scheme 34, reacting triene 109 with an excess of terminal alkene 129 and 10 
mol% of Grubbs 2nd generation catalyst 125 in refluxing CH2Cl2 for 24 h only resulted in the 
dimerization of 129.  Similarly, reacting acetate 109a with 129 under CM conditions resulted in 
the recovery of 109a and the dimerization of 129.  The recovery of trienes 109 and 109a 
suggested that the electronically deficient nature of the cross-conjugated triene system, and 
sterically congested environment of the 1,1-disubstituted alkene prevented the desired cross-
metathesis reaction from occurring.  
                                                 
* modeling study conducted using Cache worksystem  Pro Version 6.1.12.33, AM1 energy minimization 
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Scheme 34: Attempted Cross-Metathesis Between Triene 109 and Alkene 129 
 The reactivity of carbonate 118 towards cross-metathesis was next investigated (Scheme 
35).  Based on a report102 that the dimer is a better cross-metathesis substrate than the respective 
monomer, we employed homodimer 130 as the cross-metathesis partner in the CM reactions. 
When carbonate 118 was reacted with excess dimer 130 and 5 mol% of ruthenium carbene 125 
in refluxing CH2Cl2, no reaction was observed and 118 was recovered in 38% yield.  Reacting 
the analogous acetate with excess 130 and 10 mol% of 125 in refluxing CH2Cl2, benzene, and 
toluene led to the recovery of 118a in 51%, 45%, and 39% yields, respectively.  Employing the 
more active Hoveyda-Grubbs catalyst for the metathesis reaction between 118a and 130 in 
refluxing CH2Cl2 and benzene again resulted in a 49% and 12% recovery of starting material, 
respectively.   
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Scheme 35: Attempted Metathesis Reaction Between Carbonate Derivatives and Alkene 130 
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1.9 REVISED RETROSYNTHETIC ANALYSIS: INSTALLATION OF THE SIDE 
CHAIN OF OVALICIN THOUGH AN OLEFINATION REACTION 
The recalcitrance of the 1,1-disubstituted alkene of 109, 109a, 118, and 118a to participate in 
cross-metathesis reactions forced a re-evaluation of the synthetic plan to include methyl ketone 
131 in the retrosynthetic analysis of ovalicin (Scheme 36).  For example, the skipped diene side 
chain of advanced intermediate 107b will be constructed from the ketone moiety of 131 through 
an olefination reaction.  In turn, the ketone group in 131 will be constructed from the 1,1-
disubstituted alkene of cross-conjugated triene 109 via a dihydroxylation and oxidative cleavage 
reaction sequence.  Triene 109 can be easily assembled from allene-yne 110 via an allenic 
carbocyclization reaction. 
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Scheme 36: Revised Retrosynthetic Analysis of Ovalicin from Ketone 131 
1.9.1 Synthesis of Epoxy Ketone 131: Construction of the Oxygenated Carbocyclic 
Framework of Ovalicin  
As seen in Scheme 37, carbonate 118 was first converted into silyl ether 132 in 70% yield 
with TESCl and imidazole.  The TES protecting group was chosen as it will allow us to intersect 
Bath’s synthesis70 of ovalicin.  The formation of silyl ether 132 is evidenced by the molecular 
ion peak [M+Na]+ m/z  419 in the high resolution mass spectrum. 
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 Reacting diene 132 with OsO4 and NMO resulted in the selective dihydroxylation of the 
appending alkene to give diol 133 in 70% yield (Scheme 37).  The 1H NMR shows an AB 
quartet corresponding to Ha at resonances 3.75 ppm and 3.41 ppm (J = 11.9 Hz) for the major 
diastereomer and at resonances 3.97 ppm and 3.46 ppm (J = 11.4 Hz) for the minor diastereomer.  
Based upon integration of the resonances at 3.75 ppm and 3.97 ppm, diol 133 was produced as a 
9:1 diastereomeric mixture. 
Oxidative cleavage of the diol moiety in 133 with NaIO4 in a 1:1 mixture of THF:H2O 
produced the corresponding methyl ketone 134 in 69% yield (Scheme 37).  The IR spectrum of 
134 has the absorbance at 1720 cm-1 that is typically observed for the carbonyl stretch of 
ketones.81 
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Scheme 37: Formation of Ketone 134 from Carbonate 118 
Epoxidation protocols for the installation of the spiroepoxide in ovalicin was 
investigated.  Reacting methyl ketone 134 with m-CPBA in the presence of Na2HPO4 resulted in 
the exclusive formation of Baeyer-Villiger product 135 in 62% yield as a single diastereomer 
(entry 1, Table 5).  Similarly, the reaction of 134 with magnesium bis(monoperoxyphthalate) 
hexahydrate (MMPP) gave ketal 135 in 69% yield (entry 2).  Performing the reaction with 
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DMDO gave no reaction and 134 was recovered in 35% yield (entry 3).  Reacting 134 with only 
m-CPBA produced the desired spiroepoxide 131 in 54% yield as a single diastereomer (entry 4).  
Warming the reaction temperature from 25 °C to 40 °C increased the yield of spiroepoxide 131 
to 73% (entry 5).  The epoxidation reaction likely occurred from less sterically hindered top face 
of vinyl silane 145, opposite of silyl ether and carbonate groups, to yield 131 with the 
stereochemistry shown.  
Table 5: Formation of Ketal 135 and Epoxide 131 from Ketone 134 
134
O
O
OTESO
TMS
O
O
OTESO
O
O
O
O
OTESO
O
O
+
131135
TMS TMS
conditions
Ha
O
 
Entry Reagent Temperature (° C) Yield 
1 m-CPBA, Na2HPO4 25 62% of 135 
2 MMPP 25 69% of 135 
3 DMDO 0 to 25 no reaction 
4 m-CPBA 25 53% of 131 
5 m-CPBA 40 73% of 131 
 
 The formation of ketal 135 is supported by the absorbance at 1749 cm-1 in the IR 
spectrum and the ester carbonyl resonance at 169.3 ppm in the 13C NMR.81  Alternatively, the 
ketone moiety of spiroepoxide 131 is evidenced by the absorbance at 1723 cm-1 in the IR and by 
a resonance at 204.5 ppm in the 13C NMR.  The epoxide group of 131 is confirmed by the 
resonance at 2.76 ppm (s, 1H) in 1H NMR corresponding to Ha.81 
The selective formation of ketal 135 from ketone 134 is attributed to the nucleophilic 
peracid anion of m-CPBA/Na2HPO4 and MMPP, which preferentially reacts with the 
electrophilic ketone moiety of 134.  Reacting 134 with only m-CPBA, however, promotes 
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nucleophilic addition of the vinyl silane to the electrophilic epoxidizing agent to afford 
spiroepoxide 131. 
1.9.2 Olefination of Methyl Ketone 131: Installation of the Masked Skipped Diene Side of 
Ovalicin 
With functionalized epoxy methyl ketone 131 in hand, a modified Julia olefination103 reaction 
with benzothiazolyl (BT) sulfone 8565 was examined for the installation of the skipped diene side 
chain (Table 6).  Sulfone 85 has been successfully employed by Mootoo for the installation of 
the side chain in fumagillol.65 
Reacting ketone 131 and BT-sulfone 85 with LiHMDS in THF gave trisubstituted alkene 136 
in 43% yield as a 2:98 mixture of E:Z isomers (entry 1, Table 6).  Employing KHMDS as the 
base produced only the Z-isomer of 136 in 27% yield and was contaminated with impurities that 
were inseparable by column chromatography (entry 2).  
Changing the solvent from THF to DME still mostly produced the Z-isomer of 136 in 44% 
yield (entry 3, Table 6).104  Employing KHMDS as the base resulted in Z-136 in 17% yield; 
using NaHMDS gave E/Z-136 in 48% yield (E:Z = 4:96) (entries 4 and 5). 
Because 1-phenyl-1H-tetrazol-5-yl (PT) sulfones typically yield functionalized alkenes in 
higher E:Z ratios than their BT-sulfone counterparts, BT-sulfone 85 was replaced with the 
analogous PT-sulfone 137.104  However, reacting PT-sulfone 137 and ketone 131 with LiHMDS 
in THF produced 136 in an E:Z ratio of 32:68 in only 5% yield (enrty 6, Table 6).  
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Table 6: Formation of Functionalized Alkene 136 
O
O
OTESO
TMS
O
O
OTESO
TMS
O
O
O
-78 °C
R S
O2
conditions
131 136
S
N
85, R =
NN
N
N
Ph
137, R =
 
Entry Solvent Base Sulfone E : Z  ratioa Yield 
1 THF LiHMDS 85 2 : 98 43% 
2b THF KHMDS 85 0 : 100 27%, 41% brsm 
3 DME LiHMDS 85 5 : 95 44% 
4b DME KHMDS 85 0 : 100 17%, 24% brsm 
5 DME NaHMDS 85 4 : 96 48% 
6 THF LiHMDS 137 32 : 68 5% 
aProduct ratios were determined by integration of alkene protons in the 1H NMR. b Product obtained contained inseparable       
byproducts  
  
The formation of functionalized alkene Z-136 is supported by the 1H NMR (Figure 6).  
For example, the resonance at 5.44 ppm (tq, J = 7.5, 1.5 Hz) corresponds to the alkenyl proton 
Ha, and the resonance at 5.05 ppm (tt, J = 7.0, 1.5 Hz) corresponds to alkenyl proton Hb.  The 
proton Hc (d, J = 3.5 Hz) correlates to the resonance at 4.72 ppm.  
The Z-geometry of the trisubstituted alkene in Z-136 was determined by nOe analysis.  
Irradiation of the resonance corresponding to appending vinyl methyl group at 1.76 ppm resulted 
in a 9% enhancement of the resonance corresponding to Ha.   
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Figure 6: 1H NMR of Skipped Diene 136 (CDCl3, rt, 500 MHz) 
Benzothiazolyl sulfones have been used to construct trisubstituted alkenes in high E:Z 
selectivites.105, 106   However, Mootoo and coworkers65 also largely obtained the Z-alkene from 
the olefination reaction between BT-sulfone 85 and the structurally similar methyl ketone 84 
(Scheme 38).  
+
OR
O
O
O
S
O2
N
S
8584, R = TBDPS
O
O
OH
86
1) LiHMDS, THF, -78 °C 
     87%, E:Z = 1:6
2) n-Bu4NF, THF, quant.
3) VO(acac)2, TBHP, CHCl3
4) Ph2PLi, THF, then MeI
     67% for two steps
 
Scheme 38: Mootoo's Formal Synthesis of Fumagillol from Ketone 84 and BT-Sulfone 85 
A reaction mechanism proposed by Julia and coworkers accounts for the predominate 
formation of Z-136 from ketone 131 and BT-sulfone 85 (Scheme 39).107, 108  First, the metallated 
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sulfone 85 undergoes a reversible nucleophilc addition to ketone 131 giving syn- and anti-β-
alkoxysulfone diastereomers syn-138 and anti-138.  In the preferred chair conformation shown, 
the cation (Li+, K+, or Na+) is chelated by the neighboring heterocyclic nitrogen atom and by one 
of the sulfone oxygen atoms.  Subsequent nucleophilic addition of the alkoxide moiety onto the 
imine-like functionality of the benzothiazole leads to spirocyclic amides syn-139 and anti-139, 
which suffer from steric strain.  However, intermediate anti-139 suffers from a more severe 
eclipsed interaction than syn-139 due to the gauche arrangement of the large cyclohexyl moiety 
(R1) and neighboring alkyl chain.  This unfavorable interaction increases the energy barrier of 
the succeeding Smiles rearrangement and suppresses the formation of E-136.  Spirocycle syn-
139, on the other hand, is able to undergo a facile Smiles rearrangement/elimination reaction that 
results in the preferential formation of Z-136.  
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Scheme 39: Explanation for the Predominate Formation of Z-136 from Ketone 131 and Sulfone 85107, 108 
1.9.3 Investigation of the Julia and Wittig Olefination Reactions for the Installation of the 
Side Chain in Ovalicin 
The Julia olefination reaction was explored for the construction of the side chain in 
ovalicin because of the high E-selectivity observed for the reductive elimination of the β-
hydroxy sulfone products (Scheme 40).109  However, reacting methyl ketone 131 with the 
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lithium anion of 1-(4-methylpent-3-enylsulfonyl)benzene 141 in THF resulted in a trace amount 
of the desired β-hydroxy sulfone 142, and the recovery of 131 (29%). 
141131
S
O2
O
O
OTESO
TMS
O
O
O
O
OTESO
TMS
O
142
n-BuLi, THF
-78 to 0 °C
OH
SO2Phtrace
 
Scheme 40: Reaction of Ketone 131 with Phenyl Sulfone 141 
The Wittig olefination was also investigated for the installation of the side chain, because 
typically the reaction of sterically hindered ketones with 4-methyl-3-
pentyltriphenylphosphonium bromide (143) produces alkene products with E-geometry.110-112  
However, reacting ketone 131 with the lithium anion of 143 at 0 to 25 °C resulted in a complex 
mixture of compounds that did not contain E-136 by 1H NMR (Scheme 41).111  Similarly, 
performing the reaction at 60 °C in DMSO resulted in a mixture of compounds that did not 
contain the desired alkene.112  The complex mixture obtained from the reaction of ketone 131 
with ylide 143 could be due to the presence of the electrophilic epoxy silane and carbonate 
moieties that are adjacent to the appending methyl ketone.  
143131
Ph3P
O
O
OTESO
TMS
O
O
n-BuLi, Et2O
0 °C to r.t.
Br complex mixture
NaH, DMSO
60 °C
 
Scheme 41: Reaction of Ketone 131 with 4-Methyl-3-pentyltriphenylphosphonium Bromide 
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1.10 THIRD GENERATION APPROACH TO OVALICIN: INSTALLATION OF THE 
SIDE CHAIN OF OVALICIN VIA A [3,3]-SIGMATROPIC REARRANGEMENT  
It is envisioned that the construction of the appending E-alkene of skipped diene 107b can be 
accomplished through via a Claisen rearrangement reaction of allylic acetate 144 (Scheme 42).  
Allylic acetate 144 will be formed from ketone 131 through a Grignard addition and 
esterification reaction.   
131
O
MeO
OHHO
O
O
O
O
TESO
TMS
O
ovalicin (61)
107b 144
O
O
OTESO
TMS
O
O
O
 
 Scheme 42: Retrosynthetic Analysis of Ovalicin from Allylic Acetate 144 
1.10.1  Synthesis of and Claisen Rearrangement of Allylic Acetate 144 
Nucleophilic addition of ethynylmagnesium bromide to the ketone moiety of 131 in the presence 
of cerium (III) chloride gave propargyl alcohol 145 in 75% yield as a single diastereomer 
(Scheme 43).113   It is presumed that the nucleophilic addition occurred from the less sterically 
hindered Re face of ketone 131 to avoid unfavorable steric interactions with the neighboring 
epoxy silane.  The formation of propargyl alcohol 145 is confirmed by the IR spectrum, which 
shows absorbances at 3402 cm-1 and 2114 cm-1, supporting the presence of the alcohol and 
alkyne functionalities, respectively.  Interestingly, performing the analogous reaction with 
vinylmagnesium bromide and cerium (III) chloride resulted in decomposition of 131. 
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Scheme 43: Formation of Allylic Acetate 144 from Ketone 131 
 Acetylation of the newly generated tertiary alcohol in 145 with acetic anhydride and 
DMAP in Et3N produced propargyl acetate 146 in 88% yield (Scheme 43).114  The IR spectrum 
of propargyl acetate 146 has the characteristic absorbances at 1814 cm-1 and 1761 cm-1 for the 
carbonyl stretch of the carbonate and ester, respectively.81   
 Hydrogenation of propargyl acetate 146 with Lindlar’s catalyst in ethanol produced 
allylic acetate 144 in 75% yield (Scheme 43).  The formation of 144 is evidenced by the 1H 
NMR, which shows resonances at 5.95 ppm (dd, J = 17.6, 11.1 Hz), 5.32 ppm (d, J = 11.1 Hz), 
and 5.21 ppm (d, J = 17.6 Hz) corresponding to the vinyl group.  
With allylic acetate 144 in hand, an Ireland-Claisen rearrangement reaction was 
employed for the construction of the side chain of ovalicin.115   Reacting 144 with LDA and 
TBSCl in the presence of HMPA resulted in the formation silyl ester 147 as a single isomer in 
96% crude yield (Scheme 44).  A resonance at 5.76-5.68 ppm (m) in the 1H NMR corresponds to 
the trisubstituted alkene proton, and resonances at 0.95 ppm (s, 9H), 0.32 ppm (s, 3H) and 0.31 
ppm (s, 3H) correspond to the tert-butyl and dimethyl groups of the TBS ester.  Furthermore, the 
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13C NMR has resonances at 172.7 ppm, 131.1 ppm, and 125.8 ppm that support the presence of 
the ester and alkene functionalities. 
O
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Scheme 44: Formation of Silyl Ester 147 from Allylic Acetate 144 
 It is presumed that E isomer of 147 was selectively produced from allylic acetate 144, as 
it is well established that the Claisen rearrangement of acyclic substrates proceeds through chair-
like transition-states 148 or 149 (Scheme 45).116  The transition state leading to the Z-isomer 
(149), however, suffers from a severe 1,3-diaxial strain induced by the large cyclohexyl ring and 
the silyl ketene acetal.  On the other hand, transition state 148 is able to undergo a facile 
rearrangement reaction that results in the selective formation of E-147.  
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Scheme 45: Explanation for the Selective Formation of E-147 
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 In continuing with the synthesis of ovalicin, the crude silyl ester 147 was reacted with 
methyllithium at low temperature to give tertiary alcohol 150 in 67% yield (Scheme 46).  
Interestingly, adding MeMgBr to silyl ester 147 resulted in no reaction and a 73% yield of 147 
was recovered.  The IR spectrum of 150 shows the typical alcohol absorbance at 3397 cm-1.  
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Scheme 46: Formation of Skipped Dienes 151/ 152 from Silyl Ester 147 
The newly generated tertiary alcohol is then converted into the corresponding mesylate 
with triethylamine and methanesulfonyl chloride (MsCl) at –15 °C (Scheme 46).117  Addition of 
Bu4NBr resulted in the formation of elimination products 151 and 152 in a 46% combined  
yield.118, 119  The formation of dienes 151 and 152 is evidenced by the alkene region in the 1H 
NMR.  A resonance at 5.07 ppm (tt, J = 7.2, 1.5 Hz) corresponds to the alkenyl proton Hb of 151, 
and resonances at 4.74-4.71 ppm and 4.67-4.64 ppm correspond to the 1,1-disubstituted alkene 
protons Hc of 152 (Figure 7).  Based upon the integrations of the resonances at 5.07 ppm and 
4.74-4.71 ppm, 151 and 152 were produced in a 2:1 isomeric ratio. The isomeric ratio obtained 
for 151 and 152 is similar to the 3:1 isomeric ratio obtained by Corey and Snider for the 
dehydration of a late-stage intermediate employed in their synthesis of fumagillol.58 
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Figure 7: Assignment of Ha, Hb, and Hc in the 1H NMR Spectrum of 151 and 152 (300 MHz, C6D6) 
1.10.2 Projected End-game of Ovalicin from Diene 151   
It is anticipated that functionalized diene 151 can be converted into ovalicin through the five-step 
reaction sequence shown in Scheme 47.   First, deprotection of the carbonate group and selective 
methylation of the secondary hydroxyl group with tBuONa, MeI, and 15-crown-562 in THF 
should produce alcohol 153.  The side chain epoxide of 61 will be installed though a vanadium-
catalyzed alcohol-directed epoxidation reaction.  Next, global deprotection of the silyl protecting 
groups and oxidation of the secondary alcohol to the corresponding ketone will afford ovalicin.  
However, the synthesis of ovalicin from diene 151 was not pursued due to the lengthy nine step-
reaction sequence required for the installation of the E-alkene side chain.  
151
1) Carbonate   
    deprotection
2) Selective   
   methylation
O
O
OHTESO
TMS
153
O
O
OH
ovalicin (61)
O2) Global deprotection
3) Oxidation
O
1) Alcohol-directed     
    epoxidation
 
Scheme 47: Projected Synthesis of Ovalicin from Diene 151 
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1.10.3 Summary and Conclusions for the Synthesis and Functionalization of Cross-
conjugated Triene 109 
In summary, we have developed a facile route to cross-conjugated triene 109 in three steps from 
known alkyne 111 and aldehyde 112 that features a high yielding Rh(I)-catalyzed allenic 
carbocyclization reaction.  An enantioselective synthetic strategy to (R)-109 from 111 and 112 
has also been developed utilizing an enantioselective alkynylation reaction, which could prove 
useful for the asymmetric syntheses of (–)-fumagillol and (–)-ovalicin. 
We have demonstrated that the double bonds of cross-conjugated triene 109 can be 
selectively functionalized via epoxidation and dihydroxylation protocol.  More specifically, a 
bis-allylic epoxide (115) was synthesized from a cross-conjugated triene precursor (109) in high 
yield using an alcohol-directed epoxidation reaction. This pivotal intermediate was then used to 
construct the oxygenated framework of fumagillol and ovalicin through diverging palladium-
catalyzed transformations. 
A modified Julia olefination reaction has been employed to transform ketone 131 into the 
Z-isomer of the masked skipped diene side chain in ovalicin.  It is envisioned that application of 
Vedejs’68 two-step isomerization procedure to Z-136 will yield E-136, which could serve as a 
useful intermediate in the synthesis of ovalicin.  Alternately, an Ireland-Claisen rearrangement 
can be used to install the skipped diene side chain of ovalicin with the required E-geometry.  
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1.11 THE CARBOCYCLIZATION REACTION OF ALLENE-YNES: 
INVESTIGATING THE CONSTITUTIONAL SITE SELECTIVITY OF 
DIFFERENTIALLY FUNCTIONALIZED 1,1-DISUBSTITUTED ALLENES AND ITS 
APPLICATION TO OVALICIN AND FUMAGILLOL 
1.11.1 Trost’s Constitutional Site Selectivity Study of 1,6-Enynes Appended to an 
Isobutylene Group 
Trost has shown that the palladium-catalyzed carbocyclization reaction of 1,6-enynes possessing 
an isobutylene group selectively yields cyclic 1,4-dienes with an appending 1,1-disubstituted 
alkene side chain.12, 120-125  For example, reacting alkynone 154 with Pd2(dba)3·CHCl3, tri-o-
tolylphosphine, and acetic acid in toluene at 80 °C  produces only carbocycle 156 in 63% yield 
(Scheme 48).124  The selective formation of 155 is attributed to coordination of the remote alkene 
in enyne 154 to the palladium catalyst.  This pseudo-cycle prevents syn periplanar alignment of 
the Pd-C-C-Ha system during the β-hydride elimination step of the carbocyclization, resulting in 
the exclusive formation of 156.  Similar observations have been reported by Trost and coworkers 
during their ruthenium-catalyzed carbocyclization studies of 1,6-enynes tethered to an 
isobutylene moiety.7, 8 
154 155
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O TMS
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Hb HbHb
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Scheme 48: Palladium-Catalyzed Carbocyclization Reaction of 1,6-Enyne 154124 
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1.11.2 Previous Studies Regarding the Constitutional Site Selectivity in the Allenic 
Carbocyclization Reaction 
With an eye towards the synthesis of ovalicin, the constitutional site selectivity of the β-hydride 
elimination step in the allenic carbocyclization reaction was investigated, i.e. the formation of 
isomeric products differing in line formulae.126  More specifically, the selective participation of 
the methylene position over the methyl position in the elimination process was examined.  
Previous studies conducted by Jamie McCabe showed that appending a coordinating 
functionality such as a hydroxyl propyl group to the distal double bond of the allene resulted in a 
mixture of trienes 159 and E/Z-160 in a 40:60 isomeric ratio (Table 7, entry 1).77  Reacting the 
analogous primary silyl ether (R1 = TBS) with a catalytic amount of [Rh(CO)2Cl]2 produced 
cross-conjugated trienes 159 and E/Z-160 in a 15:85 isomeric ratio.  The increased formation of 
triene 159 when R1 = H can be explained by coordination of the free hydroxyl group to the 
rhodium center of metallocycle 158, producing a rhodacycle that geometrically prohibits β-
hydride elimination of the β-methylene hydrogen atoms Ha. 
Table 7: Carbocyclization Reaction of Allene-yne 15777 
•
TMS
DCE, r.t.
[Rh(CO)2Cl]2
RO
OR1
159
E/Z-160
158
Rh
Me3Si
RO
H3C
Ln
O R
1
Ha
Ha
157, R = TBDPS
-Ha
-Hb
RO
TMS
OR1
RO
TMS
OR1
 
Entry R1 Ratio of 159 : E/Z160a E : Z ratioa Yield (%)b 
1 H 40 : 60 1.5  : 1 50 
2 TBS 15 : 85 1 : 1 55 
aProduct ratios were determined by integration of olefin peaks in the 1H NMR.  bCombined yield of 159 and E/Z-160  
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1.11.3 Retrosynthetic Analysis of Ovalicin and Fumagillol from α-Hydroxy Allene-yne 162 
The constitutional site selectivity of the allenic carbocyclization reaction was further 
investigated by tethering an isobutylene group to the allene moiety to determine its effect on the 
β-hydride elimination step.  In addition, the hydroxyl containing tether was deemed to be an 
important control element in the pre-cyclization and post-cyclization reactions, thus it too was 
incorporated.  Allene-yne 162 was chosen for our studies as it will allow entry into the 
carbocyclic framework of fumagillol (60) and ovalicin (61) in a single synthetic transformation 
(Scheme 49). 
 It is envisioned that reacting a catalytic amount of [Rh(CO)2Cl]2 with allene-yne 162 will 
produce cross-conjugated triene 161, which possesses the entire carbocyclic skeleton of 
structurally related natural products fumagillol (60) and ovalicin (61).  Moreover, it is anticipated 
that the allylic hydroxyl group of triene 161 can be used for the chemo- and stereoselective 
installation of epoxides and hydroxyl groups incorporated in both sesquiterpenes (Scheme 49).  
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OMeOO OH
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161 162
HO
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Scheme 49: Retrosynthetic Analysis of Ovalicin and Fumagillol from Allene-yne 162 
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1.11.4 Synthesis of Allene-ynes Tethered to an Isobutylene Group 
1.11.4.1 Substrate Design of α-Hydroxy Allene-ynes 
•R1O
R2
R1 = H, TBS, Ac, Piv
R2 = H, TMS, Ph  
Figure 8: Desired Allene-yne Substrates 
Design of 1,1-disubstituted allene-ynes required a tunable scaffold that would allow for 
substrate-controlled selectivity of the carbocyclization reaction (Figure 8).  We plan to alter the 
allene-yne hydroxyl (R1) and alkyne groups (R2) to determine the effect of the substitution at 
these sites on the regioselectivity of the carbocyclization reaction.  
Allene-yne 162 can be prepared in two steps from known propargyl tetrahydropyranyl 
ether 163127 and aldehyde 11279 (Scheme 50). Following Brandsma’s procedure for the addition 
of alkynes to aldehydes, n-BuLi was reacted with an excess of alkyne 163 at –50 °C.80  Addition 
of aldehyde 112 to the resulting lithium anion and warming the reaction to –20 °C gave 
propargyl alcohol 164 in 76% yield as an inseparable mixture of diastereomers by column 
chromatography.  Integration of the two resonances at 1.49 ppm and 1.42 ppm in the 1H NMR, 
which correspond to the diastereomeric methyl groups, indicate that 164 was produced as a 1.4:1 
diastereomeric mixture.  
Subjecting propargyl alcohol 164 to LiAlH4 in refluxing Et2O gave allene-yne 162 in 
74% yield (Scheme 50).82  The formation of allene-yne 162 is supported by a resonance at 5.20-
5.13 ppm (m) in the 1H NMR corresponding to the allene proton.  
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Scheme 50: Synthesis of Allene-yne 162 
Allene-yne 162 has been prepared in high diastereoselectivity in three steps from terminal 
alkyne 163 and Weinreb amide 165 (Scheme 51).  Alkynone 166 is formed in 68% yield by 
reacting the acetylide anion of 163 with amide 165.128  The formation of alkynone 166 is 
evidenced by IR spectrum with the absorbance at 1681 cm-1. 
Selective reduction of the ketone moiety of 163 with Noyori’s chiral ruthenium catalyst 
167 gave (R)-164 in 94% yield.129, 130  The 1H NMR and 13C NMR of (R)-164 are in agreement 
with the spectral data obtained for the 164.  
Reduction of propargyl alcohol (R)-164 with LAH afforded allene-yne (R)-162 in 56% 
yield (Scheme 51).  The low yield obtained for (R)-162 is attributed to performing the reduction 
reaction on small scale.  For example, reacting 1.13 mmol of propargyl alcohol (R)-164 with 
LAH gave allene-yne (R)-162 in 56% yield, whereas subjecting 7.58 mmol of propargyl alcohol 
164 to the same reaction conditions gave allene-yne 162 in an increased 74% yield.  The 1H 
NMR and 13C NMR of the enantioenriched allene-yne (R)-162 match the spectral data obtained 
for the racemic allene-yne 162.  The formation of the allene-yne (R)-162 is exciting as it could 
serve as a useful intermediate for the asymmetric syntheses of (–)-fumagillol and (–)-ovalicin. 
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Scheme 51: Synthesis of (R)-162 
Racemic and enantioenriched allene-ynes 162 and (R)-162 were converted into the 
analogous Mosher esters 168 and (R)-168 to determine the diastereomeric ratio of (R)-162 
(Scheme 52).  Racemic Mosher ester 168 was produced by reacting allene-yne 162 with (R)-(+)-
alpha-methoxy-alpha-(trifluromethyl)-phenylacetic acid, N,N’-dicyclohexylcarbodiimide (DCC), 
and 4-dimethylaminopyridine (DMAP) (Conditions A).  Similarly, Mosher ester (R)-168 was 
formed by reacting allene-yne (R)-162 with (R)-(+)-alpha- methoxy-alpha-(trifluromethyl)-  
162, Conditions A: DCC
•
HO
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Scheme 52: Formation of Mosher Esters 168 and (R)-168 
phenylacetic acid, 1-(3-dimethylaminopropyl)-3- ethylcarbodiimide hydrochloride (EDC), and 4-
dimethylaminopyridine (DMAP) (Conditions B). Employing EDC for the coupling reaction of 
(R)-162 avoids the urea byproduct produced by DCC, which is not water soluble and is difficult 
to remove without employing column chromatography.  The 19F NMR of racemic allene-yne 168 
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shows three resonances at -72.0 ppm, -72.1 ppm, and -72.2 ppm with integrations of 2F, 1F, and 
1F, respectively (Figure 9).  This spectral data indicates that four diastereomers of 168 are 
present in equal quantities.  The 19F NMR of (R)-168 still shows three resonances at -72.0 ppm,  
-72.1 ppm, and -72.2 ppm, however, with integrations of 0.16F, 1F, and 1F, respectively. Based 
upon the integrations in the 19F NMR of (R)-168, allene-yne (R)-162 was produced in a 93:7 
diastereomeric ratio (Scheme 51). 
  
Figure 9: 19F NMR of Racemic Allene-yne 168 and Enantioenriched Allene-yne (R)-168 
Interestingly, Carreira’s asymmetric alkynylation protocol produced (R)-164 in only 38% 
yield, even when excess (+)-N-methylephedrine (3.1 equiv), alkyne 163 (3.1 equiv), and zinc 
triflate (3 equiv) were used (Scheme 53).83  The low yield obtained from this reaction could be 
due to a self-condensation reaction of aldehyde 112, which is supported by the presence of a 
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slightly more polar product by TLC.  Aldol condensations are facile processes for aldehydes that 
do not possess any α- or β-substituents.84, 130, 131  The absolute stereochemistry of (R)-161 was 
assigned by analogy to Carreira’s substrates prepared using (+)-N-methylephedrine.83 
THPO
163
+
O
TMSH
112
(+)-N-methyl
 ephedrine
Zn(OTf)2, Et3N
toluene, 38%
(R)-164
OH
TMS
THPO
 
Scheme 53: Formation of (R)-164 via Carreira’s Asymmetric Alkynylation Protocol 
With the synthesis of allene-yne 162 in hand, allene-yne derivatives containing different 
R1 substituents were constructed to examine the role of the hydroxyl group on the β-hydride 
elimination step of the carbocyclization reaction (Scheme 54).  More specifically, silyl ether 169, 
acetate 170, and pivaloate ester 171 were synthesized to determine the effect of an electron 
donating, withdrawing, and sterically demanding functionality on the selectivity of the reaction. 
Silyl ether 169 was obtained in 70% yield by reacting 162 with TBSCl and imidazole 
(Scheme 54).  The formation of tert-butyldimethyl silyl ether 169 is evidenced by the molecular 
ion (M+˙ m/z 404) peak in the high resolution mass spectrum. 
Reaction of 162 with acetic anhydride, DMAP, and pyridine gave the analogous acetate 
170 in 70% yield.  Similarly, pivaloate ester 171 was produced in 85% yield when alcohol 162 
was reacted with pivaloyl chloride, DMAP, and triethylamine (Scheme 54).  The IR spectrum of 
acetate 170 and pivaloate ester 171 have the corresponding absorbances at 1743 cm-1 and 1731 
cm-1, indicative of the carbonyl stretch.81   
 
 66 
162
TBSCl
imidazole
CH2Cl2, 70%
169
•
HO
TMS
•
TBSO
TMS
pyridine, CH2Cl2
73%
pivaloyl chloride
Et3N, DMAP
Ac2O, DMAP
170
•
AcO
TMS
171
•
PivO
TMS
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Scheme 54: Formation of Silyl ether 169, Acetate 170, and Pivaloate ester 171 
The substitution on the alkyne terminus (R2) was adjusted by synthesizing terminal 
alkyne 172 and phenyl alkyne 173 from TMS-alkyne 162 (Scheme 55).  The TMS group of 162 
was removed with K2CO3 in MeOH to give terminal alkyne 172 in 80% yield.  The formation of 
alkyne 172 is evidenced by a resonance at 1.97 ppm (t, J = 2.7 Hz) in the 1H NMR that 
corresponds to the terminal alkyne proton.   
172 173
K2CO3
MeOH, 80% PhI, THF, 86%
Pd(PPh3)2Cl2
CuI, DIPA
162
•
HO
TMS
•
HO
•
HO
Ph
 
 Scheme 55: Formation of Allene-ynes 172 and 173 
A Sonogashira coupling reaction was then performed with Pd(PPh3)2Cl2, CuI, 
diisopropylamine (DIPA), and iodobenzene to afford the analogous phenyl-alkyne 173 in 86% 
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yield (Scheme 55). The molecular ion peak at M+· m/z 294 in the high resolution mass spectrum 
supports that 173 was obtained.  
1.11.4.2 Synthesis of Malonate and Heteroatom Tethered Allene-ynes 
X
•
R2
X = C(CO2Et), NTs, O
R2 = H, TMS, Ph, Me  
Figure 10: Malonate and Heteroatom Tethered Allene-yne Derivatives 
The selectivity study of the allenic carbocyclization reaction of allenes attached to an isobutylene 
group was expanded to include allene-ynes with different tether substituents X (Figure 10).  Our 
goal is to use malonate, sulfonamide, and ether tethered allene-ynes to determine if modification 
of the allene-yne backbone will affect the β-hydride elimination step in the carbocyclization 
reaction 
Allene-yne 175, the synthetic precursor to malonate and heteroatom tethered allene-ynes, 
was constructed from propargyl tetrahydropyranyl ether 163127 and paraformaldehyde (Scheme 
56).  The alkyne terminus of 163 was first deprotonated with n-butyllithium at 0 °C and then 
reacted with paraformaldehyde.  Warming the reaction to room temperature produced the desired 
propargyl alcohol 174 in 79% yield.  Alcohol 174 was afforded as a 1.2:1 mixture of 
diastereomers based upon integration of the two resonances at 1.49 ppm and 1.41 ppm in the 1H 
NMR that correspond to the diastereomeric tertiary methyl groups.  
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Reacting propargyl alcohol 174 with LAH in refluxing ether resulted in allene-yne 175 in 
53% yield (Scheme 56).82  A resonance at 5.29-5.21 ppm (m) in the 1H NMR of 175 corresponds 
to Ha, and a resonance at 200.0 ppm in the 13C NMR corresponds to C3. 
n-BuLi, THF
0°C to rt, 79%
OH
•
THPO
163
+
O
H
OHTHPO
H
LAH, ether
reflux, 53%
174 175
Ha
3
 
Scheme 56: Formation of Allene-yne 175 
With allene-yne 175 in hand, malonate tethered allene-ynes 176-179 were synthesized to 
examine the effect of the tether on the selectivity of the carbocyclization reaction (Table 8).  
Malonate tethered allene-yne derivatives 176-179 were constructed through an alkylation 
reaction between α-allenyl mesylate 175a and a variety of malonate carbanions.132 
For example, the formation of malonate-tethered allene-yne 176 was accomplished by 
converting alcohol 175 into mesylate 175a with triethylamine, DMAP, and methanesulfonyl 
chloride (MsCl) at 0 °C (Table 8).  In a separate reaction flask, diethyl 2-(3-(trimethylsilyl)prop-
2-ynyl)malonate was deprotonated with sodium hydride and the crude mesylate was then added 
to the resulting carbanion at 0 °C.  Warming the reaction to room temperature followed by the 
addition of sodium iodide resulted in the formation of allene-yne 176 in 62% yield (entry 1, 
Table 8).  The alkylation reactions illustrated in entries 2 through 4 of Table 8 were performed 
similarly and gave allene-ynes 177-179 in yields of 73-76%. The formation of malonate-tethered 
allene-yne 176 is evidenced by the molecular ion (M+· m/z 418) peak in the high resolution mass 
spectrum and by absorbances in the IR at 2180 cm-1 and 1737 cm-1.  The spectral data obtained 
for allene-ynes 177 though 179 are similar to that obtained for 176.  
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Table 8: Synthesis of Malonate tethered Allene-ynes 176 through 179 
Et3N, MsCl, 
DMAP
CH2Cl2, 0 °C
HO
•
MsO
•
175 175a
EtO2C
CO2Et
R
NaH, NaI, THF
0 °C to r.t., 62%
•
R
EtO2C
EtO2C
176  
Entry R2 Allene-yne Yield (%) 
1 TMS 176 62 
2 Ph 177 73 
3 Me 178 76 
4 H 179 76 
 
Next, a nitrogen heteroatom was incorporated into the allene-yne tether by synthesizing 
N-tosylallene-ynes 181-183 to investigate if a coordinating functionality in the allene-yne 
backbone will affect the selectivity of the carbocyclization reaction (Table 9). For example, N-
tosylallene-yne 181 was prepared using a Mitsunobu reaction by adding diisopropyl 
azodicarboxylate (DIAD) to a mixture of 3-phenyl-N-tosylprop-2-yn-1-amine, 
triphenylphosphine, and allenic alcohol 175 in THF at 0 °C.  Warming the reaction to room 
temperature produced the desired allene-yne 181 in 78% yield.  
The construction of N-tosylallene-yne 181 from allenyl alcohol 175 is supported by 
resonances at 5.04-4.96 ppm (m, 1H) and 2.34 ppm (s, 3H) in the 1H NMR that correspond to the 
allene proton and the tosylate methyl group, respectively.  Allene-ynes 182 and 183 were 
prepared according to the procedure described for 180 and have comparable spectral data.  
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Table 9: Formation of N-Tosylallene-ynes 181-183 
0 °C to r.t.
HO
•
175
TsN
•
R2
DIAD, PPh3, THF
N
R2
H
Ts
181-183  
Entry R2 N-Tosylallene-yne Yield (%) 
1 Ph 181 78 
2 Me 182 80 
3 H 183 87 
 
Ether-tethered allene-ynes 185-187 were synthesized to investigate the effect of an 
oxygen heteroatom in the allene-yne tether on the constitutional site selectivity of the allenic 
Alder-ene reaction (Table 10).  The construction of allene-yne 185 was accomplished by first 
deprotonating alcohol 175 with sodium hydride.  Subsequent O-alkylation of the resulting 
oxyanion with 1-(3-bromoprop-1-ynyl)benzene gave ether-tethered allene-yne 185 in 81% yield.  
Structurally similar allene-ynes 186 and 187 were prepared in yields of 76% and 80% according 
to the described procedure. 
The 13C NMR of allene-yne 185, with resonances at 203.1 ppm, 86.01 ppm, and 85.2 
ppm, supports the presence of the allene and alkyne functionalities.81  The spectral data obtained 
for 186 and 187 is similar to that obtained for 185.  
 
 
 
 71 
Table 10: Formation of Ether-tethered Allene-ynes 185-187 
THF, 0 °C to r.t.
HO
•
175
O
•
R2
Br
R2
185-187
1) NaH
2)
 
Entry R2 Allene-yne Yield (%) 
1 Ph 185 81 
2 Me 186 76 
3 H 187 80 
 
Additionally, sulfonamide- and ether-tethered allene-yne derivatives possessing a TMS-
substituted alkyne were obtained from terminal alkyne precursors to examine the effect of a 
TMS-alkyne on the selectivity of the cycloisomerization reaction.  Reacting terminal alkynes 183 
and 187 with n-BuLi and TMSCl at low temperature produced the corresponding allene-ynes 
180 and 184 in yields of 71% and 49% (Scheme 57).  The formation of TMS-alkynes 180 and 
184 is evidenced by the 1H NMR, which has resonances corresponding to the TMS group at           
-0.02 ppm (s, 9H) and 0.18 ppm (s, 9H), respectively.   
TsN
•
H
183
TsN
•
TMS
n-BuLi, TMSCl
THF, -78 °C, 71%
180
O
•
H
187
O
•
TMS
n-BuLi, TMSCl
THF, -78 °C
184
49%, 57% brsm
(Eq. 1)
(Eq. 2)
 
Scheme 57: Formation of TMS-Substituted Alkynes 180 and 184 
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1.11.5 The Constitutional Site Selectivity of Allene-ynes Tethered to an Isobutylene Group  
1.11.5.1 Investigating the Role of the Allene-yne Functional Groups on the Selectivity 
of the Allenic Carbocyclization Reaction   
 
Reacting allene-yne 162 with 10 mol% of [Rh(CO)2Cl]2 in toluene at room temperature 
produced only cross-conjugated triene 188 in 84% yield (Scheme 58).  The selective formation 
of cross-conjugated triene 188 in yields of 83%, 77%, and 75% is also observed when t-butyl 
methyl ether, fluorobenzene, and α,α,α-trifluoromethyltoluene are employed as solvents, 
respectively.  To the best of our knowledge,133 this is the only example of a trisubstituted allene-
yne being transformed into a regioisomerically pure cross-conjugated triene. 
•
HO
TMS
[Rh(CO)2Cl]2
toluene, 0.05M
84%, 2h
TMS
HO
162 188  
Scheme 58: Selective Formation of Cross-conjugated Triene 188 from Allene-yne 162 
The selective formation of cross-conjugated triene 188 is illustrated by the alkene region 
in the 1H NMR (Table 11).  Resonances at 5.66 ppm (d, J = 3.5 Hz), 5.50 ppm (s), and 5.10 ppm 
(tt, J = 7.0, 1.5 Hz) correspond to Ha, Hb, and Hc, respectively.  The appending 1,1-disubstituted 
alkene protons Hd correspond to the resonances at 5.01-4.98 ppm and 4.88 ppm (d, J =2.0 Hz). 
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Table 11:  1H NMR of Cross-conjugated Triene 188 (alkene region, CDCl3, rt, 500 MHz) 
 
 Chemical Shift Spin multiplicity J Values (Hz) 
Ha 5.66 ppm d 3.5 
Hb 5.50 ppm s ----- 
Hc 5.10 ppm tt 7.0, 1.5 
Hd 5.01-4.98 ppm m ----- 
Hd 4.88 ppm d 2.0 
 
Intrigued by the selective formation of triene 188, we next sought to investigate the role 
of the hydroxyl group on the allenic carbocyclization reaction.  The corresponding silyl ether 
169, acetate 170, and pivaloate ester 171 were examined to determine the effect of an electron 
donating, withdrawing, and sterically demanding functionality on the selectivity of the reaction.  
As seen in Table 12, allene-ynes 169, 170, and 171 were selectively transformed into cross-
conjugated trienes 189, 191, and 193 in yields of 92%, 84%, and 75%, respectively.  These 
results indicate that the substitution on the α-allenic hydroxyl group has no effect on the 
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constitutional site selectivity of the carbocyclization reaction.  However, the presence of the 
bulky pivaloate ester did produce cross-conjugated triene 193 in a lower 75% yield. 
Table 12: Allenic Carbocyclization Reaction of Allene-ynes 169 through 171 
Entry Allene-yne Trienes A : Ba Time Yield 
 
•R1O
TMS
 
TMS
R1O
TMS
R1O
+
A B  
 
 
1 169, R1=TBS 189 : 190, 100 : 0 1 h 92% 
2 170, R1=Ac 191 : 192, 100 : 0 1.5 h 84% 
3 171, R1=Piv 193 : 194, 100 : 0 2 h 75% 
aSingle isomer detected by 1H NMR 
The effect of the substitution on the alkyne terminus was next investigated.  Interestingly, 
replacing the alkynyl TMS group with a phenyl substituent resulted in trienes 195 and E/Z-196 
as an 85:15 isomeric mixture in 88% yield (entry 1, Table 13).  Cross-conjugated trienes 195 and 
E/Z-196 were characterized as a mixture, because the isomeric ratio could be determined by 1H 
NMR.  For example, resonances at 5.09-5.06 ppm (m) and 4.98 ppm (d, J = 2.1 Hz) correspond 
to the appending 1,1-disubstituted alkene protons of 195, and resonances at 5.39 ppm (t, J = 6.9 
Hz) and 5.18 ppm (tt, J = 6.9, 1.2 Hz) correspond to the alkenyl protons in the diene side of E/Z-
196.  The isomeric ratio of 195 and E/Z-196 was determined by integration of the resonances at 
4.98 ppm (d, J = 2.1) and 5.39 ppm (t, J = 6.9 Hz) in the 1H NMR. 
Table 13: Allenic Carbocyclization Reaction of Allene-ynes 172 and 173 
Entry Allene-yne Trienes A : B E:Z Time Yielda  
 
•HO
R2
 
R2
HO
R2
HO
+
A B  
  
 
1 172, R2 = Ph        195 : 196, 85 : 15 1 : 1 20 min 88% 
2 173, R2 = H        197 : 198, 56 : 44 1 : 1 7 h 32% 
aCombined yield of cross-conjugated trienes A and B 
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Subjecting allene-yne 173, which possesses a terminal alkyne, to the Rh(I)-catalyzed 
Alder-ene reaction conditions gave cross-conjugated trienes 197 and E/Z-198 in a 56:44 isomeric 
ratio, but in a lower 32% combined yield (entry 2, Table 13).  The low yield and extended 
reaction time for the formation of trienes 197/E/Z-198 is attributed to the reactive acetylenic 
proton that can react with the rhodium catalyst.124  The isomeric ratio of cross-conjugated trienes 
197/E/Z-198 was determined by integration of the three peaks in the GC chromatogram at 
retention times 5.6 min, 5.8 min, and 6.1 min.  Based upon integration of the two smaller peaks 
at 5.6 min and 6.1 min, cross-conjugated triene 197 was produced as a 1:1 mixture of E:Z 
isomers.  The isomeric ratios were assigned based on the retention times of the constitutional site 
and E:Z isomer of trienes 188 and  E/Z-161, which were determined via nOe analysis and will be 
discussed later in section 1.11.5.5. 
The isomeric mixture of trienes produced from allene-ynes 172 and 173 suggests that 
substitution at the alkynyl position does influence the β-hydride elimination step of the Rh(I)-
catalyzed carbocyclization reaction.  Moreover, the substitution on the alkyne terminus could 
serve as a control element for the selective formation of isomerically pure cross-conjugated 
trienes from 1,1-disubstituted allene-yne precursors.  
The effect of the tether substituents was studied next to further probe the selectivity of the 
carbocyclization reaction, and malonate tethered allene-yne derivatives were examined (Table 
14).  Allene-yne 176, which has an alkynyl TMS group, was selectively cyclized to cross-
conjugated triene 199 in 74% yield in 20 min (entry 1).   
Replacement of the TMS-alkyne with a phenyl-substituted alkyne produced a 72% yield 
of trienes 201 and E/Z-202 in an 88:12 isomeric ratio (entry 2, Table 14).  The isomeric ratio of 
cross-conjugated trienes 201 and E/Z-202 was determined by integration of the three peaks in the 
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GC chromatogram at retention times 14.7 min (E/Z-202), 16.5 min (201), and 17.6 min (E/Z-
202).   
Subjecting methyl derived allene-yne 178 to the carbocyclization reaction conditions 
gave a 72% yield of 203 and E/Z-204 (entry 3, Table 14).  Based upon integration of the three 
peaks in the GC chromatogram at retention times 8.6 min (E/Z-204), 8.9 min (203), and 9.2 min 
(E/Z-204), cross-conjugated trienes 203 and E/Z-204 were produced in an 86:14 isomeric ratio. 
Table 14: The Carbocyclization Reaction of Malonate-Tethered Allene-ynes Containing an Appending 
Isobutylene Group 
Entry Allene-yne Trienes A : Ba E:Za Time Yieldc 
 •
R2
E
E
 
R2 R
2
+
A B
E
E
E
E
 
 
  
1b 176, R2 = TMS 199 : 200, 100 : 0 ----- 20 min 74% 
2 177, R2 = Ph 201 : 202, 88 : 12 1 : 1  2.5 h 72% 
3 178, R2 = Me 203 : 204, 86 : 14 3 : 1 1.8 h 72% 
4 179, R2 = H 205 : 206, 56 : 44 2 : 1 24h 29% 
a Product ratios determined by GC analysis. bSingle isomer detected by 1H NMR cCombined yield of trienes A and B  
 
When the cyclization reaction was performed with allene-yne 179, cross-conjugated 
trienes 205 and E/Z-206 were produced in a low 29% yield as a 56:44 isomeric mixture (entry 4, 
Table 14).  The low yield and long reaction time observed for this reaction is attributed to the 
reactive terminal alkyne in allene-yne 179.124 The formation of cross-conjugated trienes 205 and 
E/Z-206 is supported by the three peaks in the GC chromatogram at retention times 8.2 min (E/Z-
206), 8.4 min (205), and 8.8 min (E/Z-206). 
  The Rh(I)-catalyzed carbocyclization reaction conducted with malonate tethered allene-
ynes 176 through 179 produced a small amount of the corresponding α-alkylidene 
cyclopentenone products in addition to cross-conjugated trienes 199-206 (Table 15).  
Cyclocarbonylation products 207-210 were isolated in yields ranging from 8% to 14% and could 
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account for the lower yields obtained for cross-conjugated trienes 199-206 (compare Tables 12 
and 13 with Table 14). 
Table 15: Formation of Cyclopentenones 207-210 
•
R2
EtO2C
EtO2C
O
EtO2C
EtO2C
R2
H
[Rh(CO)2Cl]2
toluene
176-179 207-210  
Entry Allene-yne Cyclopentenone Yield (%) 
1 176, R2 = TMS 207 14 
2 177, R2 = Ph 208 10 
3 178, R2 = Me 209 8 
4 179, R2 = H 210 8 
 
The formation of cyclopentenones 207-210 is evidenced by resonances in the 1H NMR.  
For example, the 1H NMR of 207 shows resonances at 3.58-3.46 ppm (m, 1H) and 2.84-2.75 
ppm (m, 1H), corresponding to the methylene protons Ha; an AB quartet (J = 18.3 Hz) at 
resonances 3.32 ppm and 3.22 ppm, corresponding to Hb; and resonances at 2.96 ppm (triplet, J 
= 8.1 Hz) and 2.92* ppm (triplet, J = 8.1 Hz), corresponding to the diastereomeric ring fusion 
hydrogen Hc.  Integration of the resonances at 1.67 ppm and 1.60 ppm that correlate to the 
isomeric α-alkylidene methyl group indicate that 207 was produced as a 1:1 mixture of 
diastereomers.  
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TMS
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HbHb
Ha Ha
AB quartet, J = 18.3 Hz
3.58-3.46 ppm, multiplet
2.84-2.75 ppm, multiplet
3.32 ppm, 3.22 ppm
2.96 ppm, triplet, J = 8.1 Hz
2.92* ppm, triplet, J = 8.1 Hz
 
Figure 11: Assignment of Ha Hb, and Hc in the 1H NMR Spectrum of 207 (300 MHz, CDCl3) 
Next, the effect of heteroatoms on the regioselectively of the β-hydride elimination step 
was explored.  N-Tosylallene-yne 180 and ether-tethered allene-yne 184, which possess a TMS 
substituted alkyne, were exclusively converted into trienes 211 and 223 in yields of 63% and 
61%, respectively (entries 1 and 5, Table 16).   
 As seen in entries 2 and 6 of Table 16, exchanging the TMS-alkyne with a phenyl alkyne 
produced an isomeric mixture of trienes.  Sulfonamide 181 is cyclized to trienes 214/E/Z-215 in 
an 85:15 isomeric ratio in 56% yield, and allenyl ether 185 is converted to trienes 226/E/Z-227 in 
an isomeric ratio of 74:26 in 60% yield.  
Similarly, mixtures of cross-conjugated trienes are again observed when the allene-yne 
substrates have a methyl-substituted alkyne (compare entries 2 and 6 with entries 3 and 7).  As 
seen in entries 3 and 7, allene-ynes 182 and 186 are transformed to the corresponding cross-
conjugated trienes 217/E/Z-218 and 229/E/Z-230 in isomeric ratios of 79:21 and 75:25, 
respectively. 
Additionally, reacting terminal alkynes 183 and 187 with [Rh(CO)2Cl]2 produced cross-
conjugated trienes 220/E/Z-221 and 232/E/Z-233 in increased isomeric ratios of 43:57 and 45:55, 
respectively (entries 4 and 8, Table 16).  Cross-conjugated trienes 220/E/Z-221 and 232/E/Z-233, 
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however, were isolated with impurities that were inseparable via column chromatography in low 
yields of 36% and 21%, respectively.  
Table 16: The Carbocyclization of Heteroatom-Tethered Allene-ynes with an Appending Isobutylene Group 
Entry Allene-yne Trienes A : Ba, 
Yieldd 
E:Za Cyclopentenone, 
Yield 
Time 
 TsN •
R2
 
TsN
TsN+
A B
R2
R2
 
 
TsN O
R2
H   
1 180, R2 = TMS 211 : 212, 100 : 0, 63% ----- 213, 20% 15 min 
2 181, R2 = Ph 214 : 215, 85 : 15, 56% 1 : 1 216, 24% 8.5 h 
3 182, R2 = Me 217 : 218, 79 : 21, 64% 1 : 1 219, 25% 20 min 
4c 183, R2 = H 220 : 221, 43 : 57, 36% 2 : 1 222, 25% 24 h 
 
O
•
R2
 
O
R2
O
R2
+
A B   
O O
R2
H
  
5 184, R2 = TMS 223 : 224 100 : 0, 61% ----- 225, 39% 40 min 
6b 185, R2 = Ph 226 : 227 74 : 26, 60% 1 : 1 228, 30% 35 min 
7b 186, R2 = Me 229 : 230 75 : 25, 41% 1 : 1 231, 36% 20 min 
8c 187, R2 = H 232 : 233 45 : 55, 21% 3 : 1 234, 28% 24 h 
bProduct ratios were determined by integration of distinct protons in 1H NMR. bProduct ratios determined by GC analysis. cTriene 
products contained inseparable impurities. dCombined yield of cross-conjugated trienes A and B 
 
Unfortunately, the heteroatom-tethered allene-ynes examined produced increased 
amounts of α-alkylidene cyclopentenones.  N-Tosylallenynes 180-183 led to the corresponding 
cyclocarbonylation products in yields of 20-25%, and ether-tethered allene-ynes 184-187 gave 
cyclopentenones in yields of 28-39% (Table 16). 
The formation of α-alkylidene cyclopentenones 213-234 is evidenced by the 1H NMR.  
The 1H NMR of 231, for example, shows an AB quartet (J = 14.8 Hz) at resonances 4.58 ppm 
and 4.46 ppm corresponding to Hb and resonances at 4.38 ppm (triplet, J = 7.5 Hz) and 4.33* 
ppm (triplet, J = 7.5 Hz) that correspond to the diastereomeric ring fusion hydrogen Hc.  A 
resonance at 3.68-3.62 ppm corresponds to one Ha proton (m), while the overlapping resonances 
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at 3.16 ppm (dd, J = 11.0, 7.5 Hz) and 3.15* ppm (dd, J = 11.0, 8.0 Hz) correspond to the other 
diastereomeric Ha proton (Figure 12).  
Furthermore, the 13C NMR of 231 has resonances for the carbonyl carbon and sp3 ring 
fusion carbon of α-alkylidene cyclopentenones at 197.4/196.9* ppm and 47.7/47.5* ppm, 
respectively.134, 135  Integration of the two peaks in the GC chromatogram at retention times 7.5 
min and 7.7 min indicate that 231 was produced as a 1:1 mixture of diastereomers.   
AB quartet, J = 14.8 Hz
3.68-3.62 ppm, multiplet
4.58 ppm, 4.46 ppm
4.38 ppm, triplet, J = 7.5 Hz
4.33* ppm, triplet, J = 7.5 Hz
3.16 ppm, dd, J = 11.0, 7.5 Hz
3.15* ppm, dd, J = 11.0, 8.0 Hz
197.4 ppm
196.6* ppm
O O
Me
Hc
HbHb
Ha Ha
231  
Figure 12: Assignment of Ha Hb, and Hc in the 1H NMR Spectrum of 231 (500 MHz, CDCl3) 
To confirm the structure of 231, allene-yne 186 was reacted with 10 mol% of 
[Rh(CO)2Cl]2 at 90 °C under a carbon monoxide atmosphere, which formed α-alkylidene 
cyclopentenone 231 in 65% yield.  A small amount of the corresponding cross-conjugated trienes 
229 and E/Z-230 were obtained in 31% yield as an 88:12 isomeric mixture.  The isomeric ratio of 
229 : E/Z-230 was determined by integration of the three peaks in the GC chromatogram at 
retention times 5.3 min (E/Z-230), 5.6 min (229), and 5.9 min (E/Z-230).  It should be noted that 
these reaction conditions are typically used to form 4-alkylidene cyclopentenones.136, 137 
O
•
Me
O O
Me
H
 [Rh(CO)2Cl]2
186 65%, 231
CO, toluene, 90 °C +
O
Me
O
Me
31% 229/E/Z-230
+
10 mol%
 
Scheme 59: Formation of Cyclopentenone 231 from Allene-yne 186   
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Interestingly, subjecting allene-yne 186 to a catalyst system prepared in situ from 10 
mol% [Rh(CO)2Cl]2, 30 mol% PPh3, and 22 mol% AgBF4 under 1 atm of CO produced a 
chromatographically separable mixture of α-alkylidene cyclopentenone 231 (21%) and 4-
alkylidene cyclopentenone 235 (21%) in a 42% combined yield (Scheme 60).135  The formation 
of 4-alkylidene cyclopentenone 235 is evidenced by resonances in the 1H NMR at 5.87 ppm (t, J 
= 3.3 Hz), corresponding to Ha; 4.67 ppm, corresponding to Hb (s, 2H); and at 4.35 ppm (d, J = 
3.3 Hz), corresponding to Hc.  Further evidence that 235 was obtained is provided by the 13C 
NMR, which shows the characteristic resonance at 209.7 ppm that is typically observed for the 
carbonyl carbon of 4-alkylidene cyclopentenones.135, 136 
O
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Scheme 60: Formation of Isomeric Cyclopentenones 231 and 235 from Allene-yne 186 
The selective coordination and subsequent reaction of [Rh(CO)2Cl]2 with the proximal 
double bond of the allene might be explained by the coordination of the heteroatom in the allene-
yne tether to the rhodium metal.  This hypothesis is further supported by the increased yields of 
20-39% obtained for cyclopentenones produced from nitrogen- and oxygen-tethered allene-ynes. 
 
 
 
 
 82 
1.11.5.2 Explanation for the Constitutional Site Selectivity of the Allenic 
Carbocyclization Reaction of Allene-ynes containing an Isobutylene group  
 
The selective transformation of allene-ynes of type 236 to cross-conjugated trienes 238 can be 
explained by coordination of the appending double bond to the rhodium metal center giving 
intermediate 237 (Scheme 61).  In this conformation, syn periplanar alignment of the Rh-C-C-Ha 
system during the β-hydride elimination step is geometrically unattainable, leading to β-hydride 
elimination of Hb and the formation of cross-conjugated triene 238.   
TMS
238
RhHa
Ha
TMS
C
Hb HbHb
(III)
237
•
TMS
toluene, r.t.
[Rh(CO)2Cl]2
236
-Hb
 
Scheme 61: Explanation for the Selectivity of the Alder-ene Reaction of Allene-ynes Tethered to an Alkene 
 
1.11.5.3 Examining the Effect of Coordinating Solvents on the Regioselectivity of the 
Rh(I)-Catalyzed Allenic Carbocyclization Reaction 
 
In continuing with the investigation of the constitutional site selectivity of the allenic Alder-ene 
reaction, a variety of solvents were examined for the carbocyclization reaction.  Allene-yne 162 
was chosen for our solvent studies as it can produce the cyclic framework of fumagillol (60) and 
ovalicin (61).   
To test our hypothesis that the appended alkene of the allene-yne substrate is 
coordinating to the rhodium catalyst, toluene was replaced with a more coordinating solvent.  As 
seen in Table 17, performing the carbocyclization reaction in solvents such as acetone (entry 4) 
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and 1,4-dioxane (entry 5) lead to slightly increased ratios of  E/Z-161 : 188 (21:79 and 22:78), 
while THF (entry 6) gave trienes E/Z-161 : 188 in a 34:66 isomeric ratio.  Interestingly, using 
acetonitrile as the solvent resulted in a dramatic increase in the formation of E/Z-161, and trienes 
E/Z-161 and 188 were produced in a 99:1 isomeric ratio in 29% yield (entry 7).  The appending 
trisubstituted alkene of E/Z-161 was produced in a E:Z ratio of 1:5.  The preferential formation 
of Z-161 in entries 2 though 7 is unique, because typically the metal-catalyzed carbocyclization 
reaction predominately produces the thermodynamically favored E-isomer.6, 138  The isomeric 
ratio of E/Z-161 and 188 was determined by integration of the three peaks in the GC 
chromatogram at retention times of 6.9 min, 7.1 min, and 7.4 min, which correspond to Z-161, 
188, and E-161, respectively.  
Table 17: Solvent Study for the Allenic Carbocyclization Reaction of Allene-yne 162 
TMS
HO
188E/Z-161
•
HO
TMS
[Rh(CO)2Cl]2, r.t.
162
10 mol%
+
TMS
HO
 
Entry Solvent E/Z-161:188a E:Za Yield (%)b 
1 toluene 0 : 100 ------ 84 
2 1,2-DCE 7 : 93 1 : 4 80 
3 DME 18 : 82 1 : 4 50 
4 acetone 21 : 79 1 : 9 25 
5 1,4-dioxane 22 : 78 1 : 4 77 
6 THF 34 :  66 1 : 6 46 
7 CH3CN 99 : 1 1 : 5 29 
8 TFE ------ ------ complex mixture 
aProduct ratios determined by GC analysis.  bCombined yield of E/Z-161 and 188 
Interestingly, reacting allene-yne 162 with [Rh(CO)2Cl]2 in solvents such as DMSO,  
DMF, and MeOH gave 2,5-dihydropyran 239 in yields of 51%, 59%, and 78%, respectively 
(Scheme 62).  The 1H NMR shows that the major diastereomer of 239 has resonances at 5.74 
ppm (dd, J = 6.3, 0.9 Hz) and 5.68 ppm (dd, J = 6.0, 2.1 Hz) that correspond to the cis-alkene 
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protons Ha.  Similarly, the resonance at 5.72 ppm (s) corresponds to the cis-alkene protons of the 
minor diastereomer.139, 140    Based upon the integration of the resonances at 1.29 ppm and 1.27 
ppm in the 1H NMR corresponding to the diastereomeric methyl groups, 239 was produced as a 
1.2:1 diastereomeric mixture.  
•
HO
TMS
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162 239
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dr ~1.2:1 Ha Ha
 
Scheme 62: Formation of 2,5-Dihydropyran 239 from Allene-yne 162 
Encouraged by the results depicted in Table 17, coordinating alkenes were incorporated 
into our solvent system.  As seen in Table 18, performing the carbocyclization reaction in acyclic 
and cyclic alkenes produced an increased amount of E/Z-161 (entries 2-9 and 11-14).  Most 
notably, reacting allene-yne 162 with a catalytic amount of [Rh(CO)2Cl]2 in styrene produced 
cross-conjugated trienes E/Z-161 and 188 in 78% yield as a 61:39 isomeric mixture (entry 13).  
Triene E/Z-161 was produced in a high E:Z ratio of 8:1 during this reaction.  Alternatively, 
adding 1,5-cyclooctadiene to the reaction prohibited the cycloisomerization reaction from 
occurring and is attributed to the increased binding ability of 1,5-cyclooctadiene (COD) to the 
rhodium catalyst (entries 15-17).89  
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Table 18: Allenic Carbocyclization Reaction of Allene-yne 162 in Alkene Solvents Systems 
TMS
HO
188E/Z-161
•
HO
TMS
[Rh(CO)2Cl]2, r.t.
162
10 mol%
+
TMS
HO
 
Entry Solvent E/Z-161:188a E:Za Yield (%)b 
1 toluene 0 : 100 ------ 84 
2 toluene (ethylene atmosphere) 53 : 47 4 : 1 80 
3 toluene/1-decene (500 : 1) 11 : 89 4 : 1 69 
4 toluene/1-decene (1 : 1) 54 : 46 7 : 1 53 
5 1-decene 61: 39 6 : 1 58 
6c trans-4-octene 20 : 80 1 : 1 29 (40 brsm) 
7 cis-cyclooctene 56 : 44 3 : 1 20 (67 brsm) 
8 cycloheptene 49 : 51 3 : 1 55 
9 cyclohexene 21 : 79 3 : 1 67 
10 cyclopentene ------ ------ complex mixture 
11 1,4-cyclohexadiene 44 : 56 5 : 1 78 
12 isoprene 55 : 45  4 : 1 68 
13 styrene 61 : 39 8 : 1 78 
14 allyl benzene 14 : 86 2 : 1 21 
15 1,5-cyclooctadiene ------ ------ no reaction 
16 toluene/1,5-cyclooctadiene (1:1) ------ ------ no reaction 
17 toluene/1,5-cyclooctadiene (500:1) ------ ------ no reaction 
 aProduct ratios determined by GC analysis. bCombined yield of E/Z-161 and 188. cTriene product contaminated with impurities. 
 
The high yield and isomeric ratio of E/Z-161 : 188 produced when styrene is used as the 
solvent for the cycloisomerization reaction warranted further investigation.  To determine if the 
styrene is affecting the β-hydride elimination step of the carbocyclization reaction, the reaction 
was carried out in a mixture of toluene and styrene.  As shown in Table 20, employing this 
mixed solvent system decreased the formation of E/Z-161 (entries 3-4). 
The role of temperature on the regioselectivity of the allenic Alder-ene reaction in styrene 
was also investigated.  Performing the carbocyclization reaction in styrene at 50 °C and 90 °C 
gave E/Z-161 and 188 in decreased isomeric ratios of 39:61 and 17:83, respectively (compare 
entry 2 with entries 5 and 6). Performing the cycloisomerization reaction at -20 to 0 °C required 
 86 
the addition of AgSbF6, and 188 was still produced as the major isomer.  The results summarized 
in Table 19 indicate that the styrene solvent is affecting the selectivity of the Rh(I)-catalyzed 
carbocyclization reaction, and that elevated reaction temperatures favor the formation of Z-161 
and 188. 
Table 19: Examining the Rh(I)-Catalyzed Carbocyclization of Allene-yne 162 in Styrene 
TMS
HO
188E/Z-161
•
HO
TMS
[Rh(CO)2Cl]2, r.t.
162
10 mol%
+
TMS
HO
 
Entry Solvent/Conditions Temp (°C) E/Z-161:188a E:Za Yield(%)b 
1 toluene 25 0 : 100 ------ 84 
2 styrene 25 61 : 39 8 : 1 78 
3 toluene/styrene (1 : 1) 25 54 : 46 7 : 1 76 
4 toluene/ styrene (500 : 1) 25 12 : 88 3 : 1 81 
5 styrene 50 39 : 61 3 : 1 73 
6c styrene 90 17 : 83 1 : 16 36 
7 styrene/AgSbF6 -20 to 0 39 : 61 1 : 3 18 
aProduct ratios determined by GC analysis. bCombined yield of E/Z-161 and 188. cTriene product contaminated with impurities.  
1.11.5.4 Exploring Rhodium and Ruthenium Catalysts for the Carbocyclization of 
Allene-yne 162 
 
Next, it was postulated that formation of pseudo-cycle 237 and β-hydride elimination of Hb could 
be suppressed by the catalyst (Scheme 61).  Thus, we examined rhodium catalysts yielding a 
coordinatively saturated Rh(III)-metallocycle intermediate upon oxidative coupling of the allene-
yne substrate.   
 Reacting 10 mol% of trans-RhCl(CO)(PPh3)2141 with 162 at 25 to 50 °C in THF142 gave 
trienes E/Z-161 and 188 in a 43:57 isomeric ratio in 8% yield (entry 3, Table 20).  Allene-yne 
162 was recovered in 75% yield from this reaction.  Increasing the reaction temperature to 80 
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°C143 resulted in cross-conjugated trienes E/Z-161 and 188 in a isomeric ratio of 27:73 in 38% 
yield (compare entries 3 and 4).  As seen in entry 5, employing a more sterically encumbered 
catalyst like (PPh)3RhCl (Wilkinson’s catalyst)144 for the cyclization resulted in a 51:49 isomeric 
ratio of E/Z-161 : 188 in 44% yield.  The appending trisubstituted alkene of E/Z-161 was 
produced in a high 6:1 E:Z ratio.  The increased formation of E/Z-161 when trans-
RhCl(CO)(PPh3)2 and Rh(PPh)3Cl are employed for the carbocyclization reaction suggests that 
the phosphine ligands on the rhodium catalyst are capable of suppressing coordination of the 
appending alkene to the rhodium metallocycle. However, the low yields obtained are not 
synthetically useful.  
Table 20: Investigation of Catalysts for the Formation of Cross-Conjugated Triene 161 
TMS
HO
188E/Z-161
•
HO
TMS
[Rh(CO)2Cl]2, r.t.
162
10 mol%
+
TMS
HO
 
Entry Conditions  Solvent T(°C) E/Z-161:188a E:Za Yield (%)c 
1 [Rh(CO)2Cl]2,  toluene 25 0 : 100 ----- 84 
2 [Rh(CO)2Cl]2 DCE 25 7 : 93 1 : 4 80 
3b RhCl(CO)(PPh3)2 THF 25-50 43 : 57 2 : 1 8 (33 brsm) 
4 RhCl(CO)(PPh3)2 DCE 80 27 : 73 3 : 1 38 
5  (PPh)3RhCl toluene 110 51 : 49 6 : 1 44 
6b [Rh(COD)2Cl]2,AgBF4,PPh3 DCE 25 14 : 86 1 : 0 36 
7 [Rh(CO)2Cl]2,AgBF4, PPh3 DCE 25 ----- ----- complex mixture 
8 [Rh(CO)2Cl]2,AgBF4, BINAP THF 25-60 22 : 78 1 : 1 8 (10 brsm) 
9 CpRu(CH3CN)3PF6 DMF 25 ----- ----- unknown cmpd 
10d CpRu(CH3CN)3PF6 acetone 25 0 : 100 ----- trace 
 aProduct ratios determined by GC  analysis.  bProduct ratios determined by integration of peaks in the 1H NMR. cCombined yield 
of E/Z-161 and 188 dProduct contained impurities 
 
The Brummond group has shown that employing cationic rhodium catalysts for the 
allenic carbocyclization reaction produces the alkene side chain of the triene products with 
enhanced E:Z selectivities.19  Considering these results, we reacted 162 with 10 mol% 
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[Rh(COD)Cl]2, 22 mol% AgBF4, and 30 mol% PPh3, which lead to cross-conjugated trienes  
E/Z-161 and 188 in a 14:86 isomeric ratio in 36% yield (entry 6).  Reacting 162 with 10 mol% 
[Rh(CO)2Cl]2, 20 mol% AgBF4 and 20 mol% rac-BINAP in THF lead to trienes E/Z-161 and 
188 in 8% yield as a 22:78 isomeric mixture (entry 8).  Thin-layer chromatography (TLC) 
showed that using cationic rhodium catalysts for the carbocyclization reaction produced many 
byproducts in addition to the desired cross-conjugated trienes. 
We next examined a ruthenium-derived catalyst for the cyclization of allene-yne 162.  
Based on a report by Trost and Toste that showed CpRu(CH3CN)3PF6 in DMF could transform 
geranyl derived enynes into their carbocyclic counterparts with high E selectivity, we reacted 
162 with 10 mol% of CpRu(CH3CN)3PF6.8  Interestingly, these reaction conditions resulted in 
the formation of an unknown compound (6 mg on 28 mg scale) with olefinic resonances at 5.66 
ppm (d, J = 3.3 Hz, 1H), 5.61 ppm (d, J = 2.1 Hz, 1H), 5.60 ppm (d, J = 2.1 Hz, 1H), 5.50 ppm 
(s, 1H), 5.15-5.01 ppm (m, 3H), 4.99 ppm (dt J = 2.1, 1.2 Hz, 1H), and 4.88 ppm (d, J = 2.1 Hz, 
1H) in the 1H NMR (entry 9, Table 20).  Performing the Ru-catalyzed carbocyclization reaction 
in acetone lead to a trace amount of cross-conjugated triene 188, which was contaminated with 
impurities that were inseparable via column chromatography. 
1.11.5.5 Assignment of the Stereochemistry of Cross-Conjugated Trienes E-161 and 
Z-161 through nOe Analysis 
 
Cross-conjugated triene E-161 was separated from the constitutional and Z-isomers 188 
and Z-161 using normal phase HPLC. The alkene region in the 1H NMR of E-161 is shown in 
Table 21.  The resonances corresponding to Ha (d, J = 3.6 Hz) and Hb (s) are at 5.64 ppm and 
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5.43 ppm, respectively.  Additionally, resonances at 5.29 ppm (tq, J = 7.0, 1.5 Hz) and 5.15 ppm 
(tt, J = 7.0, 1.5 Hz) correlate to alkenyl protons Hc and Hd in the skipped diene side chain.   
Table 21: 1H NMR of Cross-conjugated Triene E-161 (alkene region, CDCl3, rt, 300 MHz) 
 
 Chemical Shift Spin multiplicity J  Values (Hz) 
Ha 5.64 ppm d 3.6 
Hb 5.43 ppm s ----- 
Hc 5.29 ppm tq 7.2, 1.5 
Hd 5.15 ppm tt 7.2, 1.2 
 
The E- and Z-isomers of cross-conjugated triene 161 were assigned based upon nOe data 
(Figure 13).  For example, irradiating the resonance corresponding to He of E-161 resulted in 
3.0% and 1.9% enhancements for the resonances corresponding to the proximal alkenyl methyl 
groups.  Additional 3.2% and 1.9% enhancements were observed for the resonances 
corresponding to the adjacent alkenyl protons Hc and Hd.  Irradiating the alkenyl proton Hc 
resulted in 6.0% and 3.0% enhancements for the resonances corresponding to Ha and He, 
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respectively.  No enhancement, however, was observed for the resonance corresponding to the 
appending vinyl methyl group.  The 3.0% nOe between He and the proximal vinyl methyl group 
supports the E-geometry of E-161. 
Alternatively, irradiating Hc of Z-161 resulted in 2.8% and 2.1% enhancements of the 
resonances corresponding to the neighboring methyl and methylene groups.  The 2.8% 
enhancement of the resonance corresponding to the appending vinyl methyl group supports that 
the trisubstituted alkene of Z-161 has the assigned Z-geometry. 
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CH3
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He
He
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Figure 13: nOe Analysis of E-161 and Z-161 after HPLC separation 
1.11.5.6 The Iridium-Catalyzed Allenic Carbocyclization of Allene-ynes Containing 
Tethered Alkenes 
 
Brummond and coworkers have shown that employing [Ir(COD)Cl]2 and AgBF4 for the allenic 
carbocyclization reaction yields cross-conjugated trienes in high E:Z selectivities.19  Considering 
this, allene-yne 176 was reacted with [Ir(COD)Cl]2/AgBF4 to produce cross-conjugated trienes 
199 and E/Z-200 in 66% yield as a 27:73 isomeric mixture.  A high E:Z ratio of 21:1 was 
obtained for triene E/Z-200 (entry 2, Table 22).  Desilylation of 199 and E/Z-200 was also 
observed during this reaction (23%).  The ability of the [Ir(COD)Cl]2 and AgBF4 to convert 
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allene-yne 176 into E/Z-200 in a high E:Z ratio contrasts sharply to [Rh(CO)2Cl]2, which only 
produces cross-conjugated triene 199 (compare entries 1 and 2). 
Similarly, subjecting sulfonamide 180 to the iridium-catalyzed carbocyclization 
conditions gave 211 and E/Z-212 in 78% yield in a 32:68 isomeric ratio.  Cross-conjugated triene 
E/Z-212 was obtained with an E:Z selectivity of  6:1 (entry 4).  The increased 78% yield of 
211/E/Z-212 obtained from the iridium-catalyzed Alder-ene reaction is likely due to the 
formation of Pauson-Khand cyclopentenone products when [Rh(CO)2Cl]2 is employed for the 
cycloisomerization (compare entries 3 and 4).  
Table 22: Ir(I)- and Rh(I)-Catalyzed Carbocyclization Reaction of Allene-ynes Containing Tethered Alkenes 
X
•
TMS
X
TMS
X
TMS
+
A B
20 mol% AgBF4
10 mol% [Ir(COD)Cl]2
1,2-DCE, 60 °C
 
Entry Allene-yne Ratio of A:Bb Conditionsa E:Zb Yield(%)e 
1 176, X= CO2Et 199:200, 100:0 A ------ 74 
2 176, X= CO2Et 199:200, 27:73 B 21 : 1 66 
3 180, X= NTs 211:212, 100: 0 A ------ 63 
4 c 180, X= NTs 211:212, 32:68 B 6 : 1 78 
5 184, X= O 223:224, 100:0 A ------ 61 
6d 184, X= O 223:224, 32:68 B 10 : 1 28 
    aConditions: (A) 10 mol% [Rh(CO)2Cl]2, toluene. (B) 10 mol% [Ir(COD)Cl]2, 20 mol% AgBF4, DCE, 60 °C. b E:Z ratio 
determined by GC analysis. c Product Ratios determined by integration of peaks in the 1H NMR. d Substrate was added to a pre-
mixed solution of [Ir(COD)Cl]2 and AgBF4 in DCE. eCombined yield of trienes A and B 
 
Ether-tethered allene-yne 184 proved to be sensitive to the cationic iridium reaction 
conditions.  For example, addition of 184 to a solution of [Ir(COD)Cl]2 followed by immediate 
addition of a solution of AgBF4 gave a complex mixture of compounds.  Alternatively, addition 
of 184 to a pre-mixed solution of [Ir(COD)Cl]2 and AgBF4 gave trienes 223 and E/Z-224 in a 
32:68 isomeric ratio, albeit in 28% yield.  Triene E/Z-224 was produced in a E:Z ratio of 10:1 
(entry 6).  
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Unfortunately, as seen in Scheme 63, addition of 162 to pre-mixed solution of 
[Ir(COD)Cl]2 and AgBF4 resulted in a complex mixture of more non-polar products.  The 
absence of the resonance at 4.19 ppm corresponding to Ha in the 1H NMR indicates that the 
secondary alcohol was either eliminated or oxidized during the reaction.  However, the complex 
nature of the mixture obtained prevents conclusive identification of its many products. 
•
OH
TMS
162
10 mol% [Ir(COD)Cl]2
20 mol% AgBF4
DCE, 60°C
complex mixtureHa
4.19 ppm
 
Scheme 63: Reaction of 162 with [Ir(COD)Cl]2 and AgBF4 
The results summarized in Table 22 demonstrate that the allenic carbocyclization of 
allene-ynes containing an isobutylene group can be performed with [Ir(COD)Cl]2 and AgBF4 to 
access trienes with an appending trisubstituted alkene side chain in high E:Z selectivies.  
However, the low yield obtained for ether-tethered trienes 223/E/Z-224 and the complex mixture 
obtained from allene-yne 162 (Scheme 63) indicate that the iridium catalyst system derived from 
[Ir(COD)Cl]2/AgBF4 is not as functional group tolerant as [Rh(CO)2Cl]2. 
1.11.5.7 The Thermally Induced Ene Cyclization of Allene-yne 162 
 
In 1985 Trost and Lautens found that heating enyne 240 to 625 °C produced only skipped diene 
241 in 83% yield.120  The selective formation 241 results from exclusive abstraction of a 
methylene hydrogen during the thermally-induced cyclization (Scheme 64). Alternatively, the 
palladium-catalyzed carbocyclization121 reaction of 240 with Pd2(dba)3·CHCl3 and HOAc gave 
only 242, resulting from selective β-hydride elimination of a methyl group hydrogen. 
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Scheme 64: Carbocyclization of Enyne 240120, 121 
More recently in 2005, the Brummond group has shown that microwave irradiation 
(MWI) can be employed for the construction of bicycle[4.2.0]octa-1,6-dienes and cross-
conjugated trienes from allene-yne precursors.145  As seen in Eq. 1 of Scheme 65, microwave 
irradiation of allene-yne 243, which possesses a terminal allene, yields cyclobutene 244 in 81% 
yield.  Alternatively, subjecting disubstituted allene-yne 245 to MWI results in the selective 
formation of cross-conjugated triene 246 in 54% yield (Scheme 65, Eq. 2).  
BzN
•MeO2C
Me
MWI
250 °C, 15 min
3M ioinic liquid
in toluene, 81%
BzN
MeO2C
Me
Eq. 1
BzN
•MeO2C
Me
3M ioinic liquid
in toluene, 54%
Eq. 2
BzN
MeO2C
Me
243 244
245 246
MWI
250 °C, 15 min
 
Scheme 65: Microwave Irradiation of Allene-ynes145 
In view of these results, we investigated microwave irradiation reaction conditions for the 
carbocyclization of allene-yne 162.  Heating 162 to 225 °C for 20 min produced cyclopentene 
247 in 54% yield as a ~1:1 separable mixture of diastereomers (Scheme 66).  Interestingly, the 
formation of cyclobutene 248 and cross-conjugated triene 161 was not observed during this 
reaction.  The selective formation of 247 indicates that the ene reaction between the allene and 
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alkene functionalities of 162 is faster than both the [2 + 2] cycloaddition and the allenic 
carbocyclization between the allene and alkyne moieties.  
•
HO
TMS
162
HO
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 DMF, 20 min
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54%, dr 1.2:1
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TMS
247
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Scheme 66: Selective Formation of Cyclopentene 247 from Allene-yne 162 
The 1H NMR of the more polar diastereomer of 247 has a resonance at 4.78-4.71 ppm 
corresponding to the 1,1-disubstituted alkene protons Ha (Figure 14).  The resonances at 3.91-
3.83 ppm and 3.35-3.28 ppm correspond to Hb and the bis-allylic proton Hc, respectively.  
Additionally, the IR spectrum has absorbances at 3345 cm-1 and 2174 cm-1 that support the 
presence of the alcohol and alkyne functionalities.81 
OH
TMS
247
Ha
Ha
Hb
Hc
4.78-4.71 ppm
m, 2H
3.91-3.83 ppm
m, 1H
3.35-3.28 ppm
m, 1H
 
Figure 14: Assignment of Ha Hb, and Hc in the 1H NMR Spectrum of 247 (500 MHz, CDCl3) 
The formation of 247 is exciting as it possesses the 1-methyl-3-(prop-1-ene-
2yl)cyclopentene scaffold found in a variety of biologically interesting compounds like   
Cyclomusk®,146 a cyclopentenyl ethyl ester that has a strawberry-like musky odor (Scheme 67). 
Interestingly, cyclopentenyl aldehyde 250, a precursor to Cylcomusk®, has been previously 
synthesized via a thermally-induced ene reaction of allene-ene 249 in 38% yield by Érman and 
coworkers.147   
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Scheme 67: Thermal Cyclization of Allene-ene 249147 
1.11.5.8 Summary and Conclusions for the Allenic Carbocyclization Reaction of 
Allene-ynes with an Appending Isobutylene Group 
 
We have achieved the first instance of a Rh(I)-catalyzed allenic carbocyclization reaction 
wherein an isobutylene group is appended to the allene-yne substrate to selectively produce 
cross-conjugated trienes containing a 1,1-disubstituted alkene side chain.  The scope and 
limitation studies conducted indicate that a coordinating isobutylene functionalitity can be used 
to control the β-hydride elimination step of the cyclization reaction.  Incorporation of malonate, 
sulfonamide, and ether substituents into the allene-yne backbone minimally affects the reaction 
and regioisomerically pure cross-conjugated trienes are obtained in good yields.  Substitution at 
the alkynyl position is also tolerated.  However, the isomeric cross-conjugated trienes produced 
from allene-yne substrates containing a phenyl, methyl, or terminal alkyne indicates that the 
alkynyl-substituent can influence the selectivity of the carbocyclization reaction.  The bis-diene 
moiety of the cross-conjugated trienes produced from TMS-alkynyl allenes could function as a 
powerful building block for the rapid construction of polycyclic compounds via transmissive 
Diels-Alder reactions. 
 Complementary regioselectivity of the appending alkenyl side chain is obtained by 
performing the Rh(I)-catalyzed carbocyclization reaction in a coordinating solvent.  For 
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example, employing styrene as the reaction solvent produces a cross-conjugated triene that 
possesses the entire carbocyclic framework of fumagillol and ovalicin in high E:Z selectivity.  
This high yielding transformation demonstrates the utility of the Rh(I)-catalyzed 
carbocyclization reaction for natural product synthesis.  Furthermore, it is envisioned that 
applying these carbocyclization reaction conditions to allene-yne (R)-162 will allow for the 
asymmetric syntheses of (–)-fumagillol and (–)-ovalicin from a chiral cross-conjugated triene 
precursor.   
Our investigations showed that reacting malonate- and heteroatom-tethered allene-ynes 
containing an isobutylene group with [Rh(CO)2Cl]2 produced α-alkylidene cyclopentenones in 
yields of 8-14% and 20-39%, respectively.  The formation of these cyclocarbonylation by-
products is unique, because typically [Rh(CO)2Cl]2 reacts with the distal double bond of the 
allene to give 4-alkylidene cyclopentenones.148   
We demonstrated that [Ir(COD)Cl]2 and AgBF4 can be employed to transform allene-
ynes containing an isobutylene group into cross-conjugated triene products in high yields and 
E:Z selectivities. This cationic catalyst system is advantageous as it circumvents the formation 
cyclopentenone by-products observed with [Rh(CO)2Cl]2. 
Additionally, we have reported the construction of a cyclopentene carbocycle via a 
microwave irradiation-induced ene reaction of an allene-yne substrate possessing a remote 
alkene.  This thermally induced cyclization suggests the ene reaction between the allene and 
alkene functionalities of allene-yne 162 is faster than the alternative [2 + 2] cycloaddition or 
carbocyclization reaction pathways between the allene and alkyne moieties. 
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1.12 INVESTIGATING THE REACTIVITY OF CROSS-CONJUGATED TRIENE E-
161 TOWARDS SELECTIVE OXIDATION REACTIONS 
1.12.1 Application of Alcohol-Directed Oxidation Reactions to Cross-Conjugated Triene E-
161 
It is envisioned that the endocyclic alkene of E-161 can be selectively oxidized through an 
alcohol-directed epoxidation reaction to yield 251.  The bis-allylic epoxide will be converted into 
diol 252 through a palladium-catalyzed hydrogenolysis reaction and into carbonate 253 via a 
palladium-catalyzed CO2 insertion reaction (Scheme 68).  Diol 252 and carbonate 253 then will 
be used to access the structurally related natural products fumagillol and ovalicin, respectively.  
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Scheme 68: Anticipated Transformations of Bis-Allylic Epoxide 251 
1.12.1.1 Application of Alcohol-Directed Epoxidation Reaction Conditions to Cross-
Conjugated Triene E-161 
 
Reacting cross-conjugated triene 188 with Al(OtBu)3 and tBuOOH in the presence of 4Ǻ MS 
produced bis-allylic epoxide 254 in 56% yield as a single diastereomer and enone 255 in 14% 
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yield (Scheme 69).149-151  The formation of 254 is supported by the 1H NMR, which has a 
resonance at 3.19 ppm (d, J = 1.5 Hz) corresponding to Ha.   
TMS
HO
4 ÅMS
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+
188 254, 56%, (67% brsm) 255, 14%, (17% brsm)
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Al(OtBu)3
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Scheme 69: Alcohol-directed Epoxidation of Cross-conjugated Triene 188 
 Unfortunately, reacting the isomeric cross-conjugated triene E-161 with Al(OtBu)3 and 
tBuOOH only resulted in enone 256 in 13% yield and the recovery of starting material (entry 1, 
Table 23).  A small amount of an unknown more polar compound was also isolated from this 
reaction.  However, based upon the single resonance in the alkene region at 5.23 ppm (tt, J = 7.0, 
1.5 Hz) in the 1H NMR, over-oxidation of the cross-conjugated triene system occurred.  
Subjecting E-161 to Ti(OiPr)4, DIPT, and tBuOOH also resulted in a small amount of the over- 
oxidized compound and unreacted starting material (entry 2).87  
 Reacting E-161 with VO(acac)2/tBuOOH at reaction temperatures ranging from 70-25°C 
resulted in the isolation of enone 256 and aldehyde 257 (entries 3-5, Table 23).85  Switching from 
VO(acac)2 to VO(OEt)3 again produced enone 256 and ketone 257 (entries 6-7).152, 153  The 
formation of aldehyde 257 is likely due to a vanadium-catalyzed epoxide opening by tBuOOH.  
This process has been shown to be a favorable reaction pathway for 1,1-disubstituted alkenes and 
conjugated dienes.154, 155  A resonance at 9.23 ppm (d, J = 2 Hz) in the 1H NMR corresponds to 
the aldehyde proton and supports that 257 was obtained. 
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Table 23: Reaction of E-161 with Vanadium-catalyzed Epoxidation Reaction Conditions 
conditions
256
TMS
HO
257
OO
+
E-161
HO
TMS
O
TMS
tBuOOH
 
Entry Reagents Temp (°C) Yield of 256 (%) Yield of 257 (%) 
1 Al(OtBu)3,4 ǺMS –20 to 0 13 (17  brsm) ----- 
2 Ti(OiPr)4, 4 ǺMS –20 to 0 0 0 
3 VO(acac)2 70 24 (27 brsm) 26 (30 brsm) 
4 VO(acac)2 40 8 (10 brsm) 28 (34 brsm) 
5 VO(acac)2 25 29 (48 brsm) 5 (9 brsm) 
6 VO(OEt)3 0 11 (16 brsm) ----- 
7 VO(OEt)3 0 to 25 trace 14 
8 Mo(CO)6 25 to 80 43 (50 brsm) ----- 
   
Peracid epoxidation conditions were next investigated and E-161 was reacted with m-
CPBA and NaHCO3.  This reaction resulted in a 32% yield of epoxide 259 (entry 1, Table 24).  
A resonance at 2.81 ppm (t, J = 6.5 Hz) in the 1H NMR corresponds to Ha and supports the 
regioselectivity of the epoxidation.  Based upon integration of the resonances at 66.4 ppm and 
63.3 ppm in the 13C NMR, 259 was produced as a 1.2:1 mixture of diastereomers.  Reacting E-
161 with m-CPBA in an emulsion156 or with magnesium bis(monoperoxyphthalate) hexahydrate 
(MMPP)157, 158 also resulted in epoxidation of the remote alkene in the side chain.  
Table 24: Formation of Epoxide 259 from Cross-Conjugated Triene E-161 
conditions
258
+
E-161
HO
TMS
O
TMS
259
HO
TMS
OHa  
Entry Reagents Temp (°C) Yield of 259 (%) Yield of 259 (%) 
1 mCPBA, NaHCO3 0 ----- 32 (36 brsm) 
2 mCPBA, in emulsion 25 10 (12 brsm) 9 (11 brsm) 
3 MMPP, NaHCO3 0 to 40 -----  29 
4 TFAA, H2O2, Na2HPO4 0 complex mixture complex mixture 
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            The results summarized in Tables 23 and 24 indicate that the desired alcohol-directed 
epoxidation of E-161 is a challenging process.  The inability of the oxidizing reagents screened 
to convert E-161 into bis-allylic epoxide 251 caused the examination of alcohol-directed 
dihydroxylation protocol. 
1.12.1.2 Application of Alcohol-Directed Dihydroxylation Reaction Conditions to E-
161 
 
An alcohol–directed dihydroxylation reaction was examined to selectively oxidize the endocyclic 
alkene of E-161.  As seen in Scheme 70, reacting E-161 with OsO4 (1 equiv) and TMEDA is 
predicted to produce syn-triol 260, which could be employed for the synthesis of ovalicin. 
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Scheme 70: Predicted Formation of Triol 261 via Dihydroxylation of Tetraene E-161 
Subjecting E-161 to the stereo- and chemoselective dihydroxylation protocol developed 
by Donohoe and coworkers produced osmate ester 261 in 36% yield and a complex mixture of 
compounds (Scheme 71).159, 160 The presence of the osmate ester in 261 is supported by 
resonances at 2.85 ppm (s, 3H), 2.83 ppm (s, 3H), 2.82 ppm (s, 3H), and 2.81 ppm (s, 3H) in the 
1H NMR that correspond to the TMEDA methyl groups.  The regioselectivity of the osmate ester 
is confirmed by the absence of the resonance corresponding to Ha at 5.15 ppm (tt, J = 7.0, 1.5 
Hz). 
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Scheme 71: Reaction of E-161 with Stoichiometric OsO4 and TMEDA 
The sterically congested environment of the endocyclic alkene in E-161 could explain the 
preferential oxidation of the accessible side chain alkene.  Additionally, the electron rich nature 
of the unconjugated alkene in E-161 accounts for the increased reactivity of the remote alkene 
towards the electrophilic oxidizing reagents examined. 
1.12.1.3 Allylic 1,3-Transposition: Exploration of  Myers’  Protocol for the Reductive 
Rearrangement of E-161 
 
Myers and coworkers have developed a regio- and stereoselective method for the reductive 1,3-
transposition of allylic alcohols.161  It is anticipated that subjecting E-161 to these rearrangement 
conditions will produce the allylic diazene intermediate 262, which upon sigmatropic elimination 
will yield tetraene 263.  Subsequent dihydroxylation of the strained endocyclic alkene in 263 
using Sharpless’ asymmetric dihydroxylation protocol will result in diol 252.  syn-Diol 252 will 
be used in the synthesis of fumagillol (Scheme 72). 
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Scheme 72: Projected Synthesis of diol 252 from E-161 
 Interestingly, reacting E-161 with o-nitrobenzenesulfonylhydrazide (NBSH), diethyl 
azodicarboxylate (DEAD), and triphenylphosphine (PPh3) in N-methyl morpholine produced 264 
in 50% yield (Scheme 73).  The formation of 264 is evidenced by a resonance at 2.64-2.50 ppm 
(m) in the 1H NMR that corresponds to the allylic proton Ha.  Additional resonances at 0.79 ppm 
(dd, J = 15, 1.2 Hz), 0.73* ppm (dd, J = 15.3, 2.1 Hz), 0.61* ppm (dd, J = 15.3, 11.7 Hz), and 
0.50 ppm (dd, J = 15.0, 11.7 Hz) correspond to the diastereomeric methylene protons at C1.  
Based upon integration of the resonances at 0.61 ppm and 0.50 ppm, 264 was produced as a 
1.3:1 mixture of diastereomers, which are inseparable via column chromatography. 
TMS
HO
E-161 264
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50% HO
TMSHa 2.64-2.50 ppmmultiplet1
 
Scheme 73: Selective Vinyl Silane Reduction: Synthesis of 264 
 The selective formation of 264 from E-161 using Myers’ reductive rearrangement 
protocol is intriguing as it provides an avenue for the selective functionalization of vinyl silanes.  
O’Doherty and coworkers162 have also observed that the application of Myers’161 protocol to 
unsaturated systems can result in alkene reduction. 
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1.12.1.4 Summary and Conclusions for the Functionalization of E-161 
 
In summary we have shown that the unconjugated alkene in the side chain of E-161 can be 
selectivity oxidized under buffered peracid epoxidation conditions and Donohoe’s 
dihydroxylation protocol.  The epoxide moiety of 259 and the osmate ester in 261 could serve as 
an alkene protecting group that will allow for the selective oxidation of the cross-conjugated 
system in E-161 and the syntheses of fumagillol and ovalicin.  
Alternatively, subjecting E-161 to Myers’ reductive rearrangement reaction conditions 
with o-nitrobenzenesulfonylhydrazide (NBSH) resulted in the selective reduction of the vinyl 
silane moiety.  In the future, the observed reduction reaction will be prevented by performing the 
Mitsunobu reaction with the more stable acetone hydrazone of NBSH.  This transformation 
should allow for the formation of tetraene 263, a potentially useful intermediate in the synthesis 
of fumagillol. 
1.13 EXPERIMENTAL SECTION  
1.13.1 General Methods 
Unless otherwise noted, all reactions were performed under an atmosphere of N2 or Ar in flame 
dried glassware using standard syringe, cannula, and septum techniques.  All commercially 
available compounds were purchased from Aldrich Chemical Co., GFS Chemicals, Strem 
Chemicals, and Acros Organics and were used as received unless otherwise stated.  
Tetrahydrofuran (THF) and diethyl ether (Et2O) were further dried and deoxygenated using the 
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Sol-Tek ST-002 solvent purification system via activated alumina and Q5 columns under a 
nitrogen atmosphere.  Dichloromethane (CH2Cl2) was further purified using the Sol-Tek ST-002 
solvent purification system with an activated alumina column.  Toluene, 1,2-dichloroethane 
(DCE), triethylamine (Et3N), diisopropylamine (DIPA), and N,N,N’,N’-
tetramethylethylenediamine (TMEDA) were freshly distilled from CaH2 prior to use.  Pyridine, 
N,N'-dimethylformamide (DMF), and hexamethylphosphoric amide (HMPA) were freshly 
distilled from CaH2 and were stored over activated 4 Ǻ molecular sieves.   
The progress of reactions was monitored by silica gel thin-layer chromatography (TLC) 
plates (60 F254 plates of 250 μm thickness), and visualized using UV and charred using 
potassium permanganate, p-anisaldehyde, 2,4-dinitrophenylhydrazine, or cerium molybdate 
stain.  Flash chromatography used for the purification of compounds was carried out using silica 
gel (32-63 μm particle size, 60 Ǻ pore size) or a Biotage Horizon Flash Collector (40-63 μm 
particle size, 60 Ǻ pore size). HPLC purification was performed on a Varian-Prostar 210 
instrument using a Varian Microsorb Dynamax 100-5 Si column (5μ packing, 250 mm x 10 
mm). 
All 1H, 13C, and 19F nuclear magnetic resonance spectra were taken on a Bruker 300, 500, 
or 600 MHz instrument, with chemical shifts (δ) reported relative to the respective solvent peak 
CDCl3 (7.27 ppm).  All NMR spectra were acquired at room temperature unless otherwise stated.  
The abbreviations used to describe spin multiplicity for all 1H NMR spectra are as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, b = broad, m = multiplet, dd = doublet of doublet, dt 
= doublet of triplet, ddd = doublet of doublet of doublet, etc, etc.  All infrared spectra were 
obtained from a Nicolet Avatar E.S.P 360 FT-IR.  EI mass spectrometry was performed on a 
Fisons VG Autospec high resolution mass spectrometer. ESI low resolution mass spectrometry 
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was performed on a Hewlett Packard Series 1100 MSD LCMS and high resolution was 
performed on a Waters Q-Tof API-US mass spectrometer.  Gas chromatography was carried out 
using Shimadzu GC-17A gas chromatograph equipped with an FID detector using a Shimadzu 
RTX-5 capillary column (Crossbond®-5% diphenyl-95% dimethylpolysiloxane, 0.25 mmID, 
0.25 μm df, flow rate = 1.94 mL·min-1).  The GC ratios reported for the various isomeric cross-
conjugated trienes were obtained using the following method: Injection temperature = 250 °C, 
column temperature = 80 °C to 220 °C, ramp rate = 20 °C·min-1.  
1.13.2 Experimental Procedures 
+
O
TMSH
THPO
112
OH
TMS
THPO
113111
 
8-Methyl-1-(trimethylsilyl)-8-(tetrahydro-2H-pyran-2-yloxy)nona-1,6-diyn-5-ol (113). 
A two-necked, 25-mL round-bottomed flask is equipped with a stir bar, rubber septum, a low-
temperature thermometer, and a nitrogen inlet.  The flask is charged with alkyne 11178 (0.92 g, 
5.5 mmol) and Et2O (4 mL).  The mixture is cooled between –50 and –60 ˚C with a dry ice -
acetone bath and n-butyllithium (3.1 mL of a 1.6 M hexane soln, 5.0 mmol) is added dropwise 
via syringe.  The reaction is stirred between –50 and –60 ˚C  for 10 min before aldehyde 11279 
(0.92 mg, 6.0 mmol) is added to the reaction via cannula.  The reaction is warmed to –20 ˚C over 
1 h before ice cold sat’d aq NH4Cl is added.  The aq layer was separated and extracted with 
EtOAc.  The combined organic layers are dried over MgSO4, filtered using gravity filtration, and 
concentrated under reduced pressure by rotary evaporation.  The residue is purified by silica gel 
eluting with 5-20% EtOAc/hexanes to afford 1.25 g of the title compound as viscous yellow oil 
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in 78% yield.  Rƒ 0.2 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 5.07-5.00 (m, 1H), 
4.54 (q, J = 5.5 Hz, 1H), 3.99-3.92 (m, 1H), 3.54-3.47 (m, 1H), 2.52-2.34 (m, 2H), 2.32 (bs, 1H), 
1.91 (q, J = 6.5 Hz, 2H), 1.88-1.78 (m, 1H), 1.76-1.65 (m, 1H), 1.62-1.50 (m, 4H), 1.53 (s, 3H), 
1.48 (s, 3H), 0.15 (s, 9H);   13C NMR (75 MHz, CDCl3): δ 106.1, 95.9, 87.8, 85.4, 84.1, 70.8, 
63.2, 61.4, 36.4, 32.0, 30.4, 29.9, 25.4, 20.3, 15.9, 0.1 (3C);  IR (thin film): 3396, 2938, 2167, 
1244 cm-1;  EI-MS m/z (%) 237 (5), 221 (16), 131 (55), 85 (97), 73 (100); EI-HRMS calcd for 
C13H21O2Si: m/z (M-C5H9O) 237.1311; found: 237.1315.  
•HO
TMS
110
OH
TMS
THPO
113
 
8-Methyl-1-(trimethylsilyl)nona-6,7-dien-1-yn-5-ol (110).  A 50-mL, single-necked round-
bottomed flask equipped with a reflux condenser, nitrogen inlet, and stir bar is charged with 
LAH (0.38 g, 9.9 mmol) and Et2O (18 mL).  The mixture is heated and stirred at reflux (oil bath 
temperature 40-45 °C) for 15 min before a solution of propargylic alcohol 113 (2.9 g, 9.0 mmol) 
in Et2O (3.6 mL) is added dropwise over 5-10 min to the refluxing reaction via cannula.  
Immediately after the addition is complete, the reaction mixture is cooled to rt and diluted with 
Et2O.  To the flask is slowly added H2O (0.4 mL), 10% NaOH (0.8 mL), followed by sat’d aq KF 
solution (1.5 mL).  After stirring for 5 min at rt, the resulting solids are filtered off via gravity 
filtration.  The solids are washed with Et2O and the filtrate is concentrated under reduced 
pressure by rotary evaporation.  The residue is purified by silica gel chromatography eluting with 
5-10% Et2O/pentanes to afford allenyl alcohol 110 (1.61 g in 81% yield) as a light yellow oil.  Rƒ 
0.4 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 5.12-5.04 (m, 1H), 4.22 (q, J = 6.7 
Hz, 1H), 2.39-2.33 (m, 2H), 1.84 (bs, 1H), 1.82-1.70 (m, 2H), 1.73 (s, 3H), 1.72 (d, J = 0.6 Hz, 
 107 
3H), 0.15 (s, 9H);  13C NMR (75 MHz, CDCl3): δ 199.8, 106.9, 99.1, 93.1, 84.9, 69.1, 36.0, 20.6 
(2C), 16.1, 0.1 (3C); IR (thin film): 3356, 2958, 2175, 1968, 1249 cm-1;  EI-MS m/z (%) 222 (3, 
M+˙), 207 (4), 179 (23), 70 (51), 61 (100); EI-HRMS calcd for C13H22OSi: m/z (M+˙) 222.1440; 
found: 222.1435. 
+
O
TMSH
THPO
112
OH
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(R)-8-Methyl-1-(trimethylsilyl)-8-(tetrahydro-2H-pyran-2-yloxy)nona-1,6-diyn-5-ol (R-113) 
A 100-mL, single-necked, round-bottomed flask equipped with a stir bar, nitrogen inlet, rubber 
septum, Zn(OTf)2 (2.83 g, 7.79 mmol) and (+)-N-methylephedrine (1.44 g, 8.05 mmol) is purged 
with nitrogen for 15 min.  To the flask is then added anhydrous toluene (22 mL), and Et3N (1.12 
mL, 8.05 mmol) via syringe.  The resulting mixture is vigorously stirred at rt for 2 h before 
alkyne 111 (1.35 g, 8.05 mmol) is added to the reaction flask by syringe.  After 15 min, a 
solution of aldehyde 112 (400 mg, 2.60 mmol) in toluene (6.5 mL) is added to the flask over 4 h 
via syringe pump addition.  When the addition of aldehyde 112 is complete, the reaction is 
observed to be complete by TLC and sat’d aq NH4Cl is added.  The reaction mixture is 
transferred to a separatory funnel and the layers are separated.  The aq layer is extracted with 
Et2O and the combined organic layers are washed with brine, dried over MgSO4, and filtered 
using gravity filtration.  The filtrate is concentrated under reduced pressure by rotary evaporation 
and the resulting residue is purified on silica gel eluting with 5-20% EtOAc/hexanes to afford 
611 mg of the title compound as viscous yellow oil in 73% yield.  Rƒ 0.2 (20% EtOAc/hexanes); 
1H NMR (300 MHz, CDCl3): δ 5.05-5.00 (m, 1H), 4.51 (q, J = 5.7 Hz, 1H), 3.99-3.90 (m, 1H), 
3.55-3.46 (m, 1H), 2.84-2.65 (m, 1H), 2.51-2.30 (m, 2H), 1.89 (q, J = 6.9 Hz, 2H), 1.85-1.75 (m, 
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1H), 1.75-1.64 (m, 1H), 1.61-1.50 (m, 4H), 1.51 (s, 3H), 1.47 (s, 3H), 0.13 (s, 9H);   13C NMR 
(75 MHz, CDCl3): δ 106.1, 95.9, 87.6, 85.3, 84.2, 70.8, 63.1, 61.2, 36.4, 31.9, 30.4, 29.9, 25.3, 
20.3, 15.9, 0.0 (3C). 
•HO
TMS
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(R)-8-Methyl-1-(trimethylsilyl)nona-6,7-dien-1-yn-5-ol (R-110).  A 5-mL, single-necked 
round-bottomed flask equipped with a reflux condenser, nitrogen inlet, and stir bar is charged 
with LAH (48 mg, 1.3 mmol) and Et2O (2.3 mL).  The mixture is heated and stirred at reflux (oil 
bath temperature 40-45 °C) for 15 min before a solution of propargylic alcohol (R)-113 (370 mg, 
1.14 mmol) in Et2O (0.5 mL) is added dropwise over 2-5 min to the refluxing reaction via 
cannula.  Immediately after the addition is complete, the reaction mixture is cooled to rt and 
diluted with Et2O.  To the flask is slowly added H2O (48 μL), 10% NaOH (96 μL), followed by 
sat’d aq KF solution (192 μL).  After stirring for 5 min at rt, the resulting solids are filtered off 
via gravity filtration.  The solids are washed with Et2O and the filtrate is concentrated under 
reduced pressure by rotary evaporation.  The residue is purified by silica gel chromatography 
eluting with 5-10% Et2O/pentanes to afford allenyl alcohol (R)-110 (114 mg in 45% yield) as a 
light yellow oil.  Rƒ 0.4 (20% EtOAc/hexanes); [α]D23 = -29.6 (c = 1.14 in CH2Cl2). 
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8-Methyl-1-(trimethylsilyl)nona-6,7-dien-1-yn-5-yl  3,3,3-trifluro-2-methoxy-2-phenyl- 
propanoate (114).  A 5-mL, single-necked round-bottomed flask equipped with a rubber 
septum, nitrogen inlet, and stir bar is charged with (R)-(+)-alpha-methoxy-alpha-
(trifluromethyl)-phenylacetic acid (41 mg, 0.18 mmol), N,N'-dicyclohexylcarbodiimide (36 
mg, 0.18 mmol), and CH2Cl2 (0.3 mL).  To the flask is then sequentially added allene-yne 
110 (13 mg, 0.06 mmol) in CH2Cl2 (0.3 mL) via cannula, and DMAP (4 mg, 0.03 mmol) in 
one portion. The reaction is stirred at rt until consumption of 110 is observed by TLC.  The 
reaction mixture is transferred into a separatory funnel containing Et2O and sat’d aq 
NaHCO3. The aq layer is separated and extracted with Et2O (3X).  The combined organic 
layers are washed with H2O, brine, are dried over MgSO4, and filtered via gravity filtration. 
The filtrate is concentrated under reduced pressure by rotary evaporation to give 21 mg of 
ester 114 in 82% crude yield.  Rƒ 0.7 (20% EtOAc/hexanes); 19F NMR (300 MHz, CDCl3): δ 
-72.1 (s, 1F), -72.2 (s, 1F). Enantiomeric excess: 0%.  
(R)-110
•HO
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(2S)-(R)-8-Methyl-1-(trimethylsilyl)nona-6,7-dien-1-yn-5-yl 3,3,3-trifluro-2-methoxy-2- 
phenylpropanoate (R-114).  A 5-mL, single-necked round-bottomed flask equipped with a 
rubber septum, nitrogen inlet, and stir bar is charged with (R)-(+)-alpha-methoxy-alpha-
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(trifluromethyl)-phenylacetic acid (66 mg, 0.28 mmol), N,N'-dicyclohexylcarbodiimide (58 
mg, 0.28 mmol), and CH2Cl2 (0.4 mL).  To the flask is then sequentially added allene-yne 
(R)-110 (21 mg, 0.09 mmol) in CH2Cl2 (0.4 mL) via cannula, and DMAP (6 mg, 0.05 mmol) 
in one portion. The reaction is stirred at rt until consumption of (R)-110 is observed by TLC.  
The reaction mixture is transferred into a separatory funnel containing Et2O and sat’d aq 
NaHCO3. The aq layer is separated and extracted with Et2O (3X).  The combined organic 
layers are washed with H2O, brine, are dried over MgSO4, and filtered via gravity filtration. 
The filtrate is concentrated under reduced pressure by rotary evaporation to give 35 mg of 
ester (R)-114 in 85% crude yield.  Rƒ 0.7 (20% EtOAc/hexanes); 19F NMR (300 MHz, 
CDCl3): δ -72.1 (s, 1F), -72.2 (s, 28F). Enantiomeric excess: 93%.  
•
TMS
HO
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(4E)-3-(6-Methylhepta-1,5-dien-2-yl)-4-((trimethylsilyl)methylene)cyclohexen-2-ol (109) 
A flame-dried 500-mL, single-necked round-bottomed flask equipped with a stir bar, rubber 
septum, and argon balloon is charged with allene-yne 110 (2.19 g, 9.85 mmol) and 1,4-
dioxane (197 mL).  Argon is bubbled through the solution using a balloon filled with argon 
attached to a syringe, then [Rh(CO)2Cl]2 (191 mg, 0.495 mmol) is added in one portion.  The 
mixture is heated and stirred at 65 °C for 20 min before consumption of 110 is observed by 
TLC.  The solution is cooled to rt and is concentrated under reduced pressure by rotary 
evaporation.  The residue is purified by silica gel chromatography eluting with 5-20% 
Et2O/pentanes to afford 1.67 g of cross-conjugated triene 109 in 76% yield.  Rƒ 0.4 (20% 
EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 5.60 (d, J = 3.2 Hz, 1H), 5.43 (s, 1H), 4.94-
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4.88 (m, 1H), 4.80-4.74 (m, 1H), 4.28-4.21 (m, 1H), 2.48 (ddd, J = 14.6, 7.9, 3.7 Hz, 1H), 
2.26 (dddd, J = 14.8, 9.9, 3.7, 1.3 Hz, 1H), 1.93 (ddt, J = 12.5, 7.9, 4.3 Hz, 1H), 1.76 (d, J = 
0.9 Hz, 3H), 1.66-1.55 (m, 1H), 0.04 (s, 9H);  13C NMR (75 MHz, CDCl3): δ 148.9, 146.0, 
145.0, 128.2, 126.9, 114.7, 107.2, 66.1, 31.4, 28.0, 23.1, 0.0 (3C);  IR (thin film): 3319, 
2953, 1578, 1248 cm-1;  EI-MS m/z (%) 222 (6, M+˙), 205 (11), 132 (71), 117 (56), 73 (100); 
EI-HRMS calcd for C13H22OSi: m/z (M+˙) 222.1440; found: 222.1439. 
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(R,4E)-3-(6-Methylhepta-1,5-dien-2-yl)-4-((trimethylsilyl)methylene)cyclohexen-2-ol  
(R-109). A flame-dried 50-mL, single-necked round-bottomed flask equipped with a stir bar, 
rubber septum, and argon balloon is charged with allene-yne (R)-110 (393 mg, 1.77 mmol) and 
1,4-dioxane (35 mL).  Argon is bubbled through the solution using a balloon filled with argon 
attached to a syringe, then [Rh(CO)2Cl]2 (34 mg, 0.09 mmol) is added in one portion.  The 
mixture is heated and stirred at 65 °C for 20 min before consumption of (R)-110 is observed by 
TLC.  The solution is cooled to rt and is concentrated under reduced pressure by rotary 
evaporation.  The residue is purified by silica gel chromatography eluting with 5-20% 
Et2O/pentanes to afford 296 mg of cross-conjugated triene (R)-109 in 75% yield.  Rƒ 0.4 (20% 
EtOAc/hexanes); [α]D
24 = 61.2 (c = 0.83 in CH2Cl2);   1H NMR (500 MHz, CDCl3): δ 5.70 (d, J 
= 3.5 Hz, 1H), 5.53 (s, 1H), 5.00 (dq, J = 3.0, 1.5 Hz,  1H), 4.88-4.85 (m, 1H), 4.35 (ddd, J = 7.0, 
5.0, 3.5 Hz, 1H), 2.58 (ddd, J = 14.5, 8.0, 3.5 Hz, 1H), 2.37 (ddd, J = 14.5, 10.0, 3.5, 1.0 Hz, 
1H), 2.04 (ddt, J = 12.5, 8.5, 4.5 Hz, 1H), 1.86 (dd, J = 1.5, 1.0 Hz, 3H), 1.71 (ddd, J = 12.5, 
10.5, 7.0, 4.0, 1H), 1.51 (bs, 1H), 0.14 (s, 9H). 
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5-((Trimethylsilyl)methylene)-6-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptan-2-ol (115).  
A 10-mL, single-necked, round-bottomed flask equipped with a stir bar, rubber septum, and 
nitrogen line is charged with VO(acac)2 (3 mg, 12 μmol) and benzene (2.4 mL).  A solution of 
allylic alcohol 109 (178 mg, 0.800 mmol) in benzene (0.4 mL) is added to the flask via cannula.  
The green solution is heated to 40 °C in an oil bath for 5 min before t-butyl hydrogen peroxide 
(0.24 mL of a 5.0–6.0 M decane solution, ~0.96 mmol) is added dropwise with a gas tight 
syringe.  Upon addition of the peroxide, the reaction mixture flashes deep red and becomes 
orange.  After 1.5 h of stirring at 40 °C (oil bath temperature), the reaction does not proceed any 
further as observed by TLC, and is cooled to rt.  The reaction mixture is directly applied to silica 
gel treated with Et3N eluting with 5-30% Et2O/pentane to afford allylic epoxide 115 (147 mg, 
77%, 86% brsm) as a light yellow oil.  Rƒ 0.5 (35% EtOAc/hexanes); 1H NMR (300 MHz, 
CDCl3): δ 5.84 (d, J = 1.9 Hz, 1H), 5.20-5.13 (m, 1H), 4.99 (t, J = 1.5 Hz, 1H), 4.15-4.03 (m, 
1H), 3.22 (d, J = 2.0 Hz, 1H), 2.52 (ddd, J = 15.0, 5.4, 3.1 Hz, 1H), 2.01 (ddd, J = 15.0, 12.5, 
3.7, 1.9 Hz, 1H), 1.90-1.78 (m, 2H), 1.76-1.71 (m, 3H), 1.53 (tdd, J = 12.5, 9.4, 3.2 Hz, 1H), 
0.12 (s, 9H);  13C NMR (75 MHz, CDCl3): δ 148.1, 142.1, 132.4, 113.0, 67.8, 67.6, 64.3, 28.8, 
28.4, 20.2, -0.2 (3C);  IR (thin film): 3319, 2953, 1578, 1249, 1072;  EI-MS m/z (%) 194 (17), 
179 (27), 165 (20), 84 (66), 73 (100); EI-HRMS calcd for C13H22O2Si: m/z (M+˙); 238.1389 
found: 238.1395 
 113 
HOHO
TMSTMS
OHO
115 117a
HOHO
TMS
117b
+
 
(E,1S,2R,3S)-4-(Trimethylsilyl)methylene)-3-(prop-1en-2-yl)cyclohexane-1,2-diol (117a),  
(E,1S,2R,3R)-4-(Trimethylsilyl)methylene)-3-(prop-1en-2-yl)cyclohexane-1,2-diol (117b).  A 
5-mL, single-necked, round-bottomed flask equipped with a stir bar, rubber septum, and argon 
balloon is charged with Pd2(dba)3·CHCl3 (16 mg, 0.02 mmol) and 1,4–dioxane (0.3 mL).  To the 
flask is added n-Bu3P (8 μL, 0.03 mmol) with a gas tight syringe.  A premixed solution of formic 
acid (118 μL, 3.08 mmol), and Et3N (171 μL, 1.23 mmol) in 1,4–dioxane (0.3 mL) is then added 
to the reaction flask via cannula.  After stirring at rt for 5 min, a solution of allylic epoxide 115 
(147 mg, 0.62 mmol) in 1,4–dioxane (1.8 mL) is added via cannula to the dark red catalyst 
mixture.  The reaction is heated and stirred at 40 °C in an oil bath for 40 min when the reaction is 
observed to be complete by TLC analysis.  The reaction is quenched with H2O which causes the 
reaction to turn from red to brown.  The aq layer is separated and extracted with Et2O.  The 
combined organic layers are washed with H2O, brine, are dried over MgSO4, and filtered via 
gravity filtration. The filtrate is concentrated under reduced pressure by rotary evaporation.  The 
resulting residue is purified via silica gel chromatography using a Biotage Horizon Flash 
Collector (Biotage Si 25 + M, 25 x 150 mm, Et2O/pentanes = 2-50%, flow rate = 10 mL/Min) to 
yield 92 mg of diastereomeric diols 117a and 117b in 62% yield as a 1:1 isomeric mixture.  Rƒ 
0.2, 0.3 (35% EtOAc/hexanes); desired diol 117a  1H NMR (500 MHz, CDCl3): δ 5.19 (s, 1H), 
5.17 (t, J = 1.4 Hz, 1H), 4.89 (s, 1H), 4.14-4.12 (m, 1H), 3.73 (dd, J = 9.7, 2.9 Hz, 1H), 3.12 (d, J 
= 9.7 Hz, 1H), 2.47 (bs, 1H), 2.38 (td, J = 13.1, 4.4 Hz, 1H), 2.31 (dt, J = 13.5, 4.4 Hz, 1H), 2.16 
(bs, 1H), 1.99 (dq, J = 13.4, 4.4 Hz, 1H), 1.77 (s, 3H), 1.59-1.49 (m, 1H), 0.10 (s, 9H);  13C 
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NMR (75 MHz, CDCl3): δ 155.0, 143.1, 123.4, 114.7, 73.3, 68.1, 56.5, 30.4, 28.1, 21.9, 0.2 
(3C);  IR (thin film): 3400, 2953, 1610, 1248, 1077 cm-1;  EI-MS m/z (%) 240 (2, M+˙), 222 (8), 
117 (32), 106 (39), 73 (100);  EI-HRMS calcd for C13H24O2Si: m/z (M+˙) 240.1546; found: 
240.1530. undesired diol 117b 1H NMR (500 MHz, CDCl3): δ 5.33 (s, 1H), 5.26 (s, 1H), 5.09-
5.06 (m, 1H), 4.13 (d, J = 8.5 Hz, 1H), 3.69 (dddd, J = 11.5, 9.0, 4.5, 2.5 Hz, 1H), 2.79 (s, 1H), 
2.60-2.54 (m, 1H), 2.11 (d, J = 9.5, 1H), 2.05-1.96 (m, 2H), 1.72 (s, 3H), 1.53 (d, J = 8.0, 1H), 
1.50-1.43 (m, 1H), 0.13 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 152.9, 143.0, 126.6, 114.1, 
73.5, 71.9, 56.3, 32.4, 31.9, 23.8, 0.2 (3C);  IR (thin film): 3400, 2953, 1618, 1248, 1077 cm-1;  
EI-MS m/z (%) 240 (18, M+˙), 222 (54), 166 (81), 106 (100);  EI-HRMS calcd for C13H24O2Si: 
m/z (M+˙) 240.1546; found: 240.1538. 
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Hexahydro-1-hydroxy-4-((trimethylsilyl)methylene)-3-(prop-1-en-2-yl)benzo[1,3]dioxol-2-
one (118).   A 5-mL, single-necked, pear-shaped flask equipped with a stir bar, rubber septum, 
and argon balloon is charged with palladium acetate (1 mg, 4 μmol) and THF (0.2 mL).  
Triisopropyl phosphite (7 μL, 30 μmol) is rapidly added to the stirring orange solution with a gas 
tight syringe.  The reaction mixture immediately turns colorless upon addition of triisopropyl 
phosphite and is stirred at rt for 5 min.  A solution of n-butyllithium (6.0 μL of a 1.6 M hexane 
soln, 8.8 μmol) is then added to the colorless solution via syringe.  After stirring for 30 min at rt, 
the catalyst solution is added via cannula into a 15 mL thick-walled tube containing a stirring 
solution of allylic epoxide 115 (35 mg, 0.15 mmol) in THF (0.2 mL) under an argon atmosphere.  
Dry ice (72 mg, 1.6 mmol)* is added in one portion and the tube is quickly capped.  The reaction 
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is stirred for 5 h in the pressurized sealed tube at rt, after which time the reaction mixture is 
directly subjected to silica gel chromatography eluting with 5-30% EtOAc/hexanes to afford 36 
mg cyclic carbonate 118 as a single diastereomer in 87% yield.  Rƒ 0.2 (30% EtOAc/hexanes); 
1H NMR (600 MHz, CDCl3): δ 6.03 (s, 1H), 5.17 (d, J = 1.4 Hz, 1H), 5.06 (s, 1H), 4.84 (d, J = 
3.5 Hz, 1H), 4.04 (tt, J = 10.9, 4.2 Hz, 1H), 2.62 (dt, J = 14.7, 4.1 Hz, 1H), 2.08 (dq, J = 12.6, 
4.3 Hz, 1H), 2.04-1.98 (m, 1H), 1.96 (d, J = 9.9 Hz, 1H), 1.82 (s, 3H), 1.68 (qd, J = 11.5, 4.2 Hz, 
1H), 0.15 (s, 9H);  13C NMR (75 MHz, CDCl3): δ 153.1, 149.0, 140.3, 130.2, 115.8, 88.8, 82.4, 
68.0, 29.6, 27.2, 18.3, -0.2 (3C); IR (thin film): 3434, 2955, 1814, 1249 cm-1; EI-MS m/z (%) 
267 (26), 224 (72), 179 (83), 69 (100); EI-HRMS calcd for C14H22O4Si: m/z (M+˙) 282.1287; 
found: 282.1295. 
• The quantity of dry ice used was based upon the calculated amount leading to a pressure 
of 2.72 atm in a 15 mL tube 
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Hexahydro-1-(triethylsilyloxy)-4-((trimethylsilyl)methylene)-2-oxo-3-(prop-1-en-yl)benzo- 
[1,3]dioxol-7-one (132).  A 10-mL, single-necked, round-bottomed flask equipped with a stir 
bar, rubber septum, and nitrogen line is charged with allylic carbonate 118 (118 mg, 0.418 
mmol), DMF (3 mL), and imidazole (43 mg, 0.63 mmol).  The reaction mixture is then cooled to 
0 °C in an ice bath and TESCl (84 μL, 0.50 mmol) is added dropwise via syringe.  The reaction 
is slowly warmed to rt and is stirred until consumption of starting material is observed by TLC.  
The reaction mixture is transferred into a separatory funnel containing H2O and Et2O.  The aq 
layer is separated and extracted with Et2O.  The combined organic layers are washed with H2O, 
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brine, are dried over MgSO4, and filtered via gravity filtration. The filtrate is concentrated under 
reduced pressure by rotary evaporation.  The residue is purified by silica gel chromatography 
eluting with 5% Et2O/pentane to give the desired silyl ether 132 (116 mg) in 70% yield as a 
colorless oil.  Rƒ 0.7 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 5.94 (s, 1H), 5.13 (s, 
1H), 5.06 (s, 1H), 4.61 (d, J = 3.3 Hz, 1H), 4.09 (dt, J = 8.1, 3.9 Hz, 1H), 2.63 (dt, J = 15.0, 5.1 
Hz, 1H), 2.14-1.98 (m, 1H), 1.91-1.77 (m, 2H), 1.79 (s, 3H), 0.97 (t, J = 8.1 Hz, 9H), 0.63 (q, J = 
8.1 Hz, 6H), 0.13 (s, 9H);  13C NMR (75 MHz, CDCl3): δ 153.7, 148.9, 141.1, 129.6, 115.1, 
88.2, 82.2, 67.6, 28.8, 26.4, 18.3, 6.7 (3C), 4.7 (3C), -0.3 (3C); IR (thin film): 2955, 1812, 1249, 
1098 cm-1; ESI-MS m/z (%) 419 (100, [M+Na]+), 375 (9), 335 (21), 131 (32);  ESI-HRMS  calcd 
for C20H36O4NaSi2: m/z [M+Na]+ 419.2050; found: 419.2035. 
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Hexahydro-7-(triethylsilyloxy)-3-(1,2-dihydroxypropan-2-yl)-4-((trimethylsilyl)methylene)- 
benzo[1,3]dioxol-2-one (133).  A 25-mL, single-necked, round-bottomed flask equipped with a 
stir bar, rubber septum, and nitrogen line is charged with silyl ether 132 (479 mg, 1.21 mmol), 
acetone (6 mL), and H2O (0.7 mL).  Osmium tetroxide (0.76 mL of a 2.5 wt% tert-butanol soln, 
0.06 mmol) and NMO (142 mg, 1.21 mmol) are sequentially added.  The resulting brown 
reaction mixture is stirred at rt until consumption of starting material is observed via TLC.  The 
reaction mixture is then diluted with ether and solid NaHCO3, Na2SO3, Na2SO4 are added.  After 
10 min of stirring, the solids are filtered off using gravity filtration, and the filtrate is 
concentrated under reduced pressure by rotary evaporation.  The residue is purified on silica gel 
eluting with 5-50% EtOAc/hexanes to afford 362 mg of the title compound as a brown oil in 
 117 
70% yield as a 9:1 mixture of diastereomers (determined by integration of the resonances at 3.97 
ppm and 3.75 ppm in the 1H NMR).  Rƒ 0.3 (35% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) 
*designates minor diastereomer where resolved: δ 5.93 (d, J = 1.8 Hz, 1H), 5.82* (d, J = 1.5 Hz, 
1H), 4.91 (d, J = 3.3 Hz, 1H), 4.33-4.25 (m, 1H), 4.21* (dt, J = 6.0, 3.3 Hz, 1H), 3.97* (A of an 
ABq, J = 11.4, 1H), 3.75 (A of an ABq, J = 11.9, 1H), 3.46* (B of an ABq, J = 11.4, 1H), 3.41 
(B of an ABq, J = 11.9, 1H), 2.95 (bs, 1H), 2.69 (dt, J = 15.3, 6.6 Hz, 1H), 2.28 (dtd, J = 15.3, 
7.2, 1.8 Hz, 1H), 2.10 (bs, 1H), 1.89-1.78 (m, 2H), 1.27 (s, 3H), 0.95 (t, J = 7.8 Hz, 9H), 0.61 (q, 
J = 7.8 Hz, 6H), 0.14 (s, 9H);   13C NMR (75 MHz, CDCl3): δ 154.1, 150.2, 128.3, 88.5, 80.3, 
75.4, 66.8, 66.3, 27.2, 26.9, 20.0, 6.7 (3C), 4.6 (3C), -0.4 (3C);  IR (thin film): 3419, 2953, 1774, 
1247 cm-1;  ESI-MS m/z (%) 453 (100, [M+Na]+), 430 (8); ESI-HRMS  calcd for 
C20H38O6NaSi2: m/z [M+Na]+ 453.2105; found: 453.2090. 
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3-Acetylhexahydro-7-(triethylsilyloxy)-4-((trimethylsilyl)methylene)benzo[1,3]dioxol-2-one 
(134).  A 10-mL, single-necked, round-bottomed flask equipped with a stir bar, rubber septum, 
and nitrogen line is charged with diol 133 (281 mg, 0.652 mmol), THF (1.8 mL) and H2O (1.8 
mL).  To the light brown solution is added NaIO4 (140 mg, 0.657 mmol) in one portion and the 
reaction is stirred until consumption of diol 133 is observed by TLC.  The reaction mixture is 
transferred into a separatory funnel containing H2O and Et2O.  The aq layer is separated and 
extracted with Et2O until no product remains in the aq layer as observed by TLC.  The combined 
organic layers are washed with H2O, brine, are dried over MgSO4, and filtered via gravity 
filtration. The filtrate is concentrated under reduced pressure by rotary evaporation.  The residue 
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is purified by silica gel chromatography eluting with 5-10% Et2O/pentane to give 180 mg of 
methyl ketone 134 as a light yellow oil in 69% yield. Rƒ 0.8 (35% EtOAc/hexanes); 1H NMR 
(300 MHz, CDCl3): δ 6.03 (s, 1H), 4.75 (d, J = 3.3 Hz, 1H), 4.24 (dt, J = 6.0, 3.3 Hz, 1H), 2.56 
(dt, J = 15.6, 5.8, 1H), 2.28 (s, 3H), 2.07 (dtd, J = 15.4, 7.8, 1.9 Hz, 1H), 1.90-1.73 (m, 2H), 0.93 
(t, J = 8.0 Hz, 9H), 0.59 (q, J = 8.0 Hz, 6H), 0.11 (s, 9H);   13C NMR (75 MHz, CDCl3): δ 203.0, 
152.6, 145.6, 128.6, 89.9, 80.0, 66.6, 27.0, 23.9, 23.6, 6.6 (3C), 4.6 (3C), -0.5 (3C);  IR (thin 
film): 2955, 1819, 1720, 1248 cm-1;  EI-MS m/z (%) 398 (14, M+˙), 355 (16), 325 (100), 267 (5), 
73 (16); EI-HRMS calcd for C19H34O5Si2: m/z (M+˙) 398.1945; found: 398.1942. 
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(E)-Hexahydro-4-(triethylsilyloxy)-7-((trimethylsilyl)methylene)-2-oxobenzo[1,3]dioxol-7-yl 
acetate (135).  A 5-mL, single-necked, round-bottomed flask equipped with a stir bar, rubber 
septum, and nitrogen line is charged with vinyl silane 134 (17 mg, 0.04 mmol), CH2Cl2 (0.2 mL), 
and Na2HPO4 (11 mg, 0.08 mmol).  The flask is cooled to 0 °C in an ice bath and a solution of  
m-CPBA (77%, 15 mg, 0.06 mmol) in 0.2 mL of CH2Cl2 is added via cannula.  The reaction is 
slowly warmed to rt and is complete after 3 h as observed by TLC.  The reaction mixture is 
transferred into a separatory funnel containing sat’d aq Na2SO3 and Et2O.  The aq layer is 
separated and extracted with Et2O.  The combined organic layers are washed with sat’d aq 
NaHCO3, H2O, brine, and are dried over MgSO4.  The solids are filtered off via gravity filtration 
and the filtrate is concentrated under reduced pressure by rotary evaporation.  The residue is 
purified by silica gel eluting with 5-20% Et2O/pentane to afford 11 mg of ketal 135 and as a light 
yellow oil in 62% yield.  Rƒ 0.7 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 6.01 (s, 
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1H), 4.81 (d, J = 4.0 Hz, 1H), 4.26 (q, J = 3.5 Hz, 1H), 2.78-2.63 (m, 1H), 2.51 (dt, J = 16.3, 4.8 
Hz, 1H), 2.10 (s, 3H), 1.93-1.83 (m, 2H), 0.96 (t, J = 7.9 Hz, 9H), 0.64 (q, J = 7.9 Hz, 6H), 0.15 
(s, 9H);   13C NMR (75 MHz, CDCl3): δ 169.3, 145.5, 130.2, 103.7, 81.1, 65.9, 25.7, 23.6, 21.6, 
6.6 (3C), 4.6 (3C), -0.7 (3C);  IR (thin film): 2955, 1828, 1749, 1016 cm-1;  EI-MS m/z (%) 414 
(43, M+˙), 341 (19), 299 (100), 283 (9), 131 (34); EI-HRMS calcd for C19H34O6Si2: m/z (M+˙) 
414.1894; found: 414.1885.  
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3-Acetyl-hexahydro-7-(triethylsilyloxy)-4-((trimethylsilyl)oxirane)-benzo[1,3]dioxol-2-one 
(136).  A 15-mL, single-necked, round-bottomed flask equipped with a stir bar, reflux condenser, 
and nitrogen line is charged with vinyl silane 134 (228 mg, 0.573 mmol), CH2Cl2 (5.7 mL), and  
m-CPBA (77%, 167 mg, 0.743 mmol).  The reaction is then heated and stirred at 40 °C in an oil 
bath until consumption of starting material is observed by TLC.  The reaction mixture is cooled 
to rt and is transferred into a separatory funnel containing sat’d aq Na2SO3 and Et2O.  The aq 
layer is separated and extracted with Et2O.  The combined organic layers are washed with sat’d 
aq NaHCO3, H2O, brine, and are dried over MgSO4.  The solids are filtered off via gravity 
filtration and the filtrate is concentrated under reduced pressure by rotary evaporation.  The 
resulting residue is purified on silica gel eluting with 50% CH2Cl2/hexanes to afford 172 mg of 
epoxide 131 in 73% yield.  Rƒ 0.6 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 4.79 
(d, J = 3.3 Hz, 1H), 4.29 (q, J = 3.6 Hz, 1H), 2.76 (s, 1H), 2.31 (s, 3H), 1.98-1.82 (m, 3H), 1.74-
1.61 (m, 1H), 0.98 (t, J = 8.1 Hz, 9H), 0.68 (q, J = 8.1 Hz, 6H), 0.18 (s, 9H);   13C NMR (75 
MHz, CDCl3): δ 204.5, 152.8, 87.5, 80.0, 66.3, 62.2, 55.9, 27.8, 26.3, 23.1, 6.8 (3C), 4.7 (3C), -
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1.9 (3C); IR (thin film): 2957, 1821, 1723, 1107 cm-1;  EI-MS m/z (%) 414 (10, M+˙), 371 (39), 
341 (34), 115 (49), 73 (100); EI-HRMS calcd for C19H34O6Si2: m/z (M+˙) 414.1894; found: 
414.1886.  
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Z/E-136  
Hexahydro-7-triethylsiloxy-((Z)-6-methylhepta-2,5-dien-2-yl)-4-((trimethylsilyl)oxirane)-
benzo[α][1,3]dioxol-2-one (Z-136), Hexahydro-((E)-6-hydroxy-6-methylhept-2-en-2-yl)-7-
triethylsiloxy-4-((trimethylsilyl)oxirane)benzo[α][1,3]dioxol-2-one (E-136). A 10-mL, single-
necked, round-bottomed flask equipped with a stir bar, rubber septum, and nitrogen line is 
charged with methyl ketone 131 (44 mg, 0.11 mmol), sulfone 8565 (150 mg, 0.533 mmol), and 5 
mL of THF.  The flask is cooled to –78 °C in a dry ice-acetone bath and LiHMDS (0.53 mL, 1.0 
M soln in THF, 0.53 mmol) is added dropwise via syringe.  Upon addition of LiHMDS, the 
reaction turns from light yellow to bright orange.  After 10 min, consumption of ketone 131 is 
observed by TLC and cold sat’d aq NH4Cl is added.  The reaction mixture is transferred into a 
separatory funnel and the aq layer is separated and extracted with Et2O.  The combined organic 
layers are washed with H2O, brine, and are dried on MgSO4.  The solids are filtered off via 
gravity filtration and the filtrate is concentrated under reduced pressure by rotary evaporation.  
The resulting residue is purified on silica gel eluting with 5% Et2O/pentane to afford 22 mg of 
diene Z/E-136 in 43% yield as a 2:98 mixture of E:Z isomers (based upon integration of the 
resonances at 5.59 ppm and 5.44 ppm).  Rƒ 0.7 (20% EtOAc/hexanes); 1H NMR (500 MHz, 
CDCl3) *designates E-isomer where resolved: δ 5.59* (t, J = 7.5 Hz, 1H),  5.44 (tq, J = 7.5, 1.5 
Hz, 1H), 5.05 (tt, J = 7.0, 1.5 Hz, 1H), 4.72 (d, J = 3.5 Hz, 1H), 4.54* (d, J = 4.0 Hz, 1H), 4.33 
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(dt, J = 8.0, 4.0 Hz, 1H), 4.07* (dt, J = 9.0, 4.0 Hz, 1H), 2.92-2.76 (m, 2H), 2.51 (ddd, J = 16.0, 
9.0, 7.5 Hz, 1H), 2.39* (dt, J = 15.5, 6.0 Hz, 1H), 2.27 (s, 1H), 1.97-1.81 (m, 2H), 1.76 (s, 3H), 
1.70 (s, 3H), 1.63 (s, 3H), 1.34 (ddd, J = 15.0, 6.5, 4.5 Hz, 1H), 0.98 (t, J = 7.8 Hz, 9H), 0.65 (q, 
J = 7.8 Hz, 6H), 0.15 (s, 9H);   13C NMR (75 MHz, CDCl3): δ 154.1, 132.9, 132.6, 128.2, 122.0, 
89.6, 81.8, 65.7, 59.5, 53.2, 28.4, 25.7, 25.1, 23.0, 22.6, 17.9, 6.7 (3C), 4.6 (3C), -1.8 (3C); IR 
(thin film): 2921, 1816, 1463, 1250 cm-1;  EI-MS m/z (%) 480 (7, M+˙), 407 (18), 279 (37), 157 
(49), 149 (100); EI-HRMS calcd for C25H44O5Si2: m/z (M+˙) 480.2727; found: 480.2743. 
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Hexahydro-3a-(2-hydroxybut-3-yn-2-yl)-7-triethylsiloxy-4-((trimethylsilyl)oxirane)-
benzo[1,3]dioxol-2-one (145).  A 5-mL, single-necked, round-bottomed flask equipped with a 
stir bar and vacuum adaptor is charged with CeCl3·7H2O (135 mg, 0.362 mmol).  The white solid 
is stirred under vacuum (4 mm Hg) and is immersed into a sand bath, which is then heated to 140 
°C for 12 h.  The flask is removed from the sand bath and allowed to cool to rt.  The vacuum 
adaptor is replaced with a rubber septum and nitrogen line, and the flask is evacuated and 
charged with N2 (1X).  To the flask is then added 2.4 mL of THF via syringe and the resulting 
white suspension is vigorously stirred for 1 h before being cooled to 0 °C in an ice bath.  
Ethynylmagnesium bromide (0.70 mL of a 0.5 M THF soln, 0.35 mmol) is added to the white 
suspension dropwise via syringe.  The resulting brown solution is stirred at 0 °C for 1.5 h before 
a solution of methyl ketone 131 (25 mg, 0.06 mmol) in 0.4 mL of THF is added to the reaction 
flask via cannula.  Immediately upon completion of addition of 131, the reaction is complete as 
observed via TLC and H2O is added dropwise.  The reaction mixture is transferred into a 
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separatory funnel, and the aq layer is separated and extracted with Et2O until no product remains 
as observed by TLC.  The combined organic layers are washed with H2O, brine, and are dried on 
MgSO4.  The solids are filtered off via gravity filtration and the filtrate is concentrated under 
reduced pressure by rotary evaporation.  The residue is purified on silica gel eluting with 5-20% 
Et2O/pentane to give 20 mg of propargyl alcohol 145 as a single diastereomer in 75% yield. Rƒ 
0.3 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 5.06 (bs, 1H), 4.64 (d, J = 3.3 Hz, 
1H), 4.27 (dt, J = 6.3, 3.3 Hz, 1H), 2.90 (s, 1H), 2.67 (s, 1H), 2.37-2.26 (m, 1H), 1.99-1.78 (m, 
3H), 1.54 (s, 3H), 0.98 (t, J = 7.8, 9H), 0.67 (q, J = 7.8, 6H), 0.19 (s, 9H);  13C NMR (75 MHz, 
CDCl3): δ 153.3, 84.3, 84.2, 80.3, 75.1, 72.8, 66.4, 65.7, 58.8, 26.4, 25.3, 24.6, 6.8 (3C), 4.6 
(3C), -1.9 (3C); IR (thin film):  3402, 3308, 2956, 2114, 1815, 1251 cm-1;  ESI-MS m/z (%) 463 
(100, [M+Na]+), 437 (19), 405 (6), 358 (5); ESI-HRMS  calcd for C21H36O6NaSi2: m/z [M+Na]+ 
463.1948; found: 463.1959. 
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2-Hexahydro-4-triethylsiloxy-7-((trimethylsilyl)oxirane)-2-oxobenzo[1,3]dioxol-7a-yl-but-3-
yn-2-yl acetate (146).  A 1-mL conical vial equipped with a stir bar, rubber septum, and nitrogen 
line is charged with propargyl alcohol 145 (25 mg, 0.06 mmol), Et3N (0.08 mL, 0.57 mmol), 
DMAP (7 mg, 57 μmol), and Ac2O (27 μL, 0.28 mmol).  The reaction is stirred at rt until 
consumption of 145 is observed by TLC.  The reaction mixture is diluted with Et2O and H2O and 
is transferred into a separatory funnel.  The aq layer is separated and extracted with Et2O and the 
combined organic layers are washed with H2O, brine, and are dried on MgSO4.  The solids are 
filtered off via gravity filtration and the filtrate is concentrated under reduced pressure by rotary 
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evaporation.  The residue is purified on silica gel eluting with 5–20% Et2O/pentane to give 24 
mg of propargyl acetate 146 in 88% yield.  Rƒ 0.8 (5% EtOAc/CH2Cl2); 1H NMR (300 MHz, 
CDCl3): δ 5.06 (d, J = 3.0 Hz, 1H), 4.24 (dt, J = 7.8, 3.6 Hz, 1H), 2.73 (s, 1H), 2.72, (s, 1H), 
2.16-1.80 (m, 3H), 2.10 (s, 3H), 1.99 (s, 3H), 1.67 (dt, J = 12.3, 6.3 Hz, 1H), 0.99 (t, J = 8.1 Hz, 
9H), 0.67 (q, J = 8.1 Hz, 6H), 0.18 (s, 9H);  13C NMR (75 MHz, CDCl3): δ 167.1, 153.0, 83.9, 
81.9, 79.9, 79.3, 73.6, 67.0, 63.2, 56.1, 27.0, 25.8, 22.4, 21.7, 6.8 (3C), 4.7 (3C), -1.7 (3C); IR 
(thin film): 3253, 2957, 2878, 1814, 1761, 1223 cm-1;  ESI-MS m/z (%) 505 (100, [M+Na]+), 443 
(21), 365 (13); ESI-HRMS  calcd for C23H38O7NaSi2: m/z [M+Na]+ 505.2054; found: 505.2032. 
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2-(Hexahydro-4-triethylsiloxy-7-((trimethylsilyl)oxirane)-2-oxobenzo[1,3]dioxol-7a-yl)-but-
3-en-2-yl acetate (144).  A 10-mL, single-necked, round-bottomed flask equipped with a stir bar 
and rubber septum is charged with propargyl acetate 146 (61 mg, 0.13 mmol), EtOH (6.3 mL), 
and Lindlar’s catalyst (39 mg).  The flask is evacuated and charged with H2 (3X) and is 
vigorously stirred until consumption of 146 is observed by TLC.  The reaction mixture is filtered 
through a sintered glass funnel of medium porosity packed with celite.  The filtrate is 
concentrated under reduced pressure by rotary evaporation and the residue is purified by silica 
gel chromatography eluting with 5–20% EtOAc/hexanes to afford 46 mg of 144 in 75% yield as 
a light yellow oil.  Rƒ 0.9 (5% EtOAc/CH2Cl2); 1H NMR (300 MHz, CDCl3): δ 5.96 (dd, J = 
17.6, 11.1, Hz, 1H), 5.33 (d, J = 11.1 Hz, 1H), 5.22 (d, J = 17.6 Hz, 1H), 4.75 (d, J = 3.6 Hz, 
1H), 4.23 (dt, J = 6.6, 3.0 Hz, 1H), 2.65 (s, 1H), 2.07 (s, 3H), 2.05-1.90 (m, 2H), 1.88 (s, 3H), 
1.90-1.73 (m, 2H), 0.98 (t, J = 7.8 Hz, 9H), 0.66 (q, J = 7.8 Hz, 6H), 0.17 (s, 9H);  13C NMR (75 
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MHz, CDCl3): δ 167.9, 153.5, 136.2, 117.7, 85.8, 85.7, 80.4, 66.6, 62.6, 56.6, 26.7, 25.7, 22.2, 
19.7, 6.8 (3C), 4.7 (3C), -1.8 (3C); IR (thin film): 2956, 2878, 1812, 1752, 1235 cm-1; ESI-MS 
m/z (%) 507 (100, [M+Na]+), 487 (64), 425 (86); ESI-HRMS  calcd for C23H40O7NaSi2: m/z 
[M+Na]+ 507.2210; found: 507.2231.  
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tert-Butyldimethylsilyl-5-((E)hexahydro-4-triethylsiloxy-7-((trimethylsilyl)oxirane)-2-
oxobenzo[1,3]dioxol-7a-yl)hex-4-enoate (147).  A 5-mL, single-necked, round-bottomed flask 
equipped with a stir bar, rubber septum, and nitrogen line is charged with THF (0.18 mL) and is 
cooled to –78 °C with a dry ice-acetone bath.  A solution of freshly prepared LDA (64 μL of a 
1.0 M THF soln, 0.06 mmol) and HMPA (18 μL) are then added to the flask via gas tight 
syringe.  The pale yellow solution is stirred at –78 °C for 5 min before a solution of allylic 
acetate 144 (15.5 mg, 0.032 mmol) in 0.1 mL of THF is added via cannula.  The reaction is 
stirred for 2 min before a solution of TBSCl (10 mg, 0.06 mmol) in 0.6 mL of THF is added to 
the stirring reaction via cannula.  At this time, consumption of 144 is observed by TLC and the 
reaction is slowly warmed to rt over 2 h.  After an additional 30 min, the reaction mixture is 
diluted with Et2O and H2O and is transferred into a separatory funnel.  The aq layer is separated 
and extracted with Et2O and the combined organic layers are washed with H2O, brine, and are 
dried on MgSO4.  The solids are filtered off via gravity filtration and the filtrate is concentrated 
under reduced pressure by rotary evaporation to give 18.5 mg of 147 in 96% crude yield.  Rƒ 0.5 
(20% EtOAc/hexanes);  1H NMR (300 MHz, C6D6): δ 5.76-5.68 (m, 1H), 4.13 (d, J = 4.5 Hz, 
1H), 3.94-3.87 (m, 1H), 2.63 (ddd, J = 14.1, 12.0, 4.5 Hz, 1H), 2.50 (s, 1H), 2.48-2.28 (m, 2H), 
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2.19-2.00 (m, 5H), 1.59 (s, 3H), 1.04 (t, J = 7.8 Hz, 9H), 0.95 (s, 9H), 0.72-0.60 (m, 6H), 0.32 (s, 
3H), 0.31 (s, 3H), 0.06 (s, 9H);  13C NMR (75 MHz, C6D6): δ 172.7, 153.6, 131.1, 125.8, 88.5, 
78.5, 65.8, 59.6, 51.7, 35.1, 26.2, 25.8 (3C), 23.1, 23.0, 17.7, 14.9, 7.0 (3C), 5.0 (3C), -1.9 (3C), -
4.7 (2C); IR (thin film): 2955, 2933, 1813, 1717, 1252 cm-1; ESI-MS m/z (%) 621 (100, 
[M+Na]+), 604 (28), 587 (8); ESI-HRMS  calcd for C29H54O7NaSi3: m/z [M+Na]+ 621.3075; 
found: 621.3055. 
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Hexahydro-((E)-6-hydroxy-6-methylhept-2-en-2-yl)-7-triethylsiloxy-4-((trimethylsilyl)-
oxirane)benzo[α][1,3]dioxol-2-one (150). A 5-mL, single-necked, round-bottomed flask 
equipped with a stir bar, rubber septum, and nitrogen line is charged with crude silyl ester 147 
(9.0 mg, 15 μmol) and THF (0.1 mL).  The flask is cooled to –78 °C with a dry ice-acetone bath 
and methyllithium (21 μL of a 1.6 M diethyl ether solution, 33 μmol) is added dropwise with a 
gas tight syringe.  After 30 min, another 2.2 equivalents of methyllithium (21 μL of a 1.6 M 
diethyl ether soln, 33 μmol) is added to the reaction flask via syringe and the reaction is stirred 
until consumption of 147 is observed by TLC.  The reaction mixture is transferred into a 
separatory funnel Et2O and H2O and the aq layer is separated and extracted with Et2O.  The 
combined organic layers are washed with H2O, brine, and are dried on MgSO4.  The solids are 
filtered off via gravity filtration and the filtrate is concentrated under reduced pressure by rotary 
evaporation.  The residue is purified on silica gel eluting with 5–20% EtOAc/hexanes to give 5 
mg of alcohol 150 in 67% yield.  Rƒ 0.1 (20% EtOAc/hexanes); 1H NMR (300 MHz, C6D6): δ 
5.84 (td, J = 7.2, 0.9 Hz, 1H), 4.14 (d, J = 4.5 Hz, 1H), 3.94-3.88 (m, 1H), 2.68 (ddd, J = 14.1, 
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12.0, 4.5 Hz, 1H), 2.50 (s, 1H), 2.07-1.89 (m, 3H), 1.64 (s, 3H), 1.41-1.18 (m, 4H), 1.04 (t, J = 
7.8, 9H), 0.96 (s, 3H), 0.95 (s, 3H), 0.72-0.60 (m, 6H), 0.03 (s, 9H);  13C NMR (75 MHz, C6D6): 
δ 153.8, 129.5, 129.4, 88.7, 78.4, 69.8, 65.8, 59.6, 51.7, 42.8, 29.4, 29.2, 26.3, 23.1, 22.9, 15.0, 
7.0 (3C), 5.0 (3C), -1.9 (3C); IR (thin film): 3397, 2924, 1808, 1250 cm-1; ESI-MS m/z (%) 521 
(100, [M+Na]+), 479 (76), 437 (70), 347 (27); ESI-HRMS  calcd for C25H46O6NaSi2: m/z 
[M+Na]+ 521.2731; found: 521.2715. 
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Hexahydro-7-triethylsiloxy-((E)-6-methylhepta-2,5-dien-2-yl)-4-((trimethylsilyl)oxirane)- 
benzo[α][1,3]dioxol-2-one (151), Hexahydro-7-triethylsiloxy-((E)-6-methylhepta-2,6-dien-2-
yl)-4-((trimethylsilyl)oxirane)benzo[α][1,3]dioxol-2-one (152). A 5-mL, single-necked, round-
bottomed flask equipped with a stir bar, rubber septum, and nitrogen line is charged with tertiary 
alcohol 150 (9 mg, 18 μmol) and THF (0.6 mL).  The flask is cooled to –78 °C with a dry ice-
acetone bath and Et3N (6 μL, 45 μmol) and MsCl (2 μL, 27 μmol) are added sequentially to the 
reaction flask with a gas tight syringe.  The reaction is stirred for 1 h before a solution of n-
Bu4NBr (6 mg, 18 μmol) in 0.6 mL of THF is added via cannula.  The reaction is slowly warmed 
to rt and is stirred for 2 h before H2O is added.  The aq layer is separated from the organic layer 
and is extracted with Et2O.  The combined organic layers are washed with H2O, brine, and are 
dried on MgSO4.  The solids are filtered off via gravity filtration and the filtrate is concentrated 
under reduced pressure by rotary evaporation.  The resulting residue is purified on silica gel 
eluting with 5% Et2O/pentane to afford 4 mg of dienes 151 and 152 in 46% combined yield. 
Based upon integrations of the resonances at 5.07 ppm and 4.74-4.71 ppm, 151 and 152 were 
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produced in a 2:1 isomeric ratio, respectively. Rƒ 0.9 (35% EtOAc/hexanes); 1H NMR (300 
MHz, CDCl3) *designates 152 where resolved: δ 5.59 (td, J = 7.2, 0.9 Hz, 1H), 5.07 (td, J = 7.2, 
1.5 Hz, 1H), 4.74-4.71* (m, 1H), 4.67-4.64* (m, 1H), 4.55 (d, J = 3.9 Hz, 1H), 4.53* (d, J = 3.3 
Hz, 1H), 4.31 (dt, J = 6.6, 3.0 Hz, 1H), 2.71 (t, J = 7.2 Hz, 2H), 2.60-2.46* (m, 4H), 2.27* (s, 
1H), 2.26 (s, 1H), 2.15-2.00 (m, 2H), 2.00-1.85 (m, 2H), 1.71* (s, 3H), 1.69 (s, 3H), 1.67 (s, 3H), 
1.61 (s, 3H), 0.99 (t, J = 7.7 Hz, 9H), 0.71-0.60 (m, 6H), 0.14 (s, 9H); IR (thin film): 2922, 1813, 
1458, 1251 cm-1;  EI-MS m/z (%) 407 (83), 131 (26), 103 (100); EI-HRMS calcd for C22H35O5Si: 
m/z (M-TMS) 407.2254; found: 407.2243. 
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8, 12-Dimethyl-1-(trimethylsilyl)-8-(tetrahydro-2H-pyran-2-yloxy)trideca-11-en-1,6-diyn-5-
ol (164).  A two-necked, 25-mL round-bottomed flask is equipped with a stir bar, rubber septum, 
low-temperature thermometer, and a nitrogen inlet.  The flask is charged with alkyne 163127 (2.4 
g, 10 mmol) and Et2O (7.2 mL).  The mixture is cooled between –50 and –60 ˚C with a dry ice-
acetone bath and n-butyllithium (5.7 mL of a 1.6 M hexane soln, 9.1 mmol) is added dropwise 
via syringe.  The reaction is stirred between –50 and –60 ˚C  for 10 min before aldehyde 11279 
(1.7 g, 11 mmol) is added to the reaction via cannula.  The reaction is warmed to –20 ˚C over 1 
h.  At this time, TLC analysis shows that the desired propargyl alcohol has been formed and ice 
cold sat’d aq NH4Cl is added.  The aq layer is separated and extracted with EtOAc (3X).  The 
combined organic layers are washed with H2O, brine, are dried over MgSO4, and filtered via 
gravity filtration. The filtrate is concentrated under reduced pressure by rotary evaporation.  The 
residue is purified on silica gel eluting with 5-30% EtOAc/hexanes to afford 2.7 g of the title 
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compound as viscous yellow oil in 76% yield in a 1.4:1 diastereomeric ratio (as determined by 
integration of the resonances at 1.49 ppm and 1.42 ppm in the 1H NMR).  Rƒ 0.3 (20% 
EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) *designates minor diastereomer where resolved: δ 
5.18-5.00 (m, 2H), 4.57-4.45 (m, 1H), 4.01-3.88 (m, 1H), 3.56-3.45 (m, 1H), 3.06-2.83 (m, 1H), 
2.51-2.29 (m, 2H), 2.21-2.06 (m, 2H), 1.93-1.63 (m, 6H), 1.67 (s, 3H), 1.61 (s, 3H), 1.58-1.50 
(m, 4H), 1.49 (s, 3H), 1.42* (s, 3H),  0.13 (s, 9H);  13C NMR (75 MHz, CDCl3) *designates 
minor diastereomers where resolved: δ 131.6, 123.9, 106.2, 106.0*, 95.8, 95.1*, 95.0*, 86.8*, 
86.2, 85.9, 85.2, 74.0, 73.5*, 73.4*, 63.0*, 62.9*, 62.8, 61.2*, 61.1, 43.0, 42.3*, 36.4, 32.1, 
31.7*, 28.3, 27.3*, 25.6, 25.4, 25.3*, 23.4*, 23.2, 20.1, 20.0*, 17.6, 15.9, 15.8*, 0.0 (3C); IR 
(thin film): 3411, 2957, 2175, 1687 cm-1;  EI-MS m/z (%) 288 (22), 273 (57), 245 (43), 85 (100), 
73 (39); EI-HRMS calcd for C18H28OSi: m/z (M-C5H9O2) 288.1909; found: 288.1920. 
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8, 12-Dimethyl-1-(trimethylsilyl)trideca-6,7,11-trien-1-yn-5-ol (162). A 50-mL, two-necked 
round-bottomed flask equipped with a cold finger, nitrogen inlet, and stir bar is charged with 
LAH (0.32 g, 8.3 mmol) and Et2O (15.4 mL).  The mixture is heated and stirred at reflux (oil 
bath temperature 40-45 °C) for 10 min before a solution of propargylic alcohol 164 (2.9 g, 7.6 
mmol) in Et2O (3 mL) is added dropwise over 5-10 min to the refluxing reaction via cannula.  
Immediately after the addition of 164 is complete, the reaction mixture is cooled to rt and diluted 
with Et2O.  To the flask is slowly added H2O (0.3 mL), then 10% NaOH (0.6 mL), followed by 
sat’d aq KF solution (1.2 mL).  After stirring for 5 min at rt, the resulting solids are filtered off 
via gravity filtration.  The solids are washed with Et2O and the filtrate is concentrated under 
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reduced pressure by rotary evaporation.  The residue is purified by silica gel chromatography 
eluting with 5-10% Et2O/pentanes to afford 1.6 g of allenyl alcohol 162 in 74% yield as a light 
yellow oil.  Allene-yne 162 was produced as a 1:1 mixture of diastereomers based upon 
integration of the resonances at 107.0 ppm and 106.9 ppm in the 13C NMR.  Rƒ 0.4 (20% 
EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 5.20-5.13 (m, 1H), 5.10 (tq, J = 6.9, 1.5 Hz, 
1H), 4.19 (q, J = 5.7 Hz, 1H), 2.35 (t, J = 7.5 Hz, 2H), 2.16-2.05 (m, 2H), 2.03-1.95 (m, 2H), 
1.95-1.84 (m, 1H), 1.84-1.70 (m, 2H), 1.71 (d, J = 2.7 Hz, 3H), 1.68 (d, J = 0.6 Hz, 3H), 1.60 (s, 
3H), 0.13 (s, 9H);  13C NMR (75 MHz, CDCl3) *designates minor diastereomer where resolved: 
δ 199.2, 132.1, 124.0*, 123.9, 107.0, 106.9*, 103.4, 94.7, 84.8, 68.9, 68.8*,36.2, 36.0*, 34.0, 
26.0, 25.7, 19.2*, 19.1, 17.7, 16.1, 16.0*, 0.1 (3C); IR (thin film): 3350, 2961, 2175, 1965, 1249 
cm-1; EI-MS m/z (%) 290 (73, M+˙), 275 (83), 273 (89), 217 (83), 137 (100); EI-HRMS calcd for 
C18H30OSi: m/z (M+˙) 290.2066; found: 290.2060. 
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N-Methoxy-N-methyl-5-(trimethylsilyl)pent-4-ynamide (165).  A 5-mL, single-necked 
round-bottomed flask equipped with a rubber septum, nitrogen inlet and stir bar is charged 
with 5-(trimethylsilyl)pent-4-ynoic acid163 (75 mg, 0.44 mmol) and CH2Cl2 (1 mL).  The 
solution is cooled to –15 ˚C with a dry ice-acetone bath before N-methylpiperdine (160 μL, 
1.3 mmol) and isobutyl chloroformate (86 μL, 0.6 mmol) are sequentially added via syringe.  
After 1 h, consumption of acid 165a is observed by TLC (Rƒ of acid 165a = 0.1 in 20% 
EtOAc/hexanes).  The reaction is warmed to 0 ˚C in an ice bath before MeNHOMe·HCl (215 
mg, 2.20 mmol) and iPrMgCl (2.2 mL of a 2.0 M THF soln, 4.4 mmol) are added.  After 30 
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min, the reaction does not progress any longer as observed by TLC and additional 
MeNHOMe·HCl (86 mg, 0.88 mmol) and iPrMgCl (0.9 mL of a 2.0 M THF soln, 1.8 mmol) 
are added.  The reaction is warmed to rt and is stirred until consumption of the mixed 
anhydride intermediate is observed via TLC (Rƒ of mixed anhydride = 0.7 in 20% 
EtOAc/hexanes).  The reaction mixture is transferred into a separatory funnel containing 
sat’d aq NH4Cl and EtOAc.  The aq layer is separated and extracted with EtOAc (3X).  The 
combined organic layers are washed with H2O, brine, are dried over MgSO4, and filtered via 
gravity filtration. The filtrate is concentrated under reduced pressure by rotary evaporation.  
The residue is purified by silica gel chromatography eluting with 5-30% EtOAc/hexanes to 
afford Weinreb amide 165 (81 mg in 87% yield).  Rƒ 0.2 (20% EtOAc/hexanes); 1H NMR 
(300 MHz, CDCl3): δ 3.71 (s, 3H), 3.19 (s, 3H), 2.74-2.61 (m, 2H), 2.61-2.50 (m, 2H), 0.15 
(s, 9H);  13C NMR (75 MHz, CDCl3): δ 172.5, 106.0, 84.9, 61.3, 36.1, 31.3, 15.3, 0.1 (3C); 
IR (thin film): 2960, 2176, 1669, 844 cm-1;  EI-MS m/z (%) 213 (68, M+˙), 182 (41), 168 
(100), 153 (42); EI-HRMS calcd for C10H19NO2Si: m/z (M+˙) 213.1185; found: 213.1184. 
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8,12-Dimethyl-1-(trimethylsilyl)-8-(tetrahydro-2H-pyran-2-yloxy)trideca-11-en-1,6-
diyn-5-one (166). A 5-mL, single-necked round-bottomed flask equipped with a rubber 
septum, nitrogen inlet and stir bar is charged with alkyne 163 (104 mg, 0.440 mmol) and 
THF (1.2 mL).  The solution is cooled to –78 ˚C with a dry ice -acetone bath and n-
butyllithium (0.27 mL of a 1.6 M hexane soln, 0.44 mmol) is added dropwise via syringe.  
The reaction is kept at –78 ˚C for 10 min before being placed in a –20 ˚C bath for 30 min.  
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The flask is then cooled to –78 ˚C and a solution of amide 165 (17 mg, 0.08 mmol) in 0.2 mL 
of THF is added via cannula.  The reaction is allowed to slowly warm to 0 ˚ C over 2  h and is 
kept at 0 ˚C for 30 min before being warmed to rt.  The reaction was monitored by TLC, and 
after an additional 30 min of stirring at rt, consumption of amide 165 is observed.  The 
reaction mixture is transferred into a separatory funnel containing sat’d aq NH4Cl and 
EtOAc.  The aq layer is separated and extracted with EtOAc (3X).  The combined organic 
layers are washed with H2O, brine, are dried over MgSO4, and filtered via gravity filtration. 
The filtrate is concentrated under reduced pressure by rotary evaporation.  The residue is 
purified by silica gel chromatography eluting with 5-20% Et2O/pentanes to afford alkynone 
166 (21 mg in 68% yield, d.r. = 1:1 based upon integration of the resonances at 185.1 ppm 
and 184.9 ppm in the 13C NMR) as a light yellow oil.  Rƒ 0.6 (20% EtOAc/hexanes); 1H 
NMR (500 MHz, CDCl3) *designates minor diastereomer where resolved: δ 5.15-5.09 (m, 
1H), 5.05-5.02 (m, 1H), 5.02-4.99* (m, 1H), 4.01-3.91 (m, 1H), 3.56-3.50 (m, 1H), 2.83-2.79 
(m, 2H), 2.57 (t, J = 7.0 Hz, 2H), 2.25-2.09 (m, 2H), 1.89-1.70 (m, 4H), 1.69 (s, 3H), 1.62 (s, 
3H),  1.59-1.53 (m, 4H), 1.51 (s, 3H), 0.14 (9H);  13C NMR (125 MHz, CDCl3) *designates 
minor diastereomer where resolved: δ 185.1*, 184.9, 132.2, 123.4*, 123.3, 104.7, 104.5*, 
96.3, 95.6*, 95.0*, 94.1, 85.6, 85.5*, 83.8, 83.0*, 73.8, 73.0*, 63.2, 63.1*, 44.4, 44.3*, 42.5, 
41.8*, 31.9*, 31.6, 27.6*, 26.4, 25.7*, 25.3*, 23.1, 23.0*, 20.1, 20.0*, 17.6, 14.5, 0.0 (3C); 
IR (thin film): 2942, 2210, 2178, 1682, 844 cm-1;  ESI-MS m/z (%) 411 (100, [M+Na]+), 365 
(21), 217 (21); ESI-HRMS calcd for C23H36O3NaSi: m/z [M+Na]+ 411.2331; found: 
411.2351. 
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(5R)-8,12-Dimethyl-1-(trimethylsilyl)-8-(tetrahydro-2H-pyran-2-yloxy)trideca-11-en-1,6-
diyn-5-ol (R-164).  A single-necked, 10-mL round-bottomed flask equipped with a stir bar, 
rubber septum, and argon balloon is charged with alkynone 166 (472 mg, 1.21 mmol) and iPrOH 
(3.6 mL).  Argon is bubbled through the solution using a balloon filled with argon attached to a 
syringe before Noyori’s catalyst 167129, 130 (109 mg, 0.18 mmol, 0.15 equiv.) is added in one 
portion.  Upon addition of 167, the reaction turns dark orange/red from colorless.  After 5 min of 
stirring at rt, consumption of alkynone 166 is observed by TLC.  The reaction mixture is 
concentrated under reduced pressure.  The residue is purified on silica gel eluting with 5-30% 
EtOAc/hexanes to afford 444 mg of the propargyl alcohol (R)-164 as viscous yellow oil in 94% 
yield, d.r. = 1.6:1 (as determined by integration of the resonances at 1.51 ppm and 1.45 ppm in 
the 1H NMR).  Rƒ 0.3 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) *designates minor 
diastereomer where resolved: δ 5.14 (tt, J = 7.2, 1.5 Hz, 1H), 5.09-5.00 (m, 1H), 4.61-4.51 (m, 
1H), 4.02-3.90 (m, 1H), 3.56-3.47 (m, 1H), 2.54-2.33 (m, 2H), 2.25-2.08 (m, 2H), 1.92 (qd, J = 
6.9, 2.7 Hz, 2H), 1.86-1.65 (m, 4H), 1.69 (s, 3H), 1.63 (s, 3H), 1.58-1.51 (m, 4H), 1.51 (s, 3H), 
1.45* (s, 3H), 0.16 (s, 9H);  13C NMR (75 MHz, CDCl3) *designates minor diastereomer where 
resolved: δ 131.6, 123.9, 106.2, 106.0*, 95.7, 95.1*, 95.0*, 86.9*, 86.2, 85.9, 85.3*, 85.2*, 85.1, 
74.0, 73.5*, 73.4*, 63.0*, 62.9*, 62.8, 61.2, 61.1*, 43.0, 42.3*, 42.2*, 36.4, 32.1, 31.7*, 28.3, 
27.3*, 25.6, 25.4, 25.3*, 23.4*, 23.2, 20.1, 20.0*, 17.6, 15.9, 15.8*, 0.0 (3C). 
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(R)-164 (R)-162  
(5R)-8,12-Dimethyl-1-(trimethylsilyl)trideca-6,7,11-trien-1-yn-5-ol (R-162). A 10-mL, two-
necked round-bottomed flask equipped with a cold finger, nitrogen inlet, and stir bar is charged 
with LAH (47 mg, 1.2 mmol) and Et2O (2.3 mL).  The mixture is heated and stirred at reflux (oil 
bath temperature 40-45 °C) for 5 min before a solution of propargylic alcohol (R)-164 (440 mg, 
1.13 mmol) in Et2O (0.5 mL) is added dropwise over 3-5 min to the refluxing solution via 
cannula.  Immediately after the addition is complete, the reaction mixture is cooled to rt and is 
diluted with Et2O.  To the flask is slowly added H2O (47 μL), then 10% NaOH (94 μL), followed 
by sat’d aq KF solution (188 μL).  After stirring for 5 min at rt, the resulting solids are filtered 
off via gravity filtration.  The solids are washed with Et2O and the filtrate is concentrated under 
reduced pressure by rotary evaporation.  The residue is purified by silica gel chromatography 
eluting with 5-10% Et2O/pentanes to afford allenyl alcohol (R)-162 as a light yellow oil (183 mg 
in 56% yield, d.r. = 1.3:1 based upon integration of the resonances at 107.0 ppm and 106.9 ppm 
in the 13C NMR).  Rƒ 0.4 (20% EtOAc/hexanes);  1H NMR (300 MHz, CDCl3): δ 5.20-5.14 (m, 
1H), 5.14-5.06 (m, 1H), 4.24-4.15 (m, 1H),  2.36 (t, J = 7.5 Hz, 2H), 2.16-2.06 (m, 2H), 2.04-
1.96 (m, 2H), 1.91-1.81 (m, 1H), 1.80-1.71 (m, 1H), 1.72 (d, J = 2.7 Hz, 3H), 1.69 (s, 3H), 1.61 
(s, 3H), 0.14 (s, 9H);  13C NMR (75 MHz, CDCl3) *designates minor diastereomer where 
resolved: δ 199.2, 132.2, 124.0, 107.0, 106.9*, 103.5, 94.7, 84.9, 68.9*, 68.8, 36.2*, 36.1, 34.0, 
26.0, 25.7, 19.2*, 19.1, 17.8, 16.1*, 16.0, 0.1 (3C). 
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168  
(2R)-8,12-Dimethyl-1-(trimethylsilyl)trideca-6,7,11-trien-1-yn-5-yl 3,3,3-trifluoro- 
2-methoxy-2-phenylpropanoate (168). A 5-mL, single-necked round-bottomed flask 
equipped with a rubber septum, nitrogen inlet, and stir bar is charged with (R)-(+)-alpha-
methoxy-alpha-(trifluromethyl)-phenylacetic acid (36 mg, 0.15 mmol), N,N'-
dicyclohexylcarbodiimide (32 mg, 0.15 mmol), and CH2Cl2 (0.3 mL).  To the flask is then 
sequentially added allene-yne 162 (15 mg, 0.05 mmol) in CH2Cl2 (0.3 mL) via cannula, and 
DMAP (3 mg, 0.03 mmol) in one portion. The reaction is stirred at rt until consumption of 
162 is observed by TLC.  The reaction mixture is transferred into a separatory funnel 
containing Et2O and sat’d aq NaHCO3. The aq layer is separated and extracted with Et2O 
(3X).  The combined organic layers are washed with H2O, brine, are dried over MgSO4, and 
filtered via gravity filtration. The filtrate is concentrated under reduced pressure by rotary 
evaporation to give ester 168 in quantitative crude yield.  Rƒ 0.6 (20% EtOAc/hexanes); 19F 
NMR (300 MHz, CDCl3): δ -72.0 (s, 2F), -72.1 (s, 1F), -72.2 (s, 1F). Diastereomeric excess: 
0%.  
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(2R,5R)-8,12-Dimethyl-1-(trimethylsilyl)trideca-6,7,11-trien-1-yn-5-yl 3,3,3-trifluoro-2- 
methoxy-2-phenylpropanoate (R-168). A 5-mL, single-necked round-bottomed flask 
equipped with a rubber septum, nitrogen inlet, and stir bar is charged with (R)-(+)-alpha-
methoxy-alpha-(trifluromethyl)-phenylacetic acid (39 mg, 0.17 mmol), 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (32 mg, 0.17 mmol), and CH2Cl2 
(0.3 mL).  To the flask is then sequentially added allene-yne (R)-162 (16 mg, 0.06 mmol) in 
CH2Cl2 (0.3 mL) via cannula, and DMAP (3 mg, 0.03 mmol) in one portion. The reaction is 
stirred at rt until consumption of (R)-162 is observed by TLC. The reaction mixture is 
transferred into a separatory funnel containing Et2O and sat’d aq NaHCO3.  The aq layer is 
separated and extracted with Et2O (3X).  The combined organic layers are washed with H2O, 
brine, are dried over MgSO4, and filtered via gravity filtration. The filtrate is concentrated 
under reduced pressure by rotary evaporation to give ester (R)-168 in quantitative crude 
yield.  Rƒ 0.6 (20% EtOAc/hexanes); 19F NMR (300 MHz, CDCl3): δ -72.0 (s, 0.16F), -72.1 
(s, 1F), -72.2 (s, 1F). Diastereomeric ratio: 97:3. 
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5-(tert-Butyldimethylsilyloxy)-8,12-dimethyl-1-(trimethylsilyl)trideca-6,7,11-trien-1-yn 
(169).  A 5-mL, single-necked round-bottomed flask equipped with a rubber septum, nitrogen 
inlet, and stir bar is charged with allene-yne 162 (69 mg, 0.24 mmol) and CH2Cl2 (1.7 mL). To 
the flask is sequentially added imidazole (29 mg, 0.42 mmol) and TBSCl (54 mg, 0.36 mmol).  
When consumption of starting material is observed by TLC, the reaction mixture is transferred 
into a separatory funnel containing Et2O and H2O.  The aq layer is separated and extracted with 
Et2O (3X).  The combined organic layers are washed with H2O, brine, are dried over MgSO4, 
and filtered via gravity filtration. The filtrate is concentrated under reduced pressure by rotary 
evaporation.  The residue is purified by silica gel chromatography eluting with 5% Et2O/pentanes 
to afford silyl ether 169 as a light yellow oil (67 mg in 70% yield, d.r. = 1:1 based upon 
integration of the resonances at 107.4 ppm and 107.3 ppm in the 13C NMR).  Rƒ 0.8 (5% 
EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) *designates minor diastereomer where resolved: δ 
5.17-5.09 (m, 1H), 5.03-4.96 (m, 1H), 4.26-4.15 (m, 1H), 2.30 (t, J = 7.5 Hz, 2H), 2.15-2.04 (m, 
2H), 2.01-1.91 (m, 2H), 1.83-1.67 (m, 2H), 1.70 (s, 6H), 1.62 (s, 3H), 0.90 (s, 9H), 0.15* (s, 9H), 
0.14 (s, 9H), 0.09 (s, 6H); 13C NMR (75 MHz, CDCl3) *designates minor diastereomer where 
resolved: δ 200.1, 199.9*, 131.8, 131.7*, 124.0, 107.4*, 107.3, 100.9*, 100.6,  94.6, 84.5, 84.4*, 
71.3, 70.5*, 37.4, 34.2, 34.1*, 26.4*, 26.3, 25.9 (3C), 25.8* (3C), 25.7, 19.1, 18.7*, 18.2, 18.1*, 
17.8, 17.7*, 16.3, 16.1*, 0.1 (3C), -4.2, -4.3*, -4.9; IR (thin film): 2929, 2175, 1079, 840 cm-1;  
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EI-MS m/z (%) 404 (27, M+˙), 347 (53), 73 (100). EI-HRMS calcd for C24H44OSi2: m/z (M+˙) 
404.2931; found: 404.2927. 
162 170
•
TMS
HO
•
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8,12-Dimethyl-1-(trimethylsilyl)trideca-6,7,11-trien-1-yn-5-yl acetate (170). A 5-mL, single-
necked round-bottomed flask equipped with a rubber septum, nitrogen inlet, and stir bar is 
charged with allene-yne 162 (102 mg, 0.351 mmol) and CH2Cl2 (1.2 mL). To the flask is 
sequentially added DMAP (4 mg, 0.04 mmol), pyridine (57 μL, 0.70 mmol), and acetic 
anhydride (40 μL, 0.42 mmol). When consumption of starting material is observed by TLC, the 
reaction mixture is transferred into a separatory funnel containing Et2O and H2O.  The aq layer is 
separated and extracted with Et2O.  The combined organic layers are washed with H2O, brine, 
are dried over MgSO4, and filtered via gravity filtration. The filtrate is concentrated under 
reduced pressure by rotary evaporation. The residue is purified by silica gel chromatography 
eluting with 5% Et2O/pentanes to afford allenyl acetate 170 as a light yellow oil (85 mg in 73% 
yield, d.r. = 1.2:1 based upon integration of the resonances at 102.6 ppm and 102.5 ppm in the 
13C NMR).  Rƒ 0.5 (10% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) *designates minor 
diastereomer where resolved: δ 5.30-5.20 (m, 1H), 5.16-5.06 (m, 2H), 2.31 (dd, J = 6.9, 2.7 Hz, 
1H), 2.29 (dd, J = 7.8, 3.0 Hz, 1H), 2.14-2.03 (m, 2H), 2.05 (s, 3H), 2.04* (s, 3H), 2.01-1.93 (m, 
2H), 1.92-1.83 (m, 2H), 1.71 (d, J = 3.0 Hz, 3H), 1.69 (d, J = 1.5 Hz, 3H), 1.62 (s, 3H), 0.15 (s, 
9H);  13C NMR (75 MHz, CDCl3) *designates minor diastereomer where resolved: δ 201.7, 
201.3*, 170.2, 170.1*, 131.9, 131.8*, 124.0*, 123.9, 106.1, 102.6*, 102.5, 90.3*, 90.2, 85.0*, 
84.9, 71.8, 71.6*, 33.9, 33.1, 33.0*, 26.2, 26.1*, 25.7, 21.2, 21.1*, 18.9*, 18.8, 17.7, 16.2, 16.1*, 
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0.1 (3C); IR (thin film): 2961, 2176, 1968, 1743, 1243 cm-1;  EI-MS m/z (%) 272 (49), 221 (47), 
73 (100). EI-HRMS calcd for C18H28Si: m/z (M-OAc) 272.1960; found: 272.1954. 
162 171
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8,12-Dimethyl-1-(trimethylsilyl)trideca-6,7,11-trien-1-yn-5-yl pivalate (171).  A 5-mL, 
single-necked round-bottomed flask equipped with a rubber septum, nitrogen inlet, and stir 
bar is charged with allene-yne 162 (54 mg, 0.19 mmol) and CH2Cl2 (0.3 mL). To the flask is 
sequentially added DMAP (1 mg, 9 μmol), Et3N (65 μL, 0.47 mmol), and pivaloyl chloride 
(39 μL, 0.32 mmol). When consumption of starting material is observed by TLC, the reaction 
mixture is transferred into a separatory funnel containing sat’d aq NH4Cl and Et2O.  The aq 
layer is separated and extracted with Et2O (3X).  The combined organic layers are washed 
with H2O, brine, are dried over MgSO4, and filtered via gravity filtration. The filtrate is 
concentrated under reduced pressure by rotary evaporation.  The residue is purified by silica 
gel chromatography eluting with 5% Et2O/pentanes to afford 171 as a light yellow oil (59 mg 
in 85% yield, d.r. = 1.1:1 based upon integration of the resonances at 102.6 ppm and 102.5 
ppm in the 13C NMR).  Rƒ 0.6 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 5.22 (q, 
J = 6.6 Hz, 1H), 5.16-5.07 (m, 2H), 2.36-2.25 (m, 2H), 2.13-2.03 (m, 2H), 1.99-1.84 (m, 4H), 
1.71-1.66 (m, 6H), 1.61 (s, 3H), 1.19 (s, 9H), 0.14 (s, 9H);  13C NMR (75 MHz, CDCl3) 
*designates minor diastereomer where resolved: δ 201.4, 201.0*, 177.4, 177.3*, 131.8, 
131.7*, 124.0*, 123.9, 106.2, 102.6*, 102.5, 90.7*, 90.4, 84.9, 70.9, 70.7*, 38.8, 33.9, 33.3*, 
33.2, 27.1 (3C), 26.5, 26.1, 26.0*, 25.7*, 19.0*, 18.9, 17.7, 16.1, 16.0*, 0.1 (3C); IR (thin 
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film): 2963, 2177, 1968, 1731, 1153 cm-1;  ESI-MS m/z (%) 397 (100, [M+Na]+), 365 (47), 
305 (9); ESI-HRMS calcd for C23H38O2NaSi: m/z [M+Na]+ 397.2539; found: 397.2553. 
162 172
•
TMS
HO
•
H
HO
 
 8,12-Dimethyltrideca-6,7,11-trien-1-yn-5-ol (172). A 10-mL, single-necked round-bottomed 
flask equipped with a rubber septum, nitrogen inlet, and stir bar is charged with allene-yne 162 
(171 mg, 0.589 mmol) and MeOH (4.9 mL). To the flask is added K2CO3 (122 mg, 0.883 mmol) 
in one portion. When consumption of starting material is observed by TLC, the reaction mixture 
is transferred into a separatory funnel containing sat’d aq NH4Cl and Et2O.  The aq layer is 
separated and extracted with Et2O (3X).  The combined organic layers are washed with H2O, 
brine, are dried over MgSO4, and filtered via gravity filtration. The filtrate is concentrated under 
reduced pressure by rotary evaporation.  The residue is purified by silica gel chromatography 
eluting with 5-10% Et2O/pentanes to afford terminal alkyne 172 as a light yellow oil (103 mg in 
80% yield, d.r. = 1.2:1 based upon integration of the resonances at 68.7 ppm and 68.6 ppm in the 
13C NMR).  Rƒ 0.4 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 5.21-5.15 (m, 1H), 
5.14-5.07 (m, 1H), 4.25-4.18 (m, 1H), 2.34 (td, J = 7.2, 2.7 Hz, 2H), 2.16-2.06 (m, 2H), 2.05-
1.98 (m, 2H), 1.97 (t, J = 2.7 Hz, 1H), 1.86-1.71 (m, 2H), 1.73 (d, J = 2.4 Hz, 3H), 1.70 (s, 3H), 
1.61 (s, 3H);  13C NMR (75 MHz, CDCl3) *designates minor diastereomer where resolved: δ 
199.3, 132.3, 132.2*, 124.0, 123.9*, 103.6, 94.7, 84.1, 84.1*, 68.7*, 68.6, 68.5, 36.1*, 35.9, 34.0, 
26.0, 25.7, 19.2, 19.1*,17.8, 14.7*, 14.6; IR (thin film): 3400, 3306, 2919, 2118, 1964 cm-1;  EI-
MS m/z (%) 203 (36), 160 (100), 135 (49), 83 (53); EI-HRMS calcd for C15H22O: m/z (M+˙) 
218.1671; found: 218.1675. 
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8,12-Dimethyl-1-phenyltrideca-6,7,11-trien-1-yn-5-ol (173). A 5-mL, single-necked round-
bottomed flask equipped with a rubber septum, argon balloon, and stir bar is charged with CuI 
(~1 mg, 2 μmol) and Pd(PPh3)2Cl2 (~1 mg, 1 μmol).  The flask is evacuated and purged with 
argon before 0.3 mL of THF is added.  To the flask is then sequentially added a solution of 
allene-yne 172 (25 mg, 0.11 mmol) in THF (0.3 mL), PhI (38 μL, 0.34 mmol), and 
diisopropylamine (0.16 mL, 1.2 mmol).  When consumption of starting material is observed by 
TLC, the reaction is concentrated under reduced pressure.  The residue is purified by silica gel 
chromatography eluting with 5-30% Et2O/pentanes to afford 173 as a light yellow oil (29 mg in 
86% yield, d.r. = 1.2:1 based upon integration of the resonances at 68.9 ppm and 68.8 ppm in the 
13C NMR).  Rƒ 0.6 (15% EtOAc/toluene); 1H NMR (300 MHz, CDCl3): δ 7.44-7.20 (m, 5H), 
5.28-5.18 (m, 1H), 5.13 (t, J = 6.9 Hz, 1H), 4.35-4.24 (m, 1H), 2.57 (t, J = 7.2 Hz, 2H), 2.19-
2.08 (m, 2H), 2.07-1.98 (m, 2H), 1.91-1.78 (m, 2H), 1.75 (d, J = 2.7 Hz, 3H), 1.71 (s, 3H), 1.63 
(s, 3H);  13C NMR (75 MHz, CDCl3) *designates minor diastereomer where resolved: δ 199.3, 
132.2, 131.5 (2C), 128.1 (2C), 127.5, 124.0, 123.9, 103.6, 94.8, 89.7, 89.6*, 80.9, 68.9*, 68.8, 
36.4*, 36.3, 34.1, 26.1, 25.6, 19.2, 19.1*,17.8, 15.7;  IR (thin film): 3355, 2922, 2235, 1964, 
1442 cm-1;  EI-MS m/z (%) 294 (30, M+˙), 223 (72), 179 (100); EI-HRMS calcd for C21H26O: 
m/z (M+˙) 294.1984; found: 294.1978. 
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4,8-Dimethyl-4-(tetrahydro-2H-pyran-2-yloxy)non-7-en-2-yn-ol (174).  A single-necked, 15-
mL round-bottomed flask is equipped with a stir bar, rubber septum, and nitrogen inlet is 
charged with alkyne 163127 (540 mg, 2.28 mmol) and THF (4.8 mL).  The mixture is cooled to 0 
°C in an ice bath and n-butyllithium (2.3 mL of a 1.6 M hexane soln, 3.6 mmol) is added 
dropwise via syringe.  Upon addition of n-BuLi, the reaction turns from colorless to 
yellow/brown.  After 1 h at 0 °C, paraformaldehyde (218 mg, 7.28 mmol) is added in one portion 
and the reaction is slowly warmed to rt.  When consumption of 163 is observed by TLC, the 
reaction mixture is transferred into a separatory funnel containing H2O and Et2O.  The aq layer is 
separated and extracted with Et2O (3X).  The combined organic layers are washed with H2O, 
brine, are dried over MgSO4, and filtered via gravity filtration.  The filtrate is concentrated under 
reduced pressure by rotary evaporation.  The residue is purified on silica gel eluting with 5-30% 
Et2O/pentanes to afford 468 mg of the title compound as pale yellow oil in 77% yield, d.r. = 
1.2:1 (based upon integration of the resonances at 1.49 ppm and 1.41 ppm in the 1H NMR).  Rƒ 
0.2 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) *designates minor diastereomer where 
resolved: δ 5.20-5.00 (m, 2H), 4.26 (t, J = 6.0, 2H), 4.03-3.87 (m, 1H), 3.56-3.46 (m, 1H), 3.30-
2.92 (m, 1H), 2.22-2.07 (m, 2H), 1.89-1.63 (m, 4H), 1.66 (s, 3H), 1.60 (s, 3H), 1.58-1.50 (m, 
4H), 1.49 (s, 3H), 1.41* (s, 3H);  13C NMR (75 MHz, CDCl3) *designates minor diastereomers 
where resolved: δ 131.6, 123.9, 95.6, 94.9*, 86.9, 86.3*, 84.1*, 83.4, 74.0*, 73.6, 62.8, 62.7*, 
50.7, 43.0, 42.2*, 32.0*, 31.6, 28.3*, 27.3, 25.6, 25.4, 25.3*, 23.3, 23.1*, 19.9, 19.8*, 17.5; IR 
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(thin film): 3423, 2935, 1441, 1024 cm-1;  EI-MS m/z (%) 251 (28), 235 (50), 165 (23), 85 (100); 
EI-HRMS calcd for C15H23O3: m/z (M-CH3) 251.1647; found: 251.1643. 
OH
•
175
OHTHPO
174  
4,8-Dimethylnona-2,3,7-trien-1-ol (175). A 10-mL, two-necked round-bottomed flask equipped 
with a cold finger, nitrogen inlet, and stir bar is charged with LAH (70 mg, 1.8 mmol) and Et2O 
(3.4 mL).  The mixture is heated and stirred at reflux (oil bath temperature 40-45 °C) for 5 min 
before a solution of propargylic alcohol 174 (443 mg, 1.68 mmol) in Et2O (0.7 mL) is added 
dropwise over 3-5 min to the refluxing reaction via cannula.  Immediately after the addition of 
174 is complete, the reaction mixture is cooled to rt and diluted with Et2O.  To the flask is slowly 
added H2O (70 μL), then 10% NaOH (140 μL), followed by sat’d aq KF solution (240 μL).  
After stirring for 5 min at rt, the resulting solids are filtered off via gravity filtration.  The solids 
are washed with Et2O and the filtrate is concentrated under reduced pressure by rotary 
evaporation.  The residue is purified by silica gel chromatography eluting with 5-15% 
Et2O/pentanes to afford allenyl alcohol 175 (149 mg in 53% yield) as a light yellow oil.  Rƒ 0.4 
(20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 5.30-5.20 (m, 1H), 5.09 (tq, J = 6.9, 1.2 
Hz, 1H), 4.04 (d, J = 5.4 Hz, 2H), 2.15-2.05 (m, 2H), 2.03-1.94 (m, 2H), 1.78 (bs, 1H), 1.71 (d, J 
= 3.0 Hz, 3H), 1.68 (d, J = 0.6 Hz, 3H), 1.60 (s, 3H);  13C NMR (75 MHz, CDCl3): δ 200.0, 
132.0, 124.0, 102.7, 91.4, 60.8, 33.9, 26.0, 25.6, 19.1, 17.7; IR (thin film): 3332, 2922, 1965, 
1443 cm-1; EI-MS m/z (%) 148 (34), 83 (78), 69 (84), 55 (100); EI-HRMS calcd for C11H16: m/z 
(M-H2O) 148.1252; found: 148.1255. 
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General Procedure A: Preparation of malonate-tethered allene-ynes 176-179  
Et3N, MsCl, 
DMAP
CH2Cl2, 0 °C
EtO2C
CO2Et
TMS
NaH, NaI, THF
0 °C to r.t.
•
TMS
E
E
HO
•
MsO
•
175a 176  
Diethyl 2-(4,8-dimethylnona-2,3,7-trienyl)-2-(3-(trimethylsilyl)prop-2-ynyl)malonate (176).  
A 5-mL, single-necked round-bottomed flask equipped with a stir bar, rubber septum, and 
nitrogen inlet is charged with allene-yne 175 (40 mg, 0.24 mmol), CH2Cl2 (1 mL), and DMAP (6 
mg, 0.05 mmol).  The reaction flask is cooled to 0 °C in an ice bath before Et3N (0.1 mL, 0.72 
mmol) and methanesulfonyl chloride (44 μL, 0.57 mmol) are sequentially added via syringe. The 
reaction turns from colorless to yellow upon addition of MsCl.  After 1 h the reaction is complete 
as observed by TLC and is transferred into a separatory funnel containing H2O and CH2Cl2.  The 
aq layer is separated and extracted with CH2Cl2 (3X).  The combined organic layers containing 
crushed ice are washed with 1M aq HCl, sat’d aq NaHCO3, brine, and are dried over MgSO4.  
The solids are filtered off via gravity filtration and the filtrate is concentrated under reduced 
pressure by rotary evaporation.  Mesylate 175a is produced as an orange oil and is used in the 
next step without further purification.  A 5-mL, single-necked round-bottomed flask equipped 
with a stir bar, rubber septum, and nitrogen inlet is charged with NaH (7 mg of 60% dispersion in 
mineral oil, 0.17 mmol) and 0.4 mL of THF.  The suspension is cooled to 0 °C in an ice bath and 
a solution of diethyl 2-(3-(trimethylsilyl)prop-2-ynyl)malonate (28 mg, 0.11 mmol) in 0.4 mL of 
THF is added via cannula.  The reaction is warmed to rt and is stirred for 1 h before a solution of 
the freshly prepared crude mesylate 175a in THF (1 mL) is added via cannula.  To the reaction is 
then added NaI (16 mg, 0.11 mmol) in one portion. When consumption of the propargyl 
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malonate is observed by TLC, the reaction mixture is transferred into a separatory funnel 
containing H2O and Et2O.  The aq layer is separated and extracted with Et2O (3X).  The 
combined organic layers are washed with H2O, brine, dried over MgSO4, and filtered via gravity 
filtration. The filtrate is concentrated under reduced pressure by rotary evaporation.  The residue 
is purified by silica gel chromatography eluting with 2-5% Et2O/pentanes to afford malonate 176 
(27 mg in 62% yield) as a light yellow oil.  Rƒ 0.8 (20% EtOAc/hexanes); 1H NMR (300 MHz, 
CDCl3): δ 5.12 (tt, J = 6.9, 1.5 Hz, 1H), 4.86-4.77 (m, 1H), 4.26-4.13 (m, 4H), 2.89 (s, 2H), 2.72 
(d, J = 7.8 Hz, 1H), 2.14-2.04 (m, 2H), 1.97-1.88 (m, 2H), 1.70 (s, 3H), 1.66 (d, J = 2.7 Hz, 3H), 
1.62 (s, 3H), 1.26 (t, J = 6.9 Hz, 6H), 0.12 (s, 9H);  13C NMR (75 MHz, CDCl3): δ 203.6, 169.8, 
169.7, 131.7, 124.1, 101.5, 99.3, 87.8, 83.8, 61.5 (2C), 57.2, 34.0, 32.7, 26.2, 25.7, 23.8, 19.1, 
17.7, 14.1 (2C), -0.1 (3C); IR (thin film): 2963, 2180, 1737, 844 cm-1;  EI-MS m/z (%) 418 (21, 
M+˙), 345 (24), 271 (78), 187 (100); EI-HRMS calcd for C24H38O4Si: m/z (M+˙) 418.2539; 
found: 418.2556. 
EtO2C
CO2Et
Ph •
Ph
E
E
MsO
•
175a 177
+
 
Diethyl 2-(4,8-dimethylnona-2,3,7-trienyl)-2-(3-phenylprop-2-ynyl)malonate (177). Prepared 
according to General Procedure A using:  allene-yne 175 (33 mg, 0.20 mmol), DMAP (5 mg, 
0.04 mmol), Et3N (83 μL, 0.60 mmol) and methanesulfonyl chloride (37 μL, 0.47 mmol) in 
CH2Cl2 (0.8 mL).  The subsequent alkylation reaction used NaH (6.0 mg of 60% dispersion in 
mineral oil, 0.14 mmol), diethyl-2-(3-phenylprop-2-ynyl)malonate (24 mg, 0.09 mmol), and NaI 
(15 mg, 0.10 mmol) in 0.6 mL of THF. Yield 177 (27 mg, 73%). Rƒ 0.6 (20% EtOAc/hexanes); 
1H NMR (300 MHz, CDCl3): δ 7.38-7.34 (m, 2H), 2.30-7.24 (m, 3H), 5.12 (tt, J = 7.2, 1.5 Hz, 
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1H), 4.93-4.84 (m, 1H), 4.29-4.17 (m, 4H), 3.10 (s, 2H), 2.81 (d, J = 7.5 Hz, 1H), 2.15-2.05 (m, 
2H), 1.97-1.90 (m, 2H), 1.68 (d, J = 1.2 Hz, 3H), 1.67 (d, J = 2.7 Hz, 3H), 1.60 (s, 3H) 1.27 (t, J 
= 7.2 Hz, 6H);  13C NMR (75 MHz, CDCl3): δ 203.6, 169.9 (2C), 131.7, 131.6 (2C), 128.1 (2C), 
127.8, 124.1, 123.4, 99.5, 84.6, 83.8, 83.3, 61.5 (2C), 57.4, 34.0, 32.8, 26.2, 25.7, 23.4, 19.1, 
17.7, 14.1 (2C); IR (thin film): 2923, 1735, 1443, 1202 cm-1;  EI-MS m/z (%) 422 (51, M+˙), 353 
(17), 308 (100); EI-HRMS calcd for C27H34O4: m/z (M+˙) 422.2457; found: 422.2460. 
EtO2C
CO2Et
Me •
Me
E
E
MsO
•
175a 178
+
 
Diethyl 2-(but-2-ynyl)-2-(4,8-dimethylnona-2,3,7-trienyl)malonate (178). Prepared according 
to General Procedure A using:  allene-yne 175 (36 mg, 0.22 mmol), DMAP (5 mg, 0.04 mmol), 
Et3N (92 μL, 0.66 mmol) and methanesulfonyl chloride (41 μL, 0.52 mmol) in CH2Cl2 (0.9 mL).  
The subsequent alkylation reaction used NaH (6 mg of 60% dispersion in mineral oil, 0.15 
mmol), diethyl 2-(but-2-ynyl)malonate (20 mg, 0.09 mmol), and NaI (17 mg, 0.11 mmol) in 0.7 
mL of THF. Yield 178 (26 mg, 76%). Rƒ 0.7 (20% EtOAc/hexanes); 1H NMR (300 MHz, 
CDCl3): δ 5.11 (tt, J = 6.9, 1.5 Hz, 1H), 4.87-4.78 (m, 1H), 4.25-4.13 (m, 4H), 2.80 (q, J = 2.4 
Hz, 2H), 2.73-2.68 (m, 2H), 2.13-2.04 (m, 2H), 1.96-1.88 (m, 2H), 1.74 (t, J = 2.4 Hz, 3H), 1.69 
(d, J = 0.9 Hz, 3H), 1.65 (d, J = 2.7 Hz, 3H), 1.61 (s, 3H) 1.25 (t, J = 7.2 Hz, 6H);  13C NMR (75 
MHz, CDCl3): δ 203.5, 170.1 (2C), 131.6, 124.1, 99.3, 83.9, 78.5, 73.5, 61.4 (2C), 57.3, 34.0, 
32.6, 26.2, 25.7, 22.8, 19.0, 17.7, 14.0 (2C), 3.5; IR (thin film): 2979, 1736, 1443, 1203 cm-1;  
EI-MS m/z (%) 360 (36, M+˙), 345 (15), 268 (100); EI-HRMS calcd for C22H32O4: m/z (M+˙) 
360.2301; found: 360.2311.  
 146 
EtO2C
CO2Et
•
E
E
MsO
•
175a 179
+
  
Diethyl 2-(4,8-dimethylnona-2,3,7-trienyl)-2-prop-2-ynyl)malonate (179). Prepared according 
to General Procedure A using: allene-yne 175 (58 mg, 0.35 mmol), DMAP (9 mg, 0.07 mmol), 
Et3N (0.15 mL, 1.1 mmol) and methanesulfonyl chloride (65 μL, 0.83 mmol) in CH2Cl2 (1.4 
mL).  The subsequent alkylation reaction used NaH (10 mg of 60% dispersion in mineral oil, 
0.24 mmol), diethyl 2-(prop-2-ynyl)malonate (30 mg, 0.15 mmol), and NaI (27 mg, 0.18 mmol) 
in 1.1 mL of THF. Yield 179 (40 mg, 76%). Rƒ 0.6 (20% EtOAc/hexanes); 1H NMR (300 MHz, 
CDCl3): δ 5.11 (tt, J = 6.9, 1.5 Hz, 1H), 4.87-4.76 (m, 1H), 4.26-4.14 (m, 4H), 2.87 (d, J = 2.4 
Hz, 2H), 2.73 (d, J = 7.8 Hz, 2H), 2.13-2.03 (m, 2H), 1.99 (t, J = 2.4 Hz, 1H), 1.96-1.88 (m, 2H), 
1.69 (s, 3H), 1.65 (d, J = 2.7 Hz, 3H), 1.61 (s, 3H) 1.26 (t, J = 7.2 Hz, 6H);  13C NMR (75 MHz, 
CDCl3): δ 203.6, 169.7 (2C), 131.7, 124.1, 99.5, 83.6, 79.0, 71.1, 61.6 (2C), 57.0, 34.0, 32.6, 
26.2, 25.7, 22.4, 19.0, 17.7, 14.0 (2C); IR (thin film): 3289, 2979, 1966, 1736, 1204 cm-1;  EI-
MS m/z (%) 346 (31, M+˙), 331 (15), 303 (48), 84 (100); EI-HRMS calcd for C21H30O4: m/z 
(M+˙)  346.2144; found: 346.2141. 
General Procedure B: Formation of N-tosylallene-ynes via a Mitsunobu reaction   
HO
•
175
TsN
•
N
H
Ts
181
Ph
DIAD, PPh3, THF
0 °C to  r.t.
Ph
 
4,8-Dimethyl-N-(3-phenylprop-2-ynyl)-N-tosylnona-2,3,7-trien-1-amine (181).  A 5-mL, 
single-necked round-bottomed flask equipped with a nitrogen inlet and stir bar is charged with 3-
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phenyl-N-tosylprop-2-yn-1-amine (65 mg, 0.23 mmol), allene-yne 175 (49 mg, 0.29 mmol), 
triphenylphosphine (78 mg, 0.29 mmol), and THF (1.5 mL).  The flask is cooled to 0 °C in an ice 
bath and diisopropyl azodicarboxylate (DIAD, 58 μL, 0.29 mmol) is added via syringe.  The 
reaction is slowly warmed to rt and stirred until consumption of starting material is observed by 
TLC.  The reaction is then concentrated under reduced pressure, diluted with cold Et2O, and 
filtered though a pad of celite.  The filtrate is concentrated under reduced pressure by rotary 
evaporation.  The residue is purified by silica gel chromatography eluting with 5% Et2O/pentane 
to afford 181 (77 mg in 78% yield) as a light yellow oil.  Rƒ 0.5 (20% EtOAc/hexanes); 1H NMR 
(300 MHz, CDCl3): δ 7.78 (d, J = 8.4 Hz, 2H), 7.34-7.20 (m, 5H), 7.05 (dd, J = 8.4, 1.8 Hz, 2H), 
5.08 (tt, J = 6.9, 1.5 Hz, 1H), 5.04-4.96 (m, 1H), 4.39 (s, 2H), 3.86 (dd, J = 6.9, 1.2 Hz, 2H), 2.34 
(s, 3H), 2.13-2.03 (m, 2H), 1.98-1.90 (m, 2H), 1.68 (d, J = 2.7 Hz, 3H), 1.65 (s, 3H), 1.57 (s, 
3H);  13C NMR (75 MHz, CDCl3): δ 203.5, 143.4, 136.1, 131.9, 131.5 (2C), 129.5 (2C), 128.3, 
128.1 (2C), 127.8 (2C), 123.8, 122.4, 101.4, 85.5, 81.8, 77.2, 47.0, 36.5, 33.8, 26.1, 25.6, 21.4, 
19.0, 17.7;  IR (thin film): 2919, 1965, 1598, 1349 cm-1;  ESI-MS m/z (%) 456 (7), 312 (20), 122 
(100). 
HO
•
175
TsN
•
N
H
Ts
182
+
Me
Me
 
N-(But-2-ynyl)-4,8-dimethyl-N-tosylnona-2,3,7-trien-1-amine (182). Prepared according to 
General Procedure B using: N-tosylbut-2-yn-1-amine (34 mg, 0.15 mmol), allene-yne 175 (33 
mg, 0.20 mmol), triphenylphosphine (52 mg, 0.20 mmol), and DIAD (39 μL, 0.20 mmol) in THF 
(1 mL). Yield 182 (45 mg, 80%). Rƒ 0.6 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 
7.74 (d, J = 8.1 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 5.13-1.04 (m, 1H), 4.97-4.87 (m, 1H), 4.10 (q, 
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J = 2.1 Hz, 2H), 3.77 (d, J = 6.9 Hz, 2H), 2.42 (s, 3H), 2.13-2.02 (m, 2H), 1.98-1.89 (m, 2H), 
1.67 (s, 3H), 1.66 (s, 3H), 1.59 (s, 3H), 1.54 (t, J = 2.1 Hz, 3H);  13C NMR (75 MHz, CDCl3): δ 
203.3, 143.1, 136.4, 131.8, 129.2 (2C), 127.8 (2C), 123.9, 101.2, 85.5, 81.2, 71.7, 46.7, 36.1, 
33.9, 26.1, 25.6, 21.5, 18.9, 17.7, 3.2;  IR (thin film): 2919, 1965, 1598, 1349 cm-1;  EI-MS m/z 
(%) 373 (100), 372 (52); EI-HRMS calcd for C22H29NO2S: m/z (M+˙) 371.1919; found: 
371.1922. 
HO
•
175
TsN
•
N
H
Ts
183
+
 
4,8-Dimethyl-N-(prop-2-ynyl)-N-tosylnona-2,3,7-trien-1-amine (183). Prepared according to 
General Procedure B using:  N-tosylprop-2-yn-1-amine (33 mg, 0.16 mmol), allene-yne 175 (34 
mg, 0.20 mmol), triphenylphosphine (54 mg, 0.21 mmol), and DIAD (41 μL, 0.21 mmol) in THF 
(1 mL). Yield 183 (49 mg, 87%). Rƒ 0.5 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 
7.74 (d, J = 8.3 Hz, 2H), 7.30 (d, J = 8.3 Hz, 2H), 5.09 (tt, J = 6.9, 1.2 Hz, 1H), 4.97-4.88 (m, 
1H), 4.18 (d, J = 2.4 Hz, 2H), 3.80 (d, J = 6.9 Hz, 2H), 2.43 (s, 3H), 2.12-2.02 (m, 2H), 1.99 (t, J 
= 2.4 Hz, 1H), 1.98-1.90 (m, 2H), 1.68 (d, J = 2.4 Hz, 3H), 1.67 (s, 3H), 1.59 (s, 3H);  13C NMR 
(75 MHz, CDCl3): δ 203.5, 143.4, 136.2, 131.9, 129.4 (2C), 127.7 (2C), 123.8, 101.4, 85.2, 73.4, 
46.7, 35.6, 33.8, 26.1, 25.7, 21.5, 18.9, 17.7;  IR (thin film): 3282, 2920, 1964, 1349 cm-1; EI-MS 
m/z (%) 357 (20, M+˙), 342 (22), 202 (32), 162 (100); EI-HRMS calcd for C21H27NO2S: m/z 
(M+˙) 357.1763; found: 357.1768. 
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General Procedure C: O-alkylation of allenic alcohol 175 with propargyl bromides  
THF, 0 °C to r.t.
HO
•
175
O
•
Ph
Br
Ph
185
1) NaH
2)
 
1-(3-(4,8-Dimethylnona-2,3,7-trienyloxy)prop-1-ynyl)benzene (185).  A 5-mL, single-necked 
round-bottomed flask equipped with a nitrogen inlet and stir bar is charged with NaH (16 mg of 
60% dispersion in mineral oil, 0.40 mmol) and 1 mL of THF.  The suspension is cooled to 0 °C 
in an ice bath and a solution of allene-yne 175 (22 mg, 0.13 mmol) in THF (1 mL) is added via 
cannula.  The reaction is warmed to rt and is stirred for 1 h before a solution of 1-(3-bromoprop-
1-ynyl)benzene (28 mg, 0.15 mmol) in THF (0.2 mL) is added via cannula.  To the reaction is 
then added HMPA (5 μL, 26 μmol) via syringe and the reaction is stirred until consumption of 
175 is observed by TLC.  The reaction mixture is then transferred into a separatory funnel 
containing sat’d aq NH4Cl and Et2O.  The aq layer is separated and extracted with Et2O (3X).  
The combined organic layers are washed with H2O, brine, dried over MgSO4, and filtered via 
gravity filtration. The filtrate is concentrated under reduced pressure by rotary evaporation.  The 
residue is purified by silica gel chromatography eluting with 2-5% Et2O/pentanes to afford 185 
(30 mg in 81% yield) as a light yellow oil.  Rƒ 0.7 (20% EtOAc/hexanes); 1H NMR (300 MHz, 
CDCl3): δ 7.51-7.42 (m, 2H), 7.40-7.29 (m, 3H), 5.24- 5.08 (m, 2H), 4.41 (s, 2H), 4.13 (d, J = 
6.9 Hz, 2H), 2.18-2.07 (m, 2H), 2.04-1.95 (m, 2H), 1.73 (d, J = 3.0 Hz, 3H), 1.69 (s, 3H), 1.61 
(s, 3H);  13C NMR (75 MHz, CDCl3): δ 203.1, 131.8, 131.7 (2C), 128.3, 128.2 (2C), 124.0, 
122.7, 100.4, 87.1, 86.1, 85.2, 68.7, 57.2, 33.9, 26.2, 25.7, 19.0, 17.7;  IR (thin film): 2922, 1965, 
1442, 1081 cm-1; EI-MS m/z (%) 265 (28), 135 (15), 115 (100); EI-HRMS calcd for C19H21O: 
m/z (M-CH3) 265.1592; found: 265.1596. 
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O
•
Me
186
HO
•
175
+ Br
Me
 
1-(But-2-ynyloxy)-4,8-dimethylnona-2,3,7-triene (186). Prepared according to General 
Procedure C using: allene-yne 175 (23 mg, 0.14 mmol), NaH (11 mg of 60% dispersion in 
mineral oil, 0.28 mmol), 1-bromobut-2-yne (13 μL, 0.15 mmol) and HMPA (5 μL, 26 μmol) in 
2.1 mL of THF.  Yield 186 (23 mg, 76%). Rƒ 0.8 (20% EtOAc/hexanes); 1H NMR (300 MHz, 
CDCl3): δ 5.20-5.05 (m, 2H), 4.12 (q, J = 2.4 Hz, 2H), 4.03 (d, J = 6.9 Hz, 2H), 2.17-2.05 (m, 
2H), 2.03-1.93 (m, 2H), 1.86 (t, J = 2.4 Hz, 3H), 1.71 (d, J = 3.0 Hz, 3H), 1.70 (s, 3H), 1.61 (s, 
3H);  13C NMR (75 MHz, CDCl3): δ 202.9, 131.7, 124.0, 100.2, 87.2, 82.2, 75.2, 68.5, 57.0, 
33.9, 26.1, 25.7, 18.9, 17.7, 3.6; IR (thin film): 2923, 1965, 1445, 1079 cm-1; EI-MS m/z (%) 218 
(10, M+˙), 203 (21), 173 (75), 53 (100); EI-HRMS calcd for C15H22O: m/z (M+˙) 218.1671; 
found: 218.1670. 
O
•
187
HO
•
175
+ Br
 
4,8-Dimethyl-1-(prop-2-ynyloxy)nona-2,3,7-triene (187). Prepared according to General 
Procedure C using: allene-yne 175 (62 mg, 0.37 mmol), NaH (45 mg of 60% dispersion in 
mineral oil, 1.1 mmol), propargyl bromide (80% wt. in toluene, 0.12 mL, 1.1 mmol), and HMPA 
(13 μL, 75 μmol) in 5.8 mL of THF.  Yield 187 (61 mg, 80%). Rƒ 0.8 (20% EtOAc/hexanes); 1H 
NMR (300 MHz, CDCl3): δ 5.18-5.06 (m, 2H), 4.17 (d, J = 2.4 Hz, 2H), 4.05 (d, J = 6.9 Hz, 
2H), 2.42 (t, J = 2.4 Hz, 1H), 2.16-2.05 (m, 2H), 2.03-1.93 (m, 2H), 1.71 (d, J = 3.0 Hz, 3H), 
1.69  (d, J = 0.9 Hz, 3H), 1.61 (s, 3H);  13C NMR (75 MHz, CDCl3): δ 203.1, 131.7, 123.9, 
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100.4, 86.9, 79.8, 74.1, 68.6, 56.3, 33.9, 26.1, 25.7, 18.9, 17.7;  IR (thin film): 3304, 2923, 2116, 
1965, 1085 cm-1; EI-MS m/z (%) 204 (41, M+˙), 148 (53), 133 (100), 55 (87); EI-HRMS calcd 
for C14H20O: m/z (M+˙) 204.1514; found: 204.1510. 
General Procedure D: Formation of TMS-alkyne heteroatom-tethered allene-ynes  
TsN
•
H
183
TsN
•
TMS
n-BuLi, TMSCl
THF, -78 °C
180  
4,8-Dimethyl-N-(3-(trimethylsilyl)prop-2-ynyl)-N-tosylnona-2,3,7-trien-1-amine (180). A 5-
mL, single-necked round-bottomed flask equipped with a rubber septum, nitrogen inlet, and stir 
bar is charged with N-tosylallene-yne 183 (27 mg, 0.08 mmol) and THF (0.6 mL).  The reaction 
flask is cooled to –78 ˚C with a dry ice -acetone bath and n-butyllithium (61 μL of a 1.6 M 
hexane soln, 0.1 mmol) is added dropwise via syringe.  After 30 min, chlorotrimethylsilane 
(TMSCl, 19 μL, 0.15 mmol) is added via syringe. The reaction is allowed to slowly warm to rt at 
which time consumption of starting material is observed by TLC analysis. The reaction mixture 
is transferred into a separatory funnel containing sat’d aq NH4Cl and Et2O.  The aq layer is 
separated and extracted with Et2O (3X).  The combined organic layers are washed with H2O, 
brine, are dried over MgSO4, and filtered via gravity filtration. The filtrate is concentrated under 
reduced pressure by rotary evaporation. The residue is purified by silica gel chromatography 
eluting with 5-10% Et2O/pentane to afford 180 (23 mg in 71% yield) as a light yellow oil.  Rƒ 0.8 
(5% EtOAc/toluene); 1H NMR (300 MHz, CDCl3): δ 7.74 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 8.3 
Hz, 2H), 5.09 (tt, J = 7.2, 1.5 Hz, 1H), 4.99-4.89 (m, 1H), 4.22 (A of an ABq, J = 19.9 Hz, 1H), 
4.15 (B of an ABq, J = 19.9 Hz, 1H), 3.86-3.71 (m, 2H), 2.42 (s, 3H), 2.13-2.03 (m, 2H), 1.97-
1.90 (m, 2H), 1.68 (d, J = 2.4 Hz, 3H), 1.67 (s, 3H), 1.60 (s, 3H), -0.02 (s, 9H);  13C NMR (75 
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MHz, CDCl3): δ 203.5, 143.3, 136.1, 131.9, 129.5 (2C), 127.7 (2C), 123.9, 101.2, 97.8, 90.7, 
85.3, 46.6, 36.5, 33.8, 26.0, 25.7, 21.5, 19.0, 17.8, -0.5 (3C);  IR (thin film): 2961, 2178, 1965, 
845 cm-1; EI-MS m/z (%) 429 (54, M+˙), 294 (100), 274 (99), 91 (99); EI-HRMS calcd for 
C24H35NO2SiS: m/z (M+˙) 429.2158; found: 429.2141. 
O
•
TMS
184
O
•
187  
(3-(4,8-Dimethylnona-2,3,7-trienyloxy)prop-1-ynyl)trimethylsilane (184). Prepared according 
to General Procedure D using: allene-yne 187 (32 mg, 0.16 mmol), n-butyllithium (0.13 mL of a 
1.6 M hexane soln, 0.20 mmol), TMSCl (40 μL, 0.31 mmol) in THF (1.3 mL).  Yield 184 (21 
mg, 49%). Rƒ 0.9 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3): δ 5.19-5.07 (m, 2H), 4.17 
(s, 2H), 4.05 (d, J = 6.9 Hz, 2H), 2.18-2.05 (m, 2H), 2.04-1.94 (m, 2H), 1.71 (d, J = 3.0 Hz, 3H), 
1.70 (s, 3H), 1.61 (s, 3H), 0.18 (s, 9H);  13C NMR (75 MHz, CDCl3): δ 203.1, 131.8, 124.0, 
101.6, 100.3, 91.1, 87.0, 68.7, 57.2, 33.9, 26.1, 25.7, 19.0, 17.7, -0.2 (3C); IR (thin film): 2924, 
2174, 1965, 844 cm-1; EI-MS m/z (%) 276 (10, M+˙), 261 (46), 203 (89), 111 (100); EI-HRMS 
calcd for C16H25OSi: m/z (M-CH3) 261.1675; found: 261.1670. 
General Procedure E: Rh(I)-catalyzed allenic carbocyclization reaction. 
•
TMS
HO
TMS
HO
162 188  
(4E)-3-(6-Methylhepta-1,5-dien-2-yl)-4-((trimethylsilyl)methylene)cyclohexen-2-ol (188). A 
flame-dried 13 х 100 mm test tube equipped with a stir bar, rubber septum, and argon balloon is 
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charged with allene-yne 162 (16 mg, 0.06 mmol) and toluene (1 mL).  Argon is bubbled through 
the solution using a balloon filled with argon attached to a syringe before [Rh(CO)2Cl]2 (2 mg, 6 
μmol) is added in one portion.  Upon completion of the reaction based upon TLC analysis, the 
solution is directly subjected to silica gel chromatography eluting with 5-20% Et2O/pentane to 
give 13.5 mg of cross-conjugated triene 188 in 84% yield.  Rƒ 0.3 (20% EtOAc/hexanes);  1H 
NMR (500 MHz, CDCl3): δ 5.66 (d, J = 3.5 Hz, 1H), 5.50 (s, 1H), 5.10 (tt, J = 7.0, 1.5 Hz, 1H), 
5.01-4.98 (m, 1H), 4.88 (d, J = 2.0 Hz, 1H), 4.35 (tdd, J = 7.0, 5.0, 3.5 Hz, 1H), 2.58 (ddd, J = 
14.5, 8.0, 4.0 Hz, 1H), 2.36 (dddd, J = 14.5, 10.0, 3.5, 1.0 Hz, 1H), 2.20-2.14 (m, 2H), 2.08-2.00 
(m, 3H), 1.70 (tdd, J = 13.0, 13.0, 7.0, 4.0 Hz, 1H), 1.69 (s, 3H), 1.59 (s, 3H), 1.46 (d, J = 6.5 
Hz, 1H), 0.13 (s, 9H);  13C NMR (75 MHz, CDCl3): δ 149.3, 149.2, 145.2, 131.6, 128.9, 127.3, 
124.0, 113.8, 66.3, 36.2, 32.9, 28.0, 26.8, 25.7, 17.7, 0.0 (3C); IR (thin film): 3338, 2954, 1576, 
1248 cm-1; EI-MS m/z (%) 290 (34, M+˙), 272 (11), 131 (91), 73 (100); EI-HRMS calcd for 
C18H30OSi: m/z (M+˙) 290.2066; found: 290.2058. 
•
TMS
TBSO
TMS
TBSO
169 189  
 ((4E)-3-(6-Methylhepta-1,5-dien-2-yl)-4-(trimethylsilyl)methylene))cyclohex-2-enyl oxy- 
tert-butyldimethylsilane (189). Prepared according to General Procedure E using: 169 (26 mg, 
0.06 mmol), [Rh(CO)2Cl]2 (2 mg, 6 μmol). Yield 189 (24 mg, 92%). Rƒ 0.9 (5% 
EtOAc/hexanes);  1H NMR (300 MHz, CDCl3): δ 5.55 (d, J = 2.7 Hz, 1H), 5.42 (s, 1H), 5.11 (tt, 
J = 6.6, 1.2 Hz, 1H), 4.99-4.95 (m, 1H), 4.87 (d, J = 2.1 Hz, 1H), 4.35 (ddd, J = 7.8, 4.5, 3.0 Hz, 
1H), 2.60 (ddd, J = 14.6, 6.6, 3.6 Hz, 1H), 2.29 (dddd, J = 14.6, 11.1, 3.3, 1.2 Hz, 1H), 2.20-2.12 
(m, 2H), 2.09-2.00 (m, 2H), 2.00-1.89 (m, 1H), 1.74-1.64 (m, 1H), 1.69 (s, 3H), 1.59 (s, 3H), 
 154 
0.91 (s, 9H), 0.12 (s, 9H), 0.09 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 149.7, 149.6, 143.8, 
131.6, 130.9, 126.0, 124.2, 113.5, 67.4, 36.2, 33.4, 28.6, 26.8, 25.9 (3C), 25.7, 18.2, 17.7, 0.1 
(3C), -4.5 (2C); IR (thin film): 2954, 1577, 1250, 1091 cm-1; EI-MS m/z (%) 404 (48, M+˙), 331 
(7), 131 (18), 73 (100); EI-HRMS calcd for C24H44OSi2: m/z (M+˙) 404.2931; found: 404.2936. 
•
TMS
AcO
TMS
AcO
170 191  
((4E)-3-(6-Methylhepta-1,5-dien-2-yl)-4-(trimethylsilyl)methylene))cyclohex-2-enyl acetate 
(191). Prepared according to General Procedure E using: 170 (19 mg, 0.06 mmol), [Rh(CO)2Cl]2 
(2 mg, 6 μmol). Yield 191 (16 mg, 84%). Rƒ 0.5 (20% EtOAc/hexanes);  1H NMR (300 MHz, 
CDCl3): δ 5.60 (d, J = 3.9 Hz, 1H), 5.54 (s, 1H), 5.39 (td, J = 5.4, 3.9 Hz, 1H), 5.10 (tt, J = 6.9, 
1.5 Hz, 1H), 5.00 (dt, J = 2.1, 1.2, Hz, 1H), 4.88 (d, J = 2.4 Hz, 1H), 2.57 (ddd, J = 13.7, 8.7, 3.6 
Hz, 1H), 2.41 (dddd, J = 13.7, 8.4, 3.6, 0.9 Hz, 1H), 2.21-2.13 (m, 2H), 2.07 (s, 3H), 2.08-1.96 
(m, 3H), 1.81 (dddd, J = 15.3, 9.0, 6.3, 4.2 Hz, 1H), 1.68 (d, J = 0.6 Hz, 3H), 1.59 (s, 3H), 0.13 
(s, 9H); 13C NMR (75 MHz, CDCl3): δ 170.8, 149.0, 148.7, 146.9, 131.7, 128.2, 124.3, 124.0, 
114.1, 68.7, 36.1, 29.2, 27.9, 26.8, 25.7, 21.4, 17.7, 0.0 (3C); IR (thin film): 2955, 1738, 1579, 
1237, 863 cm-1; EI-MS m/z (%) 332 (22, M+˙), 273 (9), 203 (22), 73 (100); EI-HRMS calcd for 
C20H32O2Si: m/z (M+˙) 332.2172; found: 332.2171. 
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•
TMS
PivO
TMS
PivO
171 193  
((4E)-3-(6-Methylhepta-1,5-dien-2-yl)-4-(trimethylsilyl)methylene))cyclohex-2-enyl pivalate 
(193).  Prepared according to General Procedure E using: 171 (20 mg, 0.05 mmol), [Rh(CO)2Cl]2 
(2 mg, 5 μmol). Yield 193 (15 mg, 75%). Rƒ 0.8 (20% EtOAc/hexanes);  1H NMR (300 MHz, 
CDCl3): δ 5.59 (d, J = 3.6 Hz, 1H), 5.53 (s, 1H), 5.35 (app q, J = 4.2 Hz, 1H), 5.10 (tt, J = 6.9, 
1.2 Hz, 1H), 4.99 (dt, J = 2.4, 1.2, Hz, 1H), 4.88 (d, J = 2.4 Hz, 1H), 2.56 (ddd, J = 13.7, 8.7, 3.6 
Hz, 1H), 2.42 (dddd, J = 13.7, 9.6, 3.9, 0.9 Hz, 1H), 2.21-2.13 (m, 2H), 2.10-1.95 (m, 3H), 1.80 
(dddd, J = 14.4, 9.0, 5.7, 3.9 Hz, 1H), 1.68 (s, 3H), 1.59 (s, 3H), 1.20 (s, 9H), 0.14 (s, 9H); 13C 
NMR (75 MHz, CDCl3): δ 178.1, 149.2, 148.9, 146.7, 131.7, 128.0, 124.5, 124.0, 114.0, 68.2, 
38.8, 36.2, 29.2, 27.9, 27.1 (3C), 26.8, 25.7, 17.7, 0.0 (3C); IR (thin film): 2958, 1727, 1579, 
1153, 863 cm-1; ESI-MS m/z (%) 381 (6), 397 (100, [M+Na]+); ESI-HRMS calcd for 
C23H38O2NaSi: m/z [M+Na]+ 397.2539; found: 397.2541. 
•
Ph
HO
Ph
HO
172 195
+
Ph
HO
E/Z-196  
(4E)-4-Benzylidene-3-(6-methylhepta-1,5-dien-2-yl)cyclohex-2-enol (195), (4E)-4-benzylid-
ene-3-(6-methylhepta-2,5-dien-2-yl)cyclohex-2-enol (E/Z-196). Prepared according to General 
Procedure E using: 172 (16 mg, 0.05 mmol), [Rh(CO)2Cl]2 (2 mg, 5 μmol). Combined yield 195 
and E/Z-196 (14 mg, 88%). The isomeric ratio of 195:E/Z-196 was determined by integration of 
the resonances at 4.98 ppm and 5.39 ppm in the 1H NMR. Rƒ 0.4 (15% EtOAc/toluene);  1H 
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NMR (300 MHz, CDCl3) *designates isomers E/Z-196 where resolved: δ 7.41-7.18 (m, 5H), 
6.49 (s, 1H), 6.43* (s, 1H),  5.73 (d, J = 3.6 Hz, 1H), 5.69-5.65* (m, 1H),  5.39* (t, J =  6.9 Hz, 
1H), 5.18* (t, J = 6.9 Hz, 1H), 5.12 (tt, J = 6.9, 1.5 Hz, 1H), 5.09-5.06 (m, 1H), 4.98 (d, J = 2.1 
Hz, 1H), 4.40 (ddd, J = 10.8, 6.9, 3.9 Hz, 1H), 2.81 (ddd, J = 14.6, 6.9, 4.2 Hz, 1H), 2.58 (dddd, 
J = 14.6, 9.6, 3.9, 1.5 Hz, 1H), 2.31-2.23 (m, 2H), 2.16-2.05 (m, 2H), 1.98 (dtd, J = 12.6, 8.4, 4.2 
Hz, 1H), 1.85 (d, J = 11.7 Hz, 1H), 1.74-1.62 (m, 1H), 1.69 (s, 3H), 1.60 (s, 3H); 13C NMR (75 
MHz, CDCl3): δ 149.1, 144.4, 137.7, 135.1, 131.7, 129.3, 129.1 (2C), 128.1 (2C), 127.8, 126.6, 
124.0, 114.2, 66.2, 36.4, 32.4, 26.8, 25.7, 24.0, 17.7; IR (thin film): 3332, 2923, 1606, 1071 cm-1; 
EI-MS m/z (%) 294 (19, M+˙), 225 (39), 91 (100), 77 (30); EI-HRMS calcd for C21H26O: m/z 
(M+˙) 294.1984; found: 294.1983. 
•
HO HO
173 197
+
HO
E/Z-198  
4-Methylene-3-(6-methylhepta-1,5-dien-2-yl)cyclohex-2-enol (197), 4-Methylene-3-(6-meth- 
ylhepta-2,5-dien-2-yl)cyclohex-2-enol (E/Z-198). Prepared according to General Procedure E 
using: 173 (19 mg, 0.09 mmol), [Rh(CO)2Cl]2 (3 mg, 9 μmol). Combined yield of 197 and E/Z-
198 (6 mg, 32%). The isomeric ratio of 197:E/Z-198 was determined by integration of the three 
peaks in the GC chromatogram at retention times 5.6 min, 5.8 min, and 6.1 min (E/Z-198 : 197 : 
E/Z-198).  Rƒ 0.3 (20% EtOAc/hexanes);  1H NMR (300 MHz, CDCl3) *designates isomers E/Z-
198 where resolved: δ 5.65 (d, J = 3.0 Hz, 1H), 5.63* (d, J = 2.7 Hz, 1H), 5.58* (s, 1H), 5.36-
5.26* (m, 1H), 5.18-5.03 (m, 1H), 5.03-4.98 (m, 1H), 4.96 (s, 2H), 4.89 (d, J = 1.5 Hz, 1H), 
4.42-4.30 (m, 1H), 2.77* (t, J = 7.2 Hz, 2H), 2.60-2.44 (m, 1H), 2.42-2.26 (m, 1H), 2.25-2.18 
(m, 2H), 2.10-1.94 (m, 3H), 1.80* (d, J = 0.9 Hz, 3H), 1.78* (s, 3H), 1.76-1.66 (m, 1H), 1.71* (s, 
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3H), 1.68 (s, 3H), 1.65* (s, 3H), 1.60 (s, 3H); 13C NMR (75 MHz, CDCl3) *designates isomers 
E/Z-198 where resolved: δ 148.6, 143.1, 141.5, 128.9, 128.1*, 127.9*, 126.4, 124.0, 123.0*, 
122.5*, 113.7, 112.5, 112.3*, 66.6*, 66.5, 36.2, 32.9*, 32.8, 28.9, 28.4*, 27.2*, 26.8, 25.7, 24.5*, 
17.7, 16.9*; IR (thin film): 3332, 2923, 1598, 1052 cm-1; EI-MS m/z (%) 218 (18, M+˙), 200 
(19), 149 (57), 131 (100); EI-HRMS calcd for C15H22O: m/z (M+˙) 218.1671; found: 218.1665. 
•
TMS TMS
EtO2C
EtO2C EtO2C
EtO2C
176 199  
(5E)-Diethyl 4-(6-methylhepta-1,5-dien-2-yl)-5-((trimethylsilyl)methylene))cyclohex-3-ene-
1,1-dicarboxylate (199).  Prepared according to General Procedure E using: 176 (13.5 mg, 0.03 
mmol), [Rh(CO)2Cl]2 (1 mg, 3 μmol). Yield 199 (10 mg, 74%). Rƒ 0.5 (5% EtOAc/toluene);  1H 
NMR (300 MHz, CDCl3): δ 5.61 (t, J = 4.2 Hz, 1H), 5.52 (s, 1H), 5.08 (tt, J = 6.9, 1.2 Hz, 1H), 
4.96 (dt, J = 2.4, 0.9, Hz, 1H), 4.79 (d, J = 2.4 Hz, 1H), 4.24-4.12 (m, 4H), 2.97 (d, J = 1.5 Hz, 
2H), 2.70 (d, J = 3.9 Hz, 2H), 2.15-2.09 (m, 2H), 2.03-1.93 (m, 2H), 1.68 (d, J = 1.2 Hz, 3H), 
1.59 (s, 3H), 1.24 (t, J = 7.2 Hz, 6H), 0.16 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 170.9 (2C), 
149.6, 145.5, 142.9, 131.5, 128.0, 124.1 (2C), 113.7, 61.4 (2C), 54.3, 36.5, 35.8, 31.4, 25.7, 17.7, 
14.0 (2C), 0.0 (3C); IR (thin film): 2959, 1736, 1246, 860 cm-1; EI-MS m/z (%) 418 (18, M+˙), 
345 (26), 73 (100); EI-HRMS calcd for C24H38O4Si: m/z (M+˙) 418.2539; found: 418.2534. 
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•
Ph Ph
EtO2C
EtO2C EtO2C
EtO2C
177 201
+
Ph
EtO2C
EtO2C
E/Z-202  
(5E)-Diethyl 5-benzylidene-4-(6-methylhepta-1,5-dien-2-yl)cyclohex-3-ene-1,1-dicarboxyl-
ate (201), (5E)-diethyl 5-benzylidene-4-(6-methylhepta-2,5-dien-2-yl)cyclohex-3-ene-1,1-
dicarboxylate (E/Z-202).  Prepared according to General Procedure E using: 177 (18 mg, 0.04 
mmol), [Rh(CO)2Cl]2 (2 mg, 4 μmol). Combined yield of 201 and E/Z-202 (13 mg, 72%).  The 
isomeric ratio of 201:E/Z-202 was determined by integration of the three peaks in the GC 
chromatogram at retention times 14.7 min, 16.6 min, and 17.6 min (E/Z-202 : 201 : E/Z-202).  Rƒ 
0.4 (5% EtOAc/toluene); 1H NMR (300 MHz, CDCl3) *designates isomers E/Z-202 where 
resolved: δ 7.38-7.18 (m, 5H), 6.51 (s, 1H), 6.49* (s, 1H), 6.44* (s, 1H), 5.67 (t, J = 3.9 Hz, 1H), 
5.60* (t, J = 4.2 Hz, 1H), 5.40-5.29* (m, 1H), 5.16* (tt, J = 7.2, 1.2 Hz, 1H), 5.11 (tt, J = 6.9, 1.2 
Hz, 1H), 5.03 (dt, J = 2.4, 1.2 Hz, 1H), 4.92 (d, J = 2.4 Hz, 1H), 4.10 (q, J = 7.2 Hz, 4H), 3.16 
(d, J = 1.5 Hz, 2H), 3.14* (d, J = 1.8 Hz, 2H), 2.76 (d, J = 4.2 Hz, 2H), 2.73* (d, J = 4.5 Hz, 2H), 
2.57* (t, J = 7.5 Hz, 2H), 2.27-2.19 (m, 2H), 2.05 (app q, J = 6.9 Hz, 2H), 1.82* (d, J = 1.2 Hz, 
3H), 1.79* (s, 3H), 1.71*  (d, J = 0.9 Hz, 3H), 1.68  (d, J = 0.9 Hz, 3H), 1.67* (s, 3H), 1.60 (s, 
3H), 1.13 (t, J = 7.2 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 170.9 (2C), 149.3, 142.0, 137.5, 
132.0, 131.6, 129.0 (2C), 128.6, 128.1 (2C), 126.5, 124.1, 124.0, 114.2, 61.4 (2C), 54.2, 36.4, 
31.6, 31.5, 26.8, 25.7, 17.7, 13.9 (2C); IR (thin film): 2921, 1734, 1246, 1060 cm-1; EI-MS m/z 
(%) 422 (23, M+˙), 353 (100), 349 (21), 69 (70); EI-HRMS calcd for C27H34O4: m/z (M+˙) 
422.2457; found: 422.2451. 
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•
Me Me
EtO2C
EtO2C EtO2C
EtO2C
178 203
+
Me
EtO2C
EtO2C
E/Z-204  
(5E)-Diethyl 5-ethylidene-4-(6-methylhepta-1,5-dien-2-yl)cyclohex-3-ene-1,1-dicarboxylate  
(203), (5E)-diethyl 5-ethylidene-4-(6-methylhepta-2,5-dien-2-yl)cyclohex-3-ene-1,1-dicarbo- 
xylate (E/Z-204). Prepared according to General Procedure E using: 178 (25 mg, 0.07 mmol), 
[Rh(CO)2Cl]2 (3 mg, 7 μmol). Combined yield of 203 and E/Z-204 (18 mg, 72%). The isomeric 
ratio of 203:E/Z-204 was determined by integration of the three peaks in the GC chromatogram 
at retention times 8.6 min, 8.9 min, and 9.2 min  (E/Z-204 : 203 : E/Z-204).  Rƒ 0.4 (5% 
EtOAc/toluene); 1H NMR (300 MHz, CDCl3) *designates isomers E/Z-204 where resolved: δ 
5.54 (q, J = 6.9 Hz, 1H), 5.44 (t, J = 4.2 Hz, 1H), 5.37* (t, J = 3.6 Hz, 1H), 5.26-5.18* (m, 1H), 
5.12* (tt, J = 6.9, 1.2 Hz, 1H), 5.07 (tt, J = 6.9, 1.2 Hz, 1H), 4.93 (dt, J = 2.1, 1.2 Hz, 1H), 4.79 
(d, J = 2.1 Hz, 1H), 4.21-4.12 (m, 4H), 2.86 (s, 2H), 2.84* (s, 2H), 2.70 (d, J = 4.2 Hz, 2H), 
2.67* (d, J = 3.9 Hz, 2H), 2.48* (t, J = 7.5 Hz, 2H), 2.17-2.09 (m, 2H), 2.02-1.92 (m, 2H), 1.73 
(d, J = 7.2 Hz, 3H), 1.67 (s, 3H), 1.64* (s, 3H), 1.62* (s, 3H), 1.58 (s, 3H), 1.24 (t, J = 7.2 Hz, 
6H); 13C NMR (75 MHz, CDCl3): δ 171.2 (2C), 149.5, 141.9, 131.5, 131.0, 124.2, 123.4, 121.0, 
113.4, 61.3 (2C), 54.1, 36.3, 31.3, 30.7, 26.8, 25.7, 17.7, 14.0 (2C), 13.3; IR (thin film): 2978, 
1735, 1444, 1245 cm-1; EI-MS m/z (%) 360 (18, M+˙), 291 (78), 287 (32), 217 (100), 145 (47); 
EI-HRMS calcd for C22H32O4: m/z (M+˙) 360.2301; found: 360.2307. 
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•
EtO2C
EtO2C EtO2C
EtO2C
179 205
+
EtO2C
EtO2C
E/Z-206  
Diethyl 5-methylene-4-(6-methylhepta-1,5-dien-2-yl)cyclohex-3-ene-1,1-dicarboxylate (205), 
diethyl 5-methylene-4-(6-methylhepta-2,5-dien-2-yl)cyclohex-3-ene-1,1-dicarboxylate (E/Z-
206). Prepared according to General Procedure E using: 179 (31 mg, 0.09 mmol), [Rh(CO)2Cl]2 
(4 mg, 9 μmol). Combined yield of 205 and E/Z-206 (9 mg, 29%). The isomeric ratio of 205: 
E/Z-206 was determined by integration of the three peaks in the GC chromatogram at retention 
times 8.2 min, 8.4 min, and 8.8 min (E/Z-206 : 205 : E/Z-206). Rƒ 0.5 (5% EtOAc/toluene); 1H 
NMR (300 MHz, CDCl3) *designates isomers E/Z-206 where resolved: δ 5.59 (t, J = 3.3 Hz, 
1H), 5.56* (t, J = 3.9 Hz, 1H), 5.52* (t, J = 3.6 Hz, 1H), 5.31-5.33* (m, 1H), 5.12* (tt, J = 6.9, 
1.5 Hz, 1H), 5.08 (tt, J = 7.2, 1.5 Hz, 1H), 4.99 (s, 1H), 4.98-4.95 (m, 2H), 4.95-4.93* (m, 2H), 
4.93-4.90* (m, 2H), 4.84 (d, J = 2.4 Hz, 1H), 4.22-4.13 (m, 4H), 2.89 (s, 2H), 2.87* (s, 2H), 2.72 
(d, J = 4.2 Hz, 2H), 2.69* (d, J = 4.2 Hz, 2H), 2.21-2.14 (m, 2H),  2.05-1.95 (m, 2H), 1.80* (s, 
3H), 1.75* (d, J = 0.9 Hz, 3H), 1.73* (s, 3H), 1.70* (s, 3H), 1.68 (s, 3H), 1.64* (s, 3H), 1.59 (s, 
3H) 1.23 (t, J = 7.2 Hz, 6H); 13C NMR (75 MHz, CDCl3) *designates isomers E/Z-206 where 
resolved: δ 170.9* (2C), 170.8 (2C), 148.7, 143.3*, 140.6, 138.4*, 135.0*, 131.5, 127.8, 126.9*, 
124.1, 123.9*, 123.0, 122.7*, 113.7, 113.6, 113.5*, 61.4 (2C), 61.3* (2C), 54.2, 37.3*, 37.2, 
36.3, 31.6, 27.2*,  26.8, 25.7, 17.7, 16.8*, 14.0 (2C); IR (thin film): 2978, 1735, 1444, 1244     
cm-1; EI-MS m/z (%) 346 (39, M+˙), 277 (42), 273 (100), 203 (81); EI-HRMS calcd for 
C21H30O4: m/z (M+˙) 346.2144; found: 346.2142. 
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180
TsN
•
TsN
TMS TMS
211  
(3Z)-1,2,3,6-Tetrahydro-4-(6-methylhepta-1,5-dien-2-yl)-3-((trimethylsilyl)methylene)-1-to- 
sylpyridine (211). Prepared according to General Procedure E using: 180 (19 mg, 0.04 mmol), 
[Rh(CO)2Cl]2 (2 mg, 4 μmol). Yield of 211 (12 mg, 63%). Rƒ 0.5 (5% EtOAc/toluene);  1H NMR 
(300 MHz, CDCl3): δ 7.68 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 5.54 (s, 1H), 5.49 (t, J = 
3.6 Hz, 1H), 5.02 (t, J = 6.6 Hz, 1H), 4.98-4.92 (m, 1H), 4.68 (d, J = 1.8 Hz, 1H), 3.92 (s, 2H), 
3.80 (d, J = 3.6 Hz, 2H), 2.43 (s, 3H), 2.07-1.99 (m, 2H), 1.97-1.88 (m, 2H), 1.66 (s, 3H), 1.55 
(s, 3H), 0.20 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 147.9, 143.5, 143.1, 142.0, 133.8, 131.7, 
129.6 (2C), 128.6, 127.7 (2C), 123.8, 121.4, 114.6, 48.1, 45.2, 35.9, 26.6, 25.6, 21.5, 17.7, 0.0 
(3C); IR (thin film): 2921, 1595, 1165, 866 cm-1; ESI-MS m/z (%) 453 (3), 452 (100, [M+Na]+); 
ESI-HRMS  calcd for C24H35NO2NaSiS: m/z [M+Na]+ 452.2055; found: 452.2068. 
+
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214
TsN
E/Z-215
Ph Ph Ph
 
(3Z)-3-Benzylidene-1,2,3,6-tetrahydro-4-(6-methylhepta-1,5-dien-2-yl)-1-tosylpyridine 
(214), (3Z)-3-benzylidene-1,2,3,6-tetrahydro-4-(6-methylhepta-2,5-dien-2-yl)-1- 
tosylpyridine (E/Z-215). Prepared according to General Procedure E using: 181 (16 mg, 0.04 
mmol), [Rh(CO)2Cl]2 (2 mg, 4 μmol). Combined yield of 214 and E/Z-215 (9 mg, 56%). The 
isomeric ratio of 214:E/Z-215 was determined by integration of the resonances at 6.40 ppm and 
6.32 ppm in the 1H NMR.  Rƒ 0.4 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) 
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*designates isomers E/Z-215 where resolved: δ 7.58* (d, J = 8.1 Hz, 2H), 7.57 (d, J = 8.1 Hz, 
2H), 7.43-7.36 (m, 2H), 7.32-7.21 (m, 3H), 7.18 (d, J = 8.4 Hz, 2H), 6.40 (s, 1H), 6.32* (s, 1H), 
5.51 (t, J = 3.6 Hz, 1H), 5.48* (t, J = 3.6 Hz, 1H), 5.32* (tq, J = 7.2, 0.9 Hz, 1H), 5.10* (tt, J = 
7.2, 1.2 Hz, 1H), 5.08-5.00 (m, 1H), 4.98 (dt, J = 2.1, 0.9, Hz, 1H), 4.68 (d, J = 2.1 Hz, 1H), 4.23 
(d, J = 0.9 Hz, 2H), 3.95 (d, J = 4.2 Hz, 2H), 3.94* (d, J = 4.8 Hz, 2H), 2.73* (t, J = 7.2 Hz, 2H), 
2.42 (s, 3H), 2.40* (s, 3H), 2.36* (t, J = 6.9 Hz, 2H), 2.14-2.06 (m, 2H), 2.03-1.93 (m, 2H), 
1.72* (d, J =  0.9, Hz, 3H), 1.69* (d, J =  1.2, Hz, 3H), 1.66 (d, J =  0.9, Hz, 3H), 1.56 (s, 3H); 
13C NMR (75 MHz, CDCl3): δ 147.8, 143.4, 141.1, 136.2, 134.5, 131.8, 129.4 (2C), 129.3, 128.9 
(2C), 128.7, 128.5 (2C), 127.4 (2C), 127.3, 123.7, 121.4, 114.8, 45.3, 44.6, 36.0, 26.7, 25.7, 21.5, 
17.7; IR (thin film): 2920, 1633, 1349, 1163 cm-1; EI-MS m/z (%) 433 (30, M+˙), 278 (68), 91 
(97), 69 (100); EI-HRMS calcd for C27H31NO2S: m/z (M+˙) 433.2076; found: 433.2069. 
+
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TsN
217
TsN
E/Z-218
Me Me Me
 
(3Z)-3-Ethylidene-1,2,3,6-tetrahydro-4-(6-methylhepta-1,5-dien-2-yl)-1-tosylpyridine (217), 
(3Z)-3-ethylidene-1,2,3,6-tetrahydro-4-(6-methylhepta-2,5-dien-2-yl)-1-tosylpyridine  
(E/Z-218). Prepared according to General Procedure E using: 182 (22 mg, 0.06 mmol), 
[Rh(CO)2Cl]2 (2 mg, 6 μmol). Combined yield of 217 and E/Z-218 (14 mg, 64%). The isomeric 
ratio of 217:E/Z-218 was determined by integration of the resonances at 5.32 ppm, 5.29 ppm, 
and 5.28 ppm in the 1H NMR.  Rƒ 0.7 (15% EtOAc/toluene);  1H NMR (500 MHz, CDCl3) 
*designates isomers E/Z-218 where resolved: 7.68 (d, J = 8.0 Hz, 2H), 7.67* (d, J = 8.0 Hz, 2H), 
7.29 (d, J = 8.0 Hz, 2H), 5.47 (q, J = 7.5 Hz, 1H), 5.39* (q, J = 7.0 Hz, 1H), 5.32 (t, J = 3.5 Hz, 
1H), 5.29* (t, J = 3.5 Hz, 1H), 5.28* (t, J = 3.5 Hz, 1H), 5.22* (tq, J = 7.5, 1.5 Hz, 1H), 5.09* (tt, 
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J = 7.0, 1.5 Hz, 1H), 5.07* (tt, J = 7.0, 1.5 Hz, 1H), 5.01 (tt, J = 7.0, 1.5 Hz, 1H), 4.90 (dt, J = 
2.5, 1.0, Hz, 1H), 4.63 (d, J = 2.5 Hz, 1H), 3.93 (s, 2H), 3.82 (d, J = 3.5 Hz, 2H), 3.80* (d, J = 
3.5 Hz, 2H), 2.68* (t, J = 7.0 Hz, 2H), 2.43* (s, 3H), 2.42 (s, 3H), 2.41* (s, 3H), 2.32* (t, J = 7.5 
Hz, 2H), 2.04-1.98 (m, 2H), 1.96-1.89 (m, 2H), 1.74 (d, J =  7.5 Hz, 3H), 1.70* (d, J = 1.0 Hz, 
3H), 1.68* (s, 3H), 1.67* (s, 3H), 1.65  (d, J = 0.5 Hz, 3H), 1.63* (s, 3H), 1.61* (d, J = 1.5 Hz, 
3H), 1.60* (s, 3H), 1.55 (s 3H); 13C NMR (75 MHz, CDCl3): δ 148.0, 143.4, 140.8, 134.2, 131.7, 
129.4 (2C), 128.8, 127.7 (2C), 123.8, 123.6, 118.7, 114.1, 45.1, 43.7, 36.0, 26.6, 25.7, 21.5, 17.7, 
13.3; IR (thin film): 2919, 1597, 1348, 1161 cm-1; ESI-MS m/z (%) 394 (100, [M+Na]+), 386 
(57); ESI-HRMS  calcd for C22H29NO2NaS: m/z [M+Na]+ 394.1817; found: 394.1844.  
+
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221  
1,2,3,6-Tetrahydro-3-methlyene-4-(6-methylhepta-1,5-dien-2-yl)-1-tosylpyridine (220),  
1,2,3,6-Tetrahydro-3-methlyene-4-(6-methylhepta-2,5-dien-2-yl)-1-tosylpyridine (E/Z-221). 
Prepared according to General Procedure E using: 183 (22 mg, 0.06 mmol), [Rh(CO)2Cl]2 (2 mg, 
6 μmol). Combined yield of 220 and E/Z-221 (8 mg in 36% yield, product contains inseparable 
impurities). The isomeric ratio of 220:E/Z-221 was determined by integration of the resonances 
at 2.70 ppm, 2.35 ppm, and 2.11-2.03 in the 1H NMR.  Rƒ 0.5 (5% EtOAc/toluene);  1H NMR 
(300 MHz, CDCl3) *designates isomers E/Z-221 where resolved: δ 7.74 (d, J = 8.4 Hz, 2H), 
7.68* (d, J = 8.4 Hz, 2H), 7.67* (d, J = 8.4 Hz, 2H), 7.34 (d, J = 7.8 Hz, 2H), 7.29* (d, J = 8.1 
Hz, 2H), 7.28* (d, J = 7.8 Hz, 2H), 5.49-5.46* (m, 1H), 5.46-5.41 (m, 1H), 5.12-5.02 (m, 1H), 
5.03-4.98 (m, 2H), 4.95 (dt, J = 2.4, 0.9 Hz, 1H), 4.93-4.90* (m, 2H), 4.70 (d, J = 2.1 Hz, 1H), 
3.87-3.84 (m, 2H), 3.83* (d, J = 3.6 Hz, 2H), 3.81 (d, J = 3.6 Hz, 2H), 2.70* (t, J = 7.2 Hz, 2H), 
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2.45* (s, 3H), 2.42 (s, 3H), 2.35* (t, J = 6.6 Hz, 2H),  2.11-2.03 (m, 2H), 1.99-1.88 (m, 2H), 
1.70* (d, J = 1.2 Hz, 3H), 1.65* (d, J = 0.9 Hz, 3H), 1.63 (s, 3H), 1.55 (s, 3H), minor inseparable 
impurities (by column chromatography): 5.31-5.28 (m, 0.4H), 4.72 (q, J = 2.7 Hz, 1.1H), 4.16 
(dq, J = 14.1, 1.8 Hz, 1.4H), 3.92 (t, J = 2.1 Hz, 1.3H), 3.66 (app t, J =  9.6 Hz, 1.6H), 3.15 (app 
t, J =  9.6 Hz, 1.3H), 2.20-2.30 (m, 2.5H); 13C NMR (75 MHz, CDCl3) *designates isomers E/Z-
221 where resolved: δ 146.6, 143.6, 143.5*, 143.4*, 139.8, 136.1, 133.9*, 133.2, 133.0*, 132.5*, 
132.0*, 131.8, 129.6 (2C), 129.5* (2C), 129.5* (2C), 127.9* (2C), 127.8* (2C), 127.7 (2C), 
123.7, 122.3*, 121.6*, 120.8*, 114.4, 113.4*, 113.2, 49.5, 49.4*, 45.5, 45.4*, 35.9, 35.7*, 30.5, 
27.2*, 26.0*, 25.6, 21.5, 21.4*, 17.7; IR (thin film): 2959, 1597, 1348, 1163 cm-1; EI-MS m/z 
(%) 357 (62, M+˙), 288 (34), 202 (61), 91 (100); EI-HRMS calcd for C21H27NO2S: m/z (M+˙) 
357.1763; found: 357.1777.  
184
O
•
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TMS TMS
223  
Trimethyl((1Z)-(4-(6-methylhepta-1,5-dien-2-yl)-2H-pyran-3(6H)-ylidene)methyl)silane 
(223). Prepared according to General Procedure E using: 184 (14 mg, 0.05 mmol), [Rh(CO)2Cl]2 
(2 mg, 5 μmol). Yield of 223 (8.5 mg, 61%). Rƒ 0.5 (5% EtOAc/toluene);  1H NMR (300 MHz, 
CDCl3): δ 5.68 (td, J = 3.0, 0.6 Hz, 1H), 5.53 (d, J = 0.6 Hz, 1H), 5.11 (tt, J = 6.9, 1.5 Hz, 1H), 
5.03 (dt, J = 2.4, 1.5, Hz, 1H), 4.90 (d, J = 2.4 Hz, 1H), 4.35 (d, J = 0.6 Hz, 2H), 4.27 (dd, J = 
3.0, 0.9 Hz, 2H), 2.23-2.14 (m, 2H), 2.11-2.00 (m, 2H), 1.69 (d, J = 1.2 Hz, 3H), 1.60 (s, 3H), 
0.14 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 148.0, 145.8, 140.7, 131.7, 125.4, 125.0, 124.0, 
114.3, 68.5, 65.8, 36.1, 26.8, 25.7, 17.7, 0.2 (3C); IR (thin film): 2926, 1583, 1249, 864 cm-1; EI-
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MS m/z (%) 276 (22, M+˙), 261 (14), 207 (78), 75 (100); EI-HRMS calcd for C17H28OSi: m/z 
(M+˙) 276.1909; found: 276.1901. 
O
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185 226
+ O
Ph
E/Z-227  
(3Z)-3-Benzylidene-3,6-dihydro-4-(6-methylhepta-1,5-dien-2-yl)-2H-pyran (226),  
(3Z)-3-Benzylidene-3,6-dihydro-4-(6-methylhepta-2,5-dien-2-yl)-2H-pyran (E/Z-227).  Pre-
pared according to General Procedure E using: 185 (15 mg, 0.05 mol), [Rh(CO)2Cl]2 (2 mg, 5 
μmol). Combined yield of 226 and E/Z-227 (9 mg, 60%). The isomeric ratio of 226:E/Z-227 was 
determined by integration of the three peaks in the GC chromatogram at retention times 8.5 min, 
8.9 min, and 9.3 min  (E/Z-227 : 226 : E/Z-227).  Rƒ 0.5 (5% EtOAc/toluene); 1H NMR (300 
MHz, CDCl3) *designates isomers E/Z-227 where resolved: δ 7.40-7.31 (m, 2H), 7.28-7.21 (m, 
1H), 7.14 (d, J = 7.8 Hz, 2H), 6.51 (s, 1H), 6.45* (s, 1H), 6.43* (s, 1H), 5.73 (t, J = 3.0 Hz, 1H), 
5.68* (t, J = 2.7 Hz, 1H), 5.44* (t, J = 7.2 Hz, 1H), 5.13 (tt, J = 6.9, 0.9 Hz, 1H), 5.12-5.09 (m, 
1H), 5.02 (d, J = 2.4 Hz, 1H), 4.59 (d, J = 1.5 Hz, 2H), 4.58* (d, J = 1.5 Hz, 2H), 4.33 (d, J = 3.0 
Hz, 2H), 4.30* (d, J = 2.7 Hz, 2H), 2.83* (t, J = 7.2 Hz, 2H), 2.68* (t, J = 7.2 Hz, 2H), 2.34-2.25 
(m, 2H), 2.18-2.07 (m, 2H), 1.89* (s, 3H), 1.86* (s, 3H), 1.73* (s, 3H), 1.70 (s, 3H), 1.61 (s, 3H) 
1.60* (s, 3H); 13C NMR (75 MHz, CDCl3): δ 148.0, 139.6, 136.7, 132.4, 131.8, 129.1 (2C), 
128.2 (2C), 126.9, 126.2, 124.9, 123.9, 114.6, 65.8, 65.2, 36.2, 26.8, 25.7, 17.8; IR (thin film): 
2923, 1444, 1121 cm-1; EI-MS m/z (%) 280 (25, M+˙), 211 (18), 91 (100), 69 (59); EI-HRMS 
calcd for C20H24O: m/z (M+˙) 280.1827; found: 280.1835. 
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(3Z)-3-Ethylidene-3,6-dihydro-4-(6-methylhepta-1,5-dien-2-yl)-2H-pyran (229),  
(3Z)-3-Ethylidene-3,6-dihydro-4-(6-methylhepta-2,5-dien-2-yl)-2H-pyran (E/Z-230).  Pre-
pared according to General Procedure E using: 186 (22 mg, 0.10 mmol), [Rh(CO)2Cl]2 (4 mg, 10 
μmol). Combined yield of 229 and E/Z-230 (9 mg, 41%). The isomeric ratio of 229:E/Z-230 was 
determined by integration of the three peaks in the GC chromatogram at retention times 5.3 min, 
5.6 min, and 5.9 min  (E/Z-230 : 229 : E/Z-230).  Rƒ 0.7 (20% EtOAc/hexanes);  1H NMR (500 
MHz, CDCl3) *designates isomers E/Z-230 where resolved: δ 5.53 (t, J = 3.0 Hz, 1H), 5.50 (q, J 
= 7.0 Hz, 1H), 5.46* (t, J = 3.0 Hz, 1H), 5.43* (q, J = 7.0 Hz, 1H), 5.42* (q, J = 7.0 Hz, 1H), 
5.34-5.29* (m, 1H), 5.14* (tt, J = 7.0, 1.5 Hz, 1H), 5.10 (tt, J = 7.0, 1.5 Hz, 1H), 5.05* (tt, J = 
7.0, 1.5 Hz, 1H), 5.00 (dt, J = 2.5, 1.5 Hz, 1H), 4.89 (d, J = 2.5 Hz, 1H), 4.36 (s, 2H), 4.35* (s, 
2H), 4.25 (d, J = 3.0 Hz, 2H), 4.23* (d, J = 3.0 Hz, 2H), 2.77* (t, J = 7.5 Hz, 2H), 2.58* (t, J = 
7.0 Hz, 2H), 2.21-2.17 (m, 2H), 2.09-2.03 (m, 2H), 1.79* (q, J = 1.5 Hz, 3H), 1.77-1.75* (m, 
3H), 1.71* (d, J = 1.5 Hz, 3H), 1.69 (d, J =  6.5 Hz, 3H), 1.69 (d, J = 1.0 Hz, 3H), 1.61* (s, 3H), 
1.60 (s, 3H), 1.58* (s, 3H); 13C NMR (75 MHz, CDCl3): δ 148.2, 139.4, 131.6, 131.2, 124.0, 
122.2, 120.8, 113.8, 65.8, 64.4, 36.2, 26.8, 25.7, 17.7, 12.8; IR (thin film): 2918, 1448, 1129   
cm-1; EI-MS m/z (%) 218 (20, M+˙),189 (24), 69 (100); EI-HRMS calcd for C15H22O2: m/z (M+˙) 
218.1671; found: 218.1670. 
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3,6-Dihydro-3-methylene-4-(6-methylhepta-1,5-dien-2-yl)-2H-pyran (232), 3,6-dihydro-3-
methylene-4-(6-methylhepta-2,5-dien-2-yl)-2H-pyran (E/Z-233). Prepared according to 
General Procedure E using: 187 (34 mg, 0.16 mmol), [Rh(CO)2Cl]2 (6 mg, 16 μmol). Combined 
yield of 232 and E/Z-233 (7 mg in 21% yield, product contains inseparable impurities). The 
isomeric ratio of 232 : E/Z-233 was determined by integration of the resonances at 5.68-5.64 
ppm, 5.64-5.62 ppm, and 5.61-5.58 ppm in the 1H NMR. Rƒ 0.5 (5% EtOAc/toluene);  1H NMR 
(500 MHz, CDCl3) *designates isomers E/Z-233 where resolved: δ 5.68-5.64 (m, 1H), 5.64-
5.62* (m, 1H), 5.61-5.58* (m, 1H), 5.37* (tq, J = 7.5, 1.5 Hz, 1H), 5.35* (tq, J = 7.5, 1.5 Hz, 
1H), 5.14* (tt, J = 7.0, 1.5 Hz, 1H), 5.10 (tt, J = 7.0, 1.5 Hz, 1H), 5.05* (tt, J = 7.0, 1.5 Hz, 1H), 
5.03 (dt, J = 2.5, 1.5 Hz, 1H), 5.01 (s, 1H), 4.95 (s, 1H), 4.94 (d, J = 2.5 Hz, 1H), 4.92-4.89* (m, 
2H), 4.30 (d, J = 3.0 Hz, 2H), 4.28* (d, J = 3.5 Hz, 2H), 4.25 (s, 2H), 4.23* (s, 2H), 2.78* (t, J = 
7.0 Hz, 2H), 2.59* (t, J = 7.0 Hz, 2H), 2.26-2.21 (m, 2H), 2.10-2.04 (m, 2H), 1.83* (s, 3H), 
1.72* (s, 3H), 1.69 (s, 3H), 1.66* (s, 3H), 1.60 (s, 3H), 1.59* (s, 3H), minor inseparable 
impurities (by column chromatography): 4.54 (A of an ABq , q, J = 13.5, 1.5 Hz, 2H),  4.48 (B 
of an ABq , q, J = 13.5, 2.0 Hz, 2H),  4.17-4.13 (m, 2H), 4.13-4.07 (m, 2H), 3.80 (dd, J = 9.0, 7.5 
Hz, 2H),  2.50-2.44 (m, 4.5H), 2.31 (q, J = 6.5 Hz, 4.4H); 13C NMR (125 MHz, CDCl3) 
*designates isomers E/Z-233 where resolved: δ 150.5, 147.3, 140.9*, 138.6, 138.5*, 138.4*, 
133.2, 132.0*, 131.7*, 128.4*, 125.1*, 125.0, 124.1*, 123.9, 122.5*, 114.1, 110.3, 110.1*, 69.9*, 
69.8, 66.2, 66.1*, 36.0, 27.3*, 26.8, 25.7, 25.6*, 24.2, 17.8*, 17.7; IR (thin film): 2917, 1453, 
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1129 cm-1; EI-MS m/z (%) 204 (65, M+˙), 189 (23), 135 (48), 107 (100); EI-HRMS calcd for 
C14H20O: m/z (M+˙) 204.1514; found: 204.1511. 
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186 231  
3a,4-Dihydro-6-methyl-4-(6-methylhepta-5-en-2-ylidene)-1H-cyclopenta[c]furan-5-(3H)-
one (231).  A flame-dried 13 х 100 mm test tube equipped with a stir bar and rubber septum is 
charged with allene-yne 186 (26 mg, 0.12 mmol) and toluene (1.2 mL).  The test tube is then 
evacuated under vacuum by insertion of an 18 gauge needle into the septum and charged three 
times with CO(g) from a balloon.  To the allene-yne solution is then added [Rh(CO)2Cl]2 (5 mg, 
12 μmol) in one portion and the test tube is evacuated and refilled with CO again (3X).  The test 
tube is placed in a preheated 90 °C oil bath and is stirred under a balloon of CO.  After 30 min, 
consumption of 186 is observed by TLC.  The reaction is cooled to rt and is directly subjected to 
silica gel chromatography eluting with 5-30% Et2O/pentane to give 19 mg of α-alkylidene 
cyclopentenone 231 in 65% yield, d.r. = 1:1 based upon integration of the resonances at 5.17 
ppm and 5.06 ppm in the 1H NMR.  Rƒ 0.2 (5% EtOAc/toluene); 1H NMR (300 MHz, CDCl3) 
*designates where minor diastereomer is resolved: δ 5.17 (t, J = 7.5 Hz, 1H), 5.06* (t, J = 6.9 
Hz, 1H), 4.58 (A of an ABq, J = 14.7, 1H), 4.45 (B of an ABq, J = 14.7, 1H), 4.38 (t, J = 7.5 Hz, 
1H), 4.33* (t, J = 7.8 Hz, 1H), 3.71-3.60 (m, 1H), 3.15 (dd, J = 11.1, 7.8 Hz, 1H), 3.14* (dd, J = 
10.8, 7.8 Hz, 1H), 2.91-2.71 (m, 1H), 2.30* (s, 3H), 2.26-2.05 (m, 3H), 1.88 (s, 3H), 1.80 (s, 
3H), 1.68 (s, 3H), 1.62 (s, 3H), 1.61* (s, 3H); 13C NMR (75 MHz, CDCl3) *designates where 
minor diastereomer is resolved: δ 197.4, 196.6*, 166.7, 166.3*, 151.3*, 150.8, 135.7, 132.8, 
132.1*, 130.6*, 130.3, 123.7*, 122.9, 70.6, 70.4*, 64.2*, 64.1, 47.7*, 47.5, 39.1, 32.7, 25.7, 22.9, 
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17.7*, 17.3, 9.5; IR (thin film): 2918, 1683, 1632, 1444 cm-1; EI-MS m/z (%) 246 (27, M+˙), 173 
(20), 148 (68), 69 (100); EI-HRMS calcd for C16H22O2: m/z (M+˙) 246.1620; found: 246.1611. 
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3a,4-Dihydro-6-methyl-4-(6-methylhepta-5-en-2-ylidene)-1H-cyclopenta[c]furan-5-(3H)-
one (231), 5,7-diemthyl-5-(4-methylpent-3-enyl)cyclopenta[c]pyran-6(1H,3H,5H)-one (235).  
A flame-dried 13 х 100 mm test tube equipped with a stir bar and rubber septum is charged with 
[Rh(CO)2Cl]2 (4 mg, 11 μmol) and DCE (0.3 mL).  To the solution is then added PPh3 (9 mg, 34 
μmol) in DCE (0.3 mL) dropwise via syringe.  The test tube is then evacuated under vacuum by 
insertion of an 18 gauge needle into the septum and charged three times with CO(g) from a 
balloon.  After 5 min of stirring, a solution of AgBF4 (0.5 mL of a 0.05 M soln in DCE, 25 μmol) 
is added dropwise via syringe.  The reaction is stirred for an additional 5 min at rt before a 
solution of allene-yne 186 (25 mg, 0.11 mmol) in DCE (0.3 mL) is added via syringe.  The test 
tube is placed in a preheated 50 °C oil bath and is stirred under a balloon of CO.  After 1 h of 
stirring, consumption of 186 is observed by TLC.  The reaction is cooled to rt and is directly 
subjected to silica gel chromatography eluting with 5-20% Et2O/pentane to give 6 mg of α-
alkylidene cyclopentenone 231 in 21% yield, and 6 mg of 4-alkylidene cyclopentenone 235 in 
21% yield. Spectral data for α-alkylidene cyclopentenone 231 matched that from above. 4-
alkylidene cyclopentenone 235: Rƒ 0.3 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) 4-
alkylidene cyclopentenone 235 (contaminated with trace amount of 231): δ 5.87 (t, J = 3.3 Hz, 
1H), 5.02-4.94 (m, 1H), 4.67 (s, 2H), 4.35 (d, J = 3.3 Hz, 2H), 1.86-1.60 (m, 4H), 1.76 (s, 3H), 
1.75 (s, 3H), 1.63 (s, 3H), 1.50 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 209.7, 156.7, 142.7, 
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131.7, 130.9, 124.1, 118.6, 64.9, 63.6, 47.7, 37.3, 25.6, 23.4, 22.8, 17.6, 7.8; IR (thin film): 2920, 
1701, 1631, 1126 cm-1; EI-MS m/z (%) 246 (50, M+˙), 164 (51), 117 (100), 69 (70); EI-HRMS 
calcd for C16H22O2: m/z (M+˙) 246.1620; found: 246.1612. 
+
•
TMS
HO
TMS
HO
162 188
TMS
HO
E/Z-161
 
(4E)-3-(6-Methylhepta-2,5-dien-2-yl)-4-((trimethylsilyl)methylene)cyclohexen-2-ol  
(E/Z-161), (4E)-3-(6-Methylhepta-1,5-dien-2-yl)-4-((trimethylsilyl)methylene)cyclohexen-2-
ol (188). A flame-dried 13 х 100 mm test tube equipped with a stir bar, rubber septum, and argon 
balloon is charged with allene-yne 162 (18 mg, 0.06 mmol) and styrene (1.2 mL).  Argon is 
bubbled through the solution using a balloon filled with argon attached to a syringe before 
[Rh(CO)2Cl]2 (2 mg, 6 μmol) is added in one portion.  Upon completion of the reaction as 
observed by TLC analysis, the solution is directly subjected to silica gel chromatography eluting 
with 5-20% Et2O/pentane to give 14 mg of cross-conjugated trienes E/Z-161 and 188 in 78% 
yield. The isomeric ratio of E/Z-161 and 188 was determined by integration of the three peaks in 
the GC chromatogram at retention times at 6.9 min, 7.1 min, and 7.4 min, which correspond to 
Z-161, 188, and E-161, respectively.  The E isomer of 161 was separated from the Z (Z-161) and 
constitutional site isomers (188) using HPLC (Varian Microsorb Dynamax 100-5 Si column, 23 
°C, isopropanol / hexanes = 1%, flow rate = 3 mL·min-1). Isomers Z-161 and 188 were 
inseparable and co-eluted using this method. Rƒ 0.3 (20% EtOAc/hexanes);  1H NMR (300 MHz, 
CDCl3) E-161: δ 5.64 (d, J = 3.6 Hz, 1H), 5.43 (s, 1H), 5.29 (tq, J = 7.2, 1.5 Hz, 1H), 5.15 (tt, J 
= 7.2, 1.5 Hz, 1H), 4.32 (s, 1H), 2.77 (t, J = 7.2 Hz, 2H), 2.56 (ddd, J = 14.7, 8.1, 3.6 Hz, 1H), 
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2.34 (dddd, J = 14.7, 10.8, 3.9, 1.2 Hz, 1H), 2.01 (ddt, J = 12.6, 8.4, 4.5 Hz, 1H), 1.73 (d, J = 0.6 
Hz, 3H), 1.72-1.62 (m, 1H), 1.71 (d, J = 0.6 Hz, 3H), 1.65 (s, 3H), 0.13 (s, 9H);  13C NMR (75 
MHz, CDCl3): δ 149.5, 147.8, 135.0, 131.9, 128.2, 127.9, 127.1, 122.6, 66.4, 33.0, 28.0, 27.2, 
25.6, 17.7, 17.0, 0.1 (3C); IR (thin film): 3306, 2920, 1577, 1247 cm-1; EI-MS m/z (%) 290 (39, 
M+˙), 221 (16), 131 (100), 73 (93); EI-HRMS calcd for C18H30OSi: m/z (M+˙) 290.2066; found: 
290.2064. 1H NMR (500 MHz, CDCl3) *designates where minor isomer Z-161 is resolved from 
188: δ 5.66 (d, J = 3.5 Hz, 1H), 5.60* (d, J = 3.0 Hz, 1H), 5.50 (s, 1H), 5.31* (tq, J = 7.0, 1.5 Hz, 
1H), 5.10 (tt, J = 7.0, 1.5 Hz, 1H), 5.05* (tt, J = 7.5, 1.5 Hz, 1H), 5.00 (d, J = 1.5 Hz, 1H), 4.88 
(d, J = 2.0 Hz, 1H), 4.40-2.31 (m, 1H), 2.58 (ddd, J = 14.5, 7.5, 3.5 Hz, 1H), 2.52* (t, J = 7.0 Hz, 
2H), 2.37 (dddd, J = 14.5, 10.0, 4.0, 1.5 Hz, 1H), 2.20-2.14 (m, 2H), 2.08-2.00 (m, 3H), 1.78* (s, 
3H), 1.71 (ddd, J = 13.5, 7.0, 3.5 Hz, 1H), 1.69 (s, 3H), 1.68* (s, 3H), 1.59 (s, 3H), 1.57* (s, 3H), 
0.13 (s, 9H). 
•
TMS
HO
162 239
OTMS
 
(4-(2,5-Dihydro-5-methyl-5-(4-methylpent-3-enyl)furan-2-yl)but-1-ynyl)trimethylsilane 
(239). A flame-dried 13 х 100 mm test tube equipped with a stir bar, rubber septum, and argon 
balloon is charged with allene-yne 162 (9 mg, 0.03 mmol) and MeOH (0.6 mL).  Argon is 
bubbled through the solution using a balloon filled with argon attached to a syringe before 
[Rh(CO)2Cl]2 (1 mg, 3 μmol) is added in one portion.  Upon completion of the reaction as 
observed by TLC analysis, the solution is directly subjected to silica gel chromatography eluting 
with 5% Et2O/pentane to give 7 mg of furan 239 in 78% yield as a 1.2:1 mixture of 
diastereomers.  Rƒ 0.8 (20% EtOAc/hexanes); 1H NMR (300 MHz, CDCl3) *designates minor 
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diastereomer where resolved: δ 5.74 (dd, J = 6.3, 0.9 Hz, 1H), 5.72* (s, 2H), 5.68 (dd, J = 6.0, 
2.1 Hz, 1H), 5.16-5.05 (m, 1H), 4.87 (t, J = 6.3 Hz, 1H), 2.39-2.26 (m, 2H), 2.07-1.87 (m, 2H), 
1.83-1.72 (m, 2H), 1.71-1.60 (m, 2H), 1.68* (s, 3H), 1.67 (s, 3H), 1.60 (s, 3H), 1.29 (s, 3H), 
1.27* (s, 3H), 0.15 (s, 9H); 13C NMR (75 MHz, CDCl3) *designates minor diastereomer where 
resolved: δ 134.6*, 134.1, 131.4, 131.2*, 128.5, 128.3*, 124.6, 124.5*, 107.3, 107.2*, 90.0, 
89.8*, 84.7, 84.6, 83.6*, 41.3*, 41.2, 35.8, 35.5*, 28.1, 26.2*, 25.7, 23.5*, 23.0, 17.6, 16.3*, 
16.0, 0.1 (3C); IR (thin film): 2924, 2175, 1456, 842 cm-1; EI-MS m/z (%) 290 (53, M+˙), 221 
(32), 207 (88), 73 (100); EI-HRMS calcd for C18H30OSi: m/z (M+˙) 290.2066; found: 290.2059. 
•
TMS
HO
162
OH
TMS
247   
1-(2-Methyl-5-(prop-1-en-2-yl)cyclopent-1-enyl)-6-(trimethylsilyl)hex-5-yn-2-ol (247).  
A Biotage microwave 2-5 mL vial is equipped with a stir bar and a solution of allene-yne 162 
(40 mg, 0.14 mmol) in 2.8 mL of DMF.  The vial is heated under microwave irradiation in a 
Biotage Initiator microwave reactor at 225 °C for 20 min (Absorption level: very high; pre-
stirring: 0; initial power: 0; dynamic deflector optimization: on; stir rate: 600; approximate ramp 
time 3 min).  Consumption of starting material was observed via TLC analysis after the 
described time.  The mixture was partitioned between Et2O and H2O.  The aq layer is separated 
and extracted with Et2O (3X).  The combined organic layers are washed with H2O, brine, dried 
over MgSO4, and filtered via gravity filtration. The filtrate is concentrated under reduced 
pressure by rotary evaporation. The residue is purified by silica gel chromatography eluting with 
2.5-10% Et2O/pentanes to afford 21.5 mg of 247 in 54% yield as approximately a 1:1 mixture of 
separable diastereomers.  Rƒ 0.6 (20% EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) :δ 4.76-
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4.69 (m, 2H), 3.83-3.76 (m, 1H), 3.37 (d, J = 8.5 Hz, 1H), 2.42 (ddd, J = 14.5, 8.5, 5.5 Hz, 1H), 
2.38 (t, J = 7.0 Hz, 2H), 2.32 (dd, J = 9.5, 5.0 Hz, 1H), 2.24 (dd, J = 13.5, 9.5 Hz, 1H), 2.10-1.98 
(m, 1H), 1.97 (d, J = 13.0 Hz, 1H), 1.72 (s, 3H), 1.74-1.63 (3 H), 1.58 (d, J = 1.0 Hz, 3H), 0.15 
(s, 9H), minor inseparable impurities (by column chromatography): 4.24-4.18 (m, 0.1H), 3.90-
3.80 (m , 0.3H), 3.70-3.63 (m, 0.1H), 3.33-3.28 (bs, 0.1H), 2.72-2.54 (m, 1.2H);  13C NMR (75 
MHz, CDCl3): δ 148.1, 138.0, 132.6, 111.0, 107.1, 84.7, 68.2, 55.7, 37.7, 35.9, 34.7, 27.7, 18.5, 
16.5, 14.3, 0.1 (3C). Rƒ 0.5 (20% EtOAc/hexanes); 1H NMR (500 MHz, CDCl3): δ 4.78-4.71 (m, 
2H), 3.91-3.83 (m, 1H), 3.35-3.28 (m, 1H), 2.37 (dd, J = 7.0, 3.5, 1H), 2.36 (dd, J = 6.5, 2.0, 
1H), 2.34-2.30 (m, 2H), 2.27 (dd, J = 13.5, 7.0 Hz, 1H), 2.07 (dd, J = 13.5, 6.5 Hz, 1H), 2.00 
(dtd, J = 13.0, 9.5, 6.0 Hz, 1H), 1.70 (s, 3H), 1.69-1.61 (m, 2H), 1.59 (d, J = 0.5 Hz, 3H), 1.59-
1.46 (m, 1H), 0.16 (s, 9H);  13C NMR (75 MHz, CDCl3): δ 148.3, 136.7, 132.7, 111.0, 107.2, 
85.1, 69.9, 56.9, 37.5, 35.3, 35.1, 27.9, 18.6, 16.6, 14.4, 0.1 (3C); IR (thin film): 3382, 2954, 
2174, 843 cm-1;  EI-MS m/z (%) 290 (82, M+˙), 247 (64), 217 (17), 84 (100); EI-HRMS calcd for 
C18H30OSi: m/z (M+˙) 290.2066; found: 290.2062. 
TMS
HO
188 254
TMS
HO O
 
(E)-6-(6-Methylhepta-1,5-dien-2-yl)-5-((trimethylsilyl)methylene)-7-oxa-bicyclo[4.1.0]hept- 
an-2-ol (254).  A 5-mL, single-necked, round-bottomed flask equipped with a stir bar, rubber 
septum, and nitrogen line is charged with allylic alcohol 188 (29 mg, 0.10 mmol), toluene (1 
mL), and 4 Å powdered molecular sieves (60 mg).  To the flask is added aluminum (III) tert-
butoxide (37 mg, 0.15 mmol) in one portion and the reaction is cooled to –20 °C.  t-Butyl 
hydrogen peroxide (48 μL of a 5.5 M decane soln, 0.26 mmol) is then added dropwise with a gas 
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tight syringe.  The reaction is stirred at –20 °C for 4 h before being warmed to 0 °C.  The 
reaction is stirred for an additional 3 h at 0 °C when TLC analysis shows trace amount of cross-
conjugated triene 188.  The reaction is quenched with sat’d aq Rochelle’s salt (1.3 mL), is 
warmed to rt, and is vigorously stirred for 1 h.  The reaction mixture is then transferred to a 
separatory funnel and the aq layer is separated and extracted with EtOAc.  The combined organic 
layers are washed with H2O, brine, and are dried on MgSO4.  The solids are filtered off via 
gravity filtration and the filtrate is concentrated under reduced pressure by rotary evaporation. 
The resulting residue is purified on silica gel eluting with 5-20% Et2O/pentane to afford 17 mg of 
epoxide 254 in 56% yield, 67% brsm.  Rƒ 0.2 (20% EtOAc/hexanes); 1H NMR (500 MHz, 
CDCl3): δ 5.83 (d, J = 2.0 Hz, 1H), 5.22 (d, J = 1.5 Hz, 1H), 5.09 (tt, J = 6.0, 1.5 Hz), 5.02 (s, 
1H), 4.06 (dt, J = 6.0, 4.0 Hz, 1H), 3.19 (d, J = 1.5 Hz, 1H), 2.53 (ddd, J = 15.0, 5.0, 3.0 Hz, 
1H), 2.14-2.04 (m, 4H), 2.02 (dddd, J = 15.0, 13.0, 3.5, 2.0 Hz, 1H), 1.85 (dq, J = 12.5, 4.0 Hz, 
1H), 1.69 (s, 3H), 1.61 (s, 3H), 1.52 (tdd, J = 13.0, 9.5, 3.0 Hz, 1H), 0.12 (9H); 13C NMR (75 
MHz, CDCl3): δ 148.3, 146.2, 132.8, 132.1, 123.7, 112.0, 68.0, 67.1, 64.6, 34.0, 29.0, 28.4, 26.3, 
25.7, 17.7, -0.2 (3C); IR (thin film): 3384, 2925, 1609, 1248 cm-1; EI-MS m/z (%) 306 (60, M+˙), 
237 (46), 179 (55), 129 (100); EI-HRMS calcd for C18H30O2Si: m/z (M+˙) 306.2015; found: 
306.2009. 
E-161
HO
TMS
257
TMS
HO OO
 
(5E,7E)-2-Hydroxy-7,11-dimethyl-5-((trimethylsilyl)methylene)-6-oxododeca-7,10-dienal 
(257).  A 5-mL, single-necked, round-bottomed flask equipped with a stir bar, rubber septum, 
and nitrogen line is charged with VO(acac)2 (1 mg, 1 μmol) and benzene (0.2 mL).  A solution of 
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allylic alcohol E-161 (26 mg, 0.09 mmol) in benzene (0.2 mL) is added to the flask via cannula.  
The green solution is heated to 40 °C in an oil bath for 5 min before t-butyl hydrogen peroxide 
(21 μL of a 5.0–6.0 M decane soln, ~0.11 mmol) is added dropwise with a gas tight syringe.  
Upon addition of the peroxide, the reaction mixture flashes deep red and becomes orange.  After 
1 h of stirring at 40 °C (oil bath temperature), the reaction does not proceed any longer as 
observed by TLC, and is cooled to rt.  The reaction mixture is directly applied to silica gel 
eluting with 5-30% Et2O/pentane to afford allylic ketone 257 (8 mg, 28%, 34% brsm) as a light 
yellow oil.  Rƒ 0.4 (20% EtOAc/hexanes); 1H NMR (500 MHz, CDCl3): δ 9.23 (d, J = 2.0 Hz, 
1H), 5.42 (t, J = 2.5 Hz, 1H), 5.17 (tq, J = 7.0, 1.0 Hz, 1H), 5.11 (tt, J = 7.0, 1.0 Hz, 1H), 4.19 
(tdd, J = 9.0, 6.0, 2.0 Hz, 1H), 3.68 (d, J = 9.5 Hz, 1H), 2.81 (t, J = 7.0 Hz, 2H), 2.62 (ddt, J = 
17.5, 9.0, 2.5 Hz, 1H), 2.31 (dddd, J = 17.5, 11.0, 8.5, 2.5 Hz, 1H), 2.09 (dddd, J = 12.0, 9.0, 6.0, 
3.0 Hz, 1H), 1.84-1.76 (m, 1H), 1.71 (s, 3H), 1.64 (s, 3H), 1.57 (s, 3H), 0.14 (s, 9H);  13C NMR 
(125 MHz, CDCl3): δ 202.4, 202.3, 154.1, 149.3, 131.8, 131.3, 130.3, 122.1, 72.2, 31.8, 30.0, 
27.6, 25.7, 17.8, 13.2, -0.5 (3C);  IR (thin film): 3444, 2956, 1705, 1611. 
E-161
HO
TMS
259
HO
TMS
O  
(4E)-3-((E)-4-(3,3-Dimethyloxiran-2-yl)but-2-en-2-yl)-((trimethylsilyl)methylene)cyclohex-
2-enol (259).  A 5-mL, single-necked, round-bottomed flask equipped with a stir bar, rubber 
septum, and nitrogen line is charged with allylic alcohol E-161 (15 mg, 0.05 mmol), CH2Cl2 (0.6 
mL) and NaHCO3 (11 mg, 0.13 mmol).  The mixture is cooled to 0 °C in an ice bath and m-
CPBA (77%, 15 mg, 0.07 mmol) is added in one portion. The reaction is slowly warmed to rt.  
After 2.5 h the reaction does not proceed further by TLC and additional amounts of NaHCO3 (4 
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mg, 0.1 mmol) and m-CPBA (77%, 6 mg, 0.03 mmol) are sequentially added. The reaction 
mixture is transferred to a separatory funnel containing sat’d aq Na2SO3 and Et2O. The aq layer 
is separated and extracted with Et2O.  The combined organic layers are washed with sat’d aq 
NaHCO3 (3X), H2O (3X), and brine (3X), and are dried on MgSO4.  The solids are filtered off 
via gravity filtration and the filtrate is concentrated under reduced pressure by rotary 
evaporation. The resulting residue is purified on silica gel eluting with 5-50% Et2O/pentane to 
afford 5 mg of epoxide 259 in 32% yield, 36% brsm as a 1.2:1 mixture of diastereomers (based 
upon integration of the resonances at 66.4 ppm and 63.3 ppm in the 13C NMR). Rƒ 0.2 (20% 
EtOAc/hexanes); 1H NMR (500 MHz, CDCl3): δ 5.66 (d, J = 3.0 Hz, 1H), 5.41 (s, 1H), 5.37 (tq, 
J = 7.5, 1.5 Hz, 1H), 4.35 (s, 1H), 2.80 (t, J = 6.5 Hz, 1H), 2.57 (ddd, J = 14.5, 8.0, 4.0 Hz, 1H), 
2.48 (dt, J = 14.5, 6.5 Hz, 1H), 2.36 (ddd, J = 13.5, 11.0, 3.5 Hz, 1H), 2.23 (dt, J = 14.5, 7.5 Hz, 
1H), 2.03 (ddt, J = 16.5, 8.0, 4.0 Hz, 1H), 1.75 (s, 3H), 1.70 (dddd, J = 16.5, 12.5, 6.5, 3.5 Hz, 
1H), 1.34 (s, 3H), 1.32 (s, 3H), 0.13 (s, 9H); 13C NMR (75 MHz, CDCl3): *designates minor 
diastereomer where resolved: δ 149.3, 147.6, 138.0*, 137.9, 128.3*, 128.2, 127.3*, 127.2, 123.6, 
66.4, 66.3*, 63.5, 58.3, 33.0*, 32.9, 28.3, 28.0*, 27.9, 24.9, 18.7, 17.4, 0.1 (3C); IR (thin film): 
3423, 2923, 1579, 1248 cm-1; EI-MS m/z (%) 306 (17, M+˙), 263 (36), 233 (29), 73 (100); EI- 
HRMS calcd for C18H30O2Si: m/z (M+˙) 306.2015; found: 306.2029. 
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HO
TMS
HO
TMS
O
Os
O
N N
OO
261
 
(4E)-((Trimethylsilyl)methylene)-2-cyclohexenol-3-((E)-5,6-N’,N’,N’’,N’’-tetramethyl- 
ethylene-diamine)osmate ester (261).  A 15-mL, single-necked, round-bottomed flask equipped 
with a stir bar, rubber septum, and nitrogen line is charged with allylic alcohol E-161 (22 mg, 
0.08 mmol), CH2Cl2 (7.6 mL) and freshly distilled TMEDA (12 μL, 0.08 mmol).  The mixture is 
cooled to –78 °C in a dry ice-acetone bath and OsO4 (203 μL of a 0.39 M CH2Cl2 soln, 0.08 
mmol) is added dropwise. Upon addition of OsO4, the reaction turns orange and then brown in 
color.  After 1 h at –78 °C, the reaction is warmed to rt and is stirred overnight.  After 24 h, the 
reaction is concentrated under reduced pressure. The residue is purified by silica gel 
chromatography eluting with 20-100% acetone/EtOAc to yield 18 mg of osmate ester 261 in 
36% yield, 47% brsm. Rƒ 0.2 (50% acetone/EtOAc); 1H NMR (500 MHz, CDCl3): δ 5.65 (d, J = 
3.0 Hz, 1H), 5.56-5.51 (m, 1H), 5.46 (s, 1H), 4.35-4.29 (m, 1H), 4.01 (td, J = 7.5, 1.0 Hz, 1H), 
3.06 (s, 4H), 2.85 (s, 3H), 2.83 (s, 3H), 2.82 (s, 3H), 2.81 (s, 3H), 2.62-2.50 (m, 3H), 2.35 (dddt, 
J = 14.5, 9.5, 3.0, 1.0 Hz, 1H), 2.01 (ddt, J = 13.0, 8.0, 4.0 Hz, 1H), 1.93 (bs, 1H), 1.76 (s, 3H), 
1.69 (dddd, J = 13.0, 9.5, 6.5, 3.5 Hz, 1H), 1.5 (s, 3H), 1.23 (d, J = 0.5 Hz, 3H), 0.12 (s, 9H);   
13C NMR (75 MHz, CDCl3): δ 149.5, 148.2, 135.5, 127.9, 127.3, 127.0, 96.2, 87.0, 66.4, 64.3, 
63.9, 51.6, 51.3, 51.2, 51.1, 32.9, 31.7, 28.0, 26.6, 21.4, 17.5, 0.1 (3C); IR (thin film): 3384, 
2926, 1577, 1459 cm-1;  ESI-MS m/z (%) 685 (100, [M+Na]+), 663 (30), 569 (76), 427 (3); ESI- 
HRMS calcd for C24H46N2O5NaOsSi: m/z [M+Na]+ 685.2689; found: 685.2665. 
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E-161 264
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(E)-3-(6-Methylhepta-2,5-dien-2-yl)-4-((trimethylsilyl)methyl)cyclcohex-2-enol (264).  A 5-
mL, single-necked, round-bottomed flask equipped with a stir bar, rubber septum, and nitrogen 
line is charged with triphenylphosphine (41 mg, 0.15 mmol) and N-methyl morpholine (0.1 mL).  
The flask is cooled to –30 °C for before diethyl azodicarboxylate (24 μL, 0.15 mmol) is added 
via gas tight syringe. After 5 min of stirring a solution of allylic alcohol E-161 (15 mg, 0.05 
mmol) in N-methyl morpholine (0.1 mL) is added via cannula.  The reaction is stirred for 10 min 
before o-nitrobenzenesulfonylhydrazide (NBSH) is added.  After 2 h at –30 °C, TLC analysis 
shows no change. The reaction is warmed to rt and is stirred overnight.  The reaction is then 
diluted with Et2O and is transferred to a separatory funnel containing sat’d aq NaHCO3 and Et2O.  
The aq layer is separated and extracted with Et2O (3X).  The combined organic layers are 
washed with H2O (3X) and brine (3X), and are dried on Na2SO4.  The solids are filtered off via 
gravity filtration and the filtrate is concentrated under reduced pressure by rotary evaporation. 
The residue is purified by silica gel chromatography eluting with 5-20% Et2O/pentane to yield 
7.5 mg of 264 in 50% yield. Based upon the integration of the resonances at 0.61 ppm and 0.50 
ppm in the 1H NMR, 264 was produced as a 1.3:1.0 mixture of diastereomers.  Rƒ 0.3 (20% 
EtOAc/hexane); 1H NMR (300 MHz, CDCl3) *designates minor diastereomer where resolved: δ 
5.65 (d, J = 4.2 Hz, 1H), 5.58* (d, J = 3.0 Hz, 1H), 5.43 (tq, J = 7.2, 1.2 Hz, 1H), 5.14 (tt, J = 
7.2, 1.2 Hz, 1H), 4.28* (s, 1H), 4.21 (s, 1H), 2.08 (t, J = 7.2 Hz, 2H), 2.64-2.50 (m, 1H), 1.97-
1.81 (m, 3H), 1.75 (s, 3H), 1.71 (s, 3H), 1.65 (s, 3H), 1.63-1.55 (m, 1H), 0.79 (dd, J = 15.0, 1.2 
Hz, 1H), 0.73* (dd, J = 15.3, 2.1 Hz, 1H), 0.61* (dd, J = 15.3, 11.7 Hz, 1H), 0.50 (dd, J = 15.0, 
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11.7 Hz, 1H), 0.03 (s, 9H);   13C NMR (75 MHz, CDCl3) *designates minor diastereomer where 
resolved: δ 149.9, 149.1*, 134.1, 133.6*, 132.0, 126.6, 126.3*, 124.1, 122.7*, 122.6, 67.9*, 65.4, 
30.2, 29.8*, 28.0*, 27.9, 27.5, 27.0*, 25.6, 25.1, 21.5*, 20.6, 17.7, 14.9, 14.8*, -0.6 (3C), -0.7* 
(3C); IR (thin film): 3320, 2949, 1448, 1247 cm-1;  EI-MS m/z (%) 292 (49, M+˙), 223 (37), 109 
(67), 73 (100); EI-HRMS calcd for C18H32OSi: m/z (M+˙) 292.2222; found: 292.2219. 
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